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 Hospital-based palliative care services aim to streamline medical care for patients with 
chronic and potentially life-limiting illnesses by focusing on individual patient needs, efficient 
use of hospital resources, and providing guidance for patients, patients’ families and clinical 
providers toward making optimal decisions concerning a patient’s care. This study examined the 
nature of palliative care provision in U.S. hospitals and its impact on selected organizational and 
patient outcomes, including hospital costs, length of stay, in-hospital mortality, and transfer to 
hospice. Hospital costs and length of stay are viewed as important economic indicators. 
Specifically, lower hospital costs may increase a hospital’s profit margin and shorter lengths of 
stay can enable patient turnover and efficiency of care. Higher rates of hospice transfers and 
lower in-hospital mortality may be considered positive outcomes from a patient perspective, as 
the majority of patients prefer to die at home or outside of the hospital setting. 
Abstract 
xvii 
 
 
 Several data sources were utilized to obtain information about patient, hospital, and 
county characteristics; patterns of hospitals’ palliative care provision; and patients’ hospital 
costs, length of stay, in-hospital mortality, and transfer to hospice (if a patient survived 
hospitalization). The study sample consisted of 3,763,339 patients; 348 urban, general, short-
term, acute care, non-federal hospitals; and 111 counties located in six states over a 5-year study 
(2007-2011). Hospital-based palliative care provision was measured by the presence of three 
palliative care services, including inpatient palliative care consultation services (PAL), inpatient 
palliative care units (IPAL), and hospice programs (HOSPC). Derived from Institutional Theory, 
Resource Dependence Theory, and Donabedian’s Structure Process-Outcome framework, 13 
hypotheses were tested using a hierarchical (generalized) linear modeling approach.  
 The study findings suggested that hospital size was associated with a higher probability 
of hospital-based palliative care provision. Conversely, the presence of palliative care services 
through a hospital’s health system, network, or joint venture was associated with a lower 
probability of hospital-based palliative care provision. The study findings also indicated that 
hospitals with an IPAL or HOSPC incurred lower hospital costs, whereas hospitals with PAL 
incurred higher hospital costs. The presence of PAL, IPAL, and HOSPC was generally 
associated with a lower probability of in-hospital mortality and transfer to hospice. Finally, the 
effects of hospital-based palliative care services on length of stay were mixed, and further 
research is needed to understand this relationship.  
 
 1 
 
 This chapter is divided into six sections. The first two sections summarize the study 
problem and research questions examined in this study. The third section provides an overview 
of the theoretical framework used to address the research questions, followed by a description of 
the analytical approach applied to test the study hypotheses. The significance of the study is 
highlighted in the fifth section. The chapter concludes with a summary of the remaining chapters.  
The Study Problem 
The chronically ill population with serious, potentially life-limiting diseases has been 
growing rapidly over the last two decades. In 2010, seven of the top ten leading causes of death 
in the United States were chronic diseases, with cancer and heart disease accounting for almost 
50% of all deaths (Murphy, Xu, & Kochanek, 2013). While 37% of U.S. adults had at least one 
chronic illness in 1987, this number rose to about 60% in 2005 (Hoffman, Rice, & Sung, 1996; 
Machlin, Cohen, & Beauregard, 2008). This percentage is significantly higher for older adults, 
with the fraction ranging from 36.4% of persons aged between 18 and 34 to 91.5% of adults aged 
65 and over (Machlin et al., 2008). These numbers are alarming considering the aging U.S. 
population. According to the Administration on Aging (AoA), Americans aged 65 and over 
constituted 13.3% of the overall population in 2011 (Administration on Aging, n.d.). This 
percentage is expected to increase to 21% in 2040. Similarly, the 85+ population is projected to 
nearly triple between 2011 and 2040, from 5.7 million in 2011 to a projected 14.1 million in 
2040. With a population that currently has a life expectancy of 78.7 years, the U.S. health care 
Chapter 1: Introduction 
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system must prepare to serve an aging population that lives longer but most likely with serious, 
chronic illnesses or conditions that require long-term, often costly specialized care (Center to 
Advance Palliative Care, 2008).  
One service explicitly tailored toward caring for individuals with serious, chronic, and 
potentially life-limiting illnesses is palliative care. Palliative care has the potential to help 
clinicians address the needs of such patients and generate cost savings. This study’s focus is on 
exploring the associations between hospital and environmental factors and the provision of 
hospital-based palliative care services and on examining how hospital-based palliative care 
services and hospitals’ experience in providing such services are associated with hospital costs, 
hospital length of stay, in-hospital mortality, and care transition to hospice. 
Palliative care is a specialized, interdisciplinary, and holistic approach to medical care 
tailored toward patients with a serious, chronic and/or worsening illness. This type of care 
emphasizes the identification, prevention, assessment, alleviation, and management of suffering 
caused by a life-limiting disease or condition (Adolph, Frier, Stawicki, Gerlach, & Papadimos, 
2011). Suffering can include physical pain and symptoms or other psychological, psychosocial, 
emotional, and spiritual distress (White & Coyne, 2011). Palliative care is typically provided by 
an interdisciplinary health care team, including specialist physicians, nurses, social workers, and 
chaplains, who focus on the complex needs of patients and their families with the goal to 
optimize quality of life across the continuum of a patient’s disease (National Quality Forum, 
2011; World Health Organization, 2016). This type of care is appropriate at any age or stage of 
illness and can be provided along with life-prolonging or curative treatments.  
The hospice and palliative care movement is rooted in Europe, where Dame Cicely 
Saunders first started to raise awareness of inadequate pain and symptom management at the end 
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of life and advocate for better care for terminally-ill patients in the mid-20th century. Her efforts 
to establish the first modern hospice in 1967 in London is considered a vital milestone in the 
history of palliative care. Seven years later, the first U.S. hospice was founded in Connecticut 
preceded by rigorous collaborative efforts of Dame Cicely Saunders and hospice and palliative 
care advocates in the United States. However, it was not until the early to mid-1980s that U.S. 
policy makers began taking tangible action to facilitate access to palliative care for individuals at 
the end of life, including the establishment of the Medicare Hospice Benefit in 1983. During that 
time, hospice and palliative care was primarily considered most appropriate for terminal patients 
subsequent to curative treatment. But over the succeeding decades, this type of care started to be 
acknowledged as a fundamental part of medical care for all patients suffering from a serious and 
life-limiting illness.  
While palliative care is provided in a variety of health care settings (e.g., long-term care 
facilities, hospitals, hospice, at home), the hospital setting remains a central source of end-of-life 
or palliative care for a large proportion of seriously ill patients. That is, while most patients with 
serious illnesses prefer to die at home, almost one in three Medicare beneficiaries with a cancer 
diagnosis or a chronic disease died in the hospital in 2007 (Goodman, Esty, Fisher, & Chang, 
2011). The importance of hospital-based palliative care has been recognized since the late 1980s 
when concerns about patients’ extended periods of suffering before death first started to take 
shape. A substantial misalignment between patient preferences and actual care provided at the 
end of life was first demonstrated in the mid-1990s, when the Study to Understand Prognoses 
and Preferences for Outcomes and Risks of Treatment (SUPPORT) documented a lack of 
communication about end-of-life preferences between physicians and their patients. The two-
year observational study of 4,301 patients revealed that 47% of physicians were unaware of their 
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patients’ preference to withhold cardiopulmonary resuscitation (CPR). Further, according to 
family members, 50% of patients who died in the hospital experienced moderate to severe pain at 
least 50% of the time during their last three days of life (The SUPPORT Principal Investigators, 
1995). The second phase of the study was a two-year controlled clinical trial with 4,804 patients 
designed to improve end-of-life decision-making by facilitating information sharing between 
patients and their physicians. The results of this study phase revealed that patient preferences for 
end-of-life care did not have a significant effect on care processes, costs, or patient outcomes. A 
follow-up study showed that almost 82% of patients who had expressed a preference for dying at 
home, in fact, died in the hospital (Pritchard et al., 2008). In 1997, the Institute of Medicine 
(IOM) published its report “Approaching death: Improving care at the end-of-life,” in which the 
need for action to improve care at the end of life was stressed (Institute of Medicine, 1997).  
Since the turn of the 21st century, palliative care has been one of the fastest growing 
health care trends in the United States. The number of inpatient palliative care consultation 
services in hospitals increased from 24.5% in 2000 to 65.7% of hospitals with at least 50 beds in 
2010 (Center to Advance Palliative Care, 2012). These numbers include inpatient palliative care 
consultation services provided by the hospital, health system, network, or a joint venture within 
the local community. Moreover, various palliative care initiatives, such as the National 
Consensus Project for Quality Palliative Care (NCP), the Center to Advance Palliative Care 
(CAPC), and the National Hospice and Palliative Care Organization (NHPCO) have been 
established, which focus on increasing the quality and availability of palliative care for 
individuals with serious, life-limiting health conditions.  
As quality of life for critically ill patients has received greater attention and palliative 
care options have expanded, some research suggests that patients’ preferences and end-of-life 
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care have become more closely aligned (Cosgriff, Pisani, Bradley, O'Leary, & Fried, 2007; 
Wright et al., 2010). Numerous studies conducted in critical care settings have identified 
successful palliative care interventions with significant improvements in quality of care through 
the reduction of ineffective curative treatments when death is inevitable (Mosenthal et al., 2012). 
Untreated suffering has been shown to be associated with low patient and family satisfaction, 
amplified symptoms of post-traumatic stress disorder (PTSD) among family members, extended 
time in the intensive care unit (ICU) without observable patient benefits, decreased quality of 
life, and increased risk of mortality (Adolph, 2011; Andersson, 2009; Katz, 2002). Palliative care 
consultations have been found to improve symptoms of ICU cancer patients, such as pain, 
fatigue, nausea, constipation, dyspnea, sleep, depression, loss of appetite, drowsiness, and 
anxiety (Delgado-Guay, Parsons, Li, Palmer, & Bruera, 2009). Another study revealed that 
symptoms of PTSD, anxiety, and depression among family members of ICU patients were 
significantly improved following the implementation of a palliative care communication 
conference and bereavement brochure (Lautrette et al., 2007).  
Hospital-based palliative care services aim to streamline patient care at the end of life 
with a specific focus on individual patient needs and efficient use of hospital resources. Access 
to palliative care in the hospital setting has the potential to guide patients, patients’ families and 
clinical providers toward making optimal decisions concerning a patient’s care, such as timely 
transitioning to other health care settings if appropriate. Avoiding prolonged hospital stays may 
be more in line with patients’ preferences for end-of-life care and may reduce the cost of patient 
care if medically unnecessary. The proposed study thus aims to explore the nature of palliative 
care provision in the hospital setting and the capability of palliative care services to facilitate 
care transitions to hospice, shorten length of stay, and reduce hospital costs and risk of mortality.  
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Research Questions 
 This research study has two main objectives. The first is to evaluate organizational and 
environmental factors associated with the likelihood of providing palliative care services among 
urban, non-federal, short-term, and acute care hospitals in the United States. The second 
objective is to examine potential associations between hospital-based palliative care services and 
subsequent organizational and patient outcomes in urban, non-federal, short-term, and acute care 
hospitals for patients who are most likely to benefit from and utilize palliative care services. The 
outcomes of interest are hospital costs per patient, hospital length of stay per patient, in-hospital 
mortality, and care transition to hospice. The following research questions are examined to 
explore the nature of hospital-based palliative care services and the association of hospital-based 
palliative care services with organizational and patient outcomes. 
1) Which organizational and environmental forces are associated with the provision of 
hospital-based palliative care services? 
2) Do hospitals that provide palliative care services have improved organizational and 
patient outcomes compared to those not providing such services?  
3) Is a hospital’s experience in providing palliative care services associated with improved 
organizational and patient outcomes? 
Theoretical Framework 
The underlying theoretical framework for this study is based on organizational theories 
and frameworks that have been used by other health services researchers to explain the nature of 
hospital service adoption and how such adoption potentially influences hospital performance. 
Five propositions and hypotheses that correspond to research question one are derived from 
Resource Dependence Theory (Pfeffer & Salancik, 1978) and Institutional Theory (DiMaggio & 
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Powell, 1983; Meyer & Rowan, 1977). Donabedian’s Structure-Process-Outcome (SPO) 
framework for quality assessment (Donabedian, 1980) is applied to derive one proposition and 
four hypotheses corresponding to research questions two and three, respectively. Besides the key 
explanatory variables to test the study’s 13 hypotheses, additional patient, hospital, and country 
control variables are included to account for factors potentially affecting the association between 
the key explanatory variables and the dependent variables.  
Analytical Approach 
To test the study’s hypotheses, longitudinal data between 2007 and 2011 from six states, 
namely Arizona, California, Florida, Maryland, New Jersey, and New York are used. This study 
utilizes data from the following databases: Healthcare Cost and Utilization Project (HCUP) state 
inpatient databases, American Hospital Association (AHA) Annual Survey of Hospitals, Area 
Health Resources Files (AHRF), the Centers for Medicare & Medicaid Services (CMS) 
Healthcare Cost Report Information System (HCRIS), the HealthLeader-Interstudy databases, 
and the website of the American Nurses Credentialing Center (ANCC). A two-level hierarchical 
generalized linear model (HGLM) is used to analyze the proposed hypotheses under research 
question one, where hospitals are nested within markets (i.e., counties). Four three-level HGLM 
and hierarchical linear models (HLM) are employed to test the proposed hypotheses under 
research questions two and three, with patients nested within hospitals nested within markets.  
Significance of the Study 
This study is significant for several reasons. First, the U.S. health care system serves an 
aging population with increasing life expectancy and serious chronic or terminal illnesses that 
require specialized care (Center to Advance Palliative Care, 2008). Palliative care services are 
uniquely equipped to care for this type of patient population.  
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Second, hospital settings remain the primary source of palliative care for the majority of 
seriously ill patients. Thus, it is important to gain a broader understanding of the nature and 
effects of hospital-based palliative care.  
Third, palliative care may play a significant role in implementing goals articulated by the 
Affordable Care Act (2010). Specifically, Fletcher and Panke (2012) reviewed the opportunities 
and challenges of palliative care in light of the Affordable Care Act and highlighted that 
palliative care may be the answer to rising healthcare costs and deficiencies in quality of care. 
The authors concluded with a call for evidence-based research efforts linking palliative care to 
improvement in quality of care and cost reduction. Despite the increased prevalence of hospital-
based palliative care services, the necessity to improve care for patients with serious medical 
conditions remains (Weissmann & Meier, 2011). Existing studies primarily focus on evaluating 
the effects of palliative care provision on patient and organizational outcomes in single hospitals 
or a small number of hospitals within a hospital system. However, these effects are potentially 
hospital- or hospital system-specific and may therefore not be generalizable to all U.S. hospitals. 
An examination of palliative care services in a larger set of hospitals, as conducted in this study, 
may provide the basis for more generalizable conclusions regarding the impact of palliative care 
services on selected patient and organizational outcomes.  
Summary of Remaining Chapters 
This manuscript is divided into six chapters. This chapter introduced the study’s thematic 
focus; defined the study problem, research questions, significance of this study; and summarized 
the theoretical framework and the analytical methodology applied in this study.  
Chapter 2 provides detailed background information and reviews relevant literature 
related to the study’s research questions. Chapter 3 describes the Structure-Process-Outcome 
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framework, Institutional Theory, and Resource Dependence Theory to derive seven propositions 
and the corresponding 13 testable hypotheses. A detailed description of the study’s data, 
methodology, research design, and empirical implementation is provided in Chapter 4. Chapter 5 
summarizes the study findings, including descriptive statistics, regression models, and 
supplemental sensitivity analyses. Finally, Chapter 6 discusses and reflects on the study’s 
findings with regard to the propositions and hypotheses and closes with outlining the study’s 
limitations and implications for theory, health care policy, and practice.  
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 This chapter is divided into eight sections. The first section sets the stage by defining 
palliative care and related concepts. The second section outlines the evolution of palliative care 
in the U.S. health care system, including the historical development of conceptual models of 
palliative care. The third and fourth sections present the major delivery models of palliative care 
and their diffusion across hospitals nationwide and in the study sample. The fifth section 
discusses the study’s dependent variables and why they are important from a hospital 
performance perspective. The sixth and seventh sections illustrate how studies have empirically 
explored the provision of hospital-based palliative care and hospital performance in regard to the 
study’s selected organizational and patient outcomes. The last section concludes this chapter by 
summarizing the potential contribution of this study to the current literature exploring similar 
research questions.  
Defining Palliative Care  
Several terminologies exist to describe palliative care and related concepts, such as end-
of-life care, palliative care, and hospice care. Recognizing their differences and commonalities is 
necessary to understand the evolution, nature, and goals of palliative care. The term “hospice” 
originates from the Latin word for hospitality (i.e., hospitium); the term “palliative” is derived 
from the Latin word for cloaked or covered (i.e., palliativus) and refers to the act of “relieving 
pain or alleviating a problem without dealing with the underlying cause” (Oxford Dictionaries, 
2015). While palliative care is appropriate for seriously ill patients at the time of diagnosis and 
Chapter 2: Literature Review 
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concurrent with curative treatment, hospice care typically starts after or independent of life-
prolonging treatments and when the patient is not expected to live longer than six months. 
Consequently, hospice care may be viewed as a specific subset of palliative care, which is 
provided at the end of life when death is inevitable. Finally, end-of-life (EOL) care is often used 
as a synonym for palliative care despite its deceptive and limited view of palliative care. Rather, 
EOL care is more closely aligned with hospice care, as it focuses on providing care to patients 
with terminal diagnoses. Several leading health care initiatives have developed definitions of 
palliative care. Table 1 provides an overview of these definitions.  
Table 1 
1Organizational Definitions of Palliative Care 
Organization Definition 
WHO 
Palliative care is an approach that improves the quality of life of patients and 
their families facing the problem associated with life-threatening illness, 
through the prevention and relief of suffering by means of early identification 
and impeccable assessment and treatment of pain and other problems, physical, 
psychosocial and spiritual. (WHO, 2016) 
NQF 
Palliative care refers to patient- and family-centered care that optimizes quality 
of life by anticipating, preventing, and treating suffering. Palliative care 
throughout the continuum of illness involves addressing physical, intellectual, 
emotional, social, and spiritual needs and facilitating patient autonomy, access 
to information, and choice. (NQF, 2006) 
CAPC 
Palliative care, also known as palliative medicine, is specialized medical care 
for people living with serious illness. It focuses on providing relief from the 
symptoms and stress of a serious illness – whatever the diagnosis. The goal is 
to improve quality of life for both the patient and the family. (CAPC, n.d.) 
NCP 
The goal of palliative care is to prevent and relieve suffering and to support the 
best possible quality of life for patients and their families, regardless of the 
stage of the disease or the need for other therapies. Palliative care is both a 
philosophy of care and an organized, highly structured system for delivering 
care. Palliative care expands traditional disease-model medical treatments to 
include the goals of enhancing quality of life for patient and family, optimizing 
function, helping with decision making, and providing opportunities for 
personal growth. As such, it can be delivered concurrently with life-prolonging 
care or as the main focus of care. (NCP, 2013) 
 
Note. CAPC=Center to Advance Palliative Care. NCP=National Consensus Project for Quality Palliative Care. 
NQF=National Quality Forum. WHO=World Health Organization. 
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The NQF’s definition is among the most widely used description of palliative care in the 
United States. Both the National Hospice and Palliative Care Organization (NHPCO) and the 
Centers for Medicare and Medicaid Services (CMS) officially refer to this definition in the 
context of palliative care. There are several notable commonalities between the definitions 
presented in Table 1, including the focus on quality of life, relief of disease-related suffering, and 
care that is centered on the patient and their families. Several definitions mention the multi-
dimensionality of palliative care, including addressing physical, psychological, social, and 
spiritual needs of patients and their families.  
In 2004, the NCP developed a set of eight domains covering the full spectrum of 
palliative care services. Each domain is associated with guidelines, which outline best palliative 
care practices, as presented in Table 2.  
A review of the guidelines in Table 2 illustrates that high-quality palliative care should be 
provided by an interdisciplinary team that carefully assesses and manages various aspects of 
patients’ and families’ needs from the time of diagnosis to bereavement support after the 
patient’s death. The domains and corresponding guidelines also highlight the importance of care-
that emphasizes quality of life and is based on goals of care that reflect patients’ and families’ 
preferences and values. To assure that patients’ and families’ needs are met, palliative care draws 
from the expertise of a wide spectrum of clinical specialists, including physicians, nurses, 
chaplains, social workers, psychologists, and other disciplines. Finally, palliative care 
distinguishes itself from other types of medical care by not only attending to medical needs (i.e., 
pain and symptom management), but also addressing other aspects of life affected by the 
patient’s illness, including bereavement support for family members after the patient’s death. 
  
1
3
 
Table 2 
2Palliative Care Domains and Corresponding Guidelines 
Table 2 (continued) 
 
Domain Guideline 
1. Structure/Processes 
1. A comprehensive and timely interdisciplinary assessment of patient and family forms the 
basis of the plan of care.  
2. The care plan is based on the identified and expressed preferences, values, goals, and needs 
of the patient and family and is developed with professional guidance and support for 
patient-family decision making. Family is defined by the patient.  
 
3. An interdisciplinary team (IDT) provides services to the patient and family consistent with 
the care plan. In addition to chaplains, nurses, physicians, and social workers, other 
therapeutic disciplines who provide palliative care services to patients and families may 
include: child-life specialists, nursing assistants, nutritionists, occupational therapists, 
recreational therapists, respiratory therapists, pharmacists, physical therapists, massage, art, 
and music therapists, psychologists, and speech and language pathologists.  
 
4. The palliative care program is encouraged to use appropriately trained and supervised 
volunteers to the extent feasible. 
  
5. Support for education, training, and professional development is available to the 
interdisciplinary team.  
 
6. In its commitment to quality assessment and performance improvement, the palliative care 
program develops, implements, and maintains an ongoing data driven process that reflects 
the complexity of the organization and focuses on palliative care outcomes.  
 
7. The palliative care program recognizes the emotional impact of the provision of palliative 
care on the team providing care to patients with serious or life-threatening illnesses and their 
families. 
 
8. Community resources ensure continuity of the highest quality palliative care across the care 
continuum. 
 
9. The physical environment in which care is provided meets the preferences, needs and 
circumstances of the patient and family, to the extent possible. 
 
  
1
4
 
Table 2 (continued) 
 
Domain Guideline 
2. Physical 
1. The interdisciplinary team assesses and manages pain and/or other symptoms and their 
subsequent effects based upon the best available evidence. 
 
2. The assessment and management of symptoms and side effects are contextualized to the 
disease status. 
3. Psychological/Psychiatric 
1. The interdisciplinary team assesses and addresses psychological and psychiatric aspects of 
care based upon the best available evidence to maximize patient and family coping and 
quality of life. 
 
2. A core component of the palliative care program is a grief and bereavement program 
available to patients and families, based on assessment of need. 
4. Social 
1. The interdisciplinary team assesses and addresses the social aspects of care to meet patient-
family needs, promote patient-family goals, and maximize patient-family strengths and 
well-being. 
 
2. A comprehensive, person-centered interdisciplinary assessment (as described in Domain 1, 
Guideline 1.1) identifies the social strengths, needs, and goals of each patient and family.  
5. Spiritual/Religious/Existential 
1. The interdisciplinary team assesses and addresses spiritual, religious, and existential 
dimensions of care. 
 
2. A spiritual assessment process, including a spiritual screening, history questions, and a full 
spiritual assessment as indicated, is performed, The assessment identifies religious or 
spiritual/existential background, preferences, and related beliefs, rituals, and practices of the 
patient and family; as well as symptoms, such as spiritual distress and/or pain, guilt, 
resentment, despair, and hopelessness.  
 
3. The palliative care service facilitates religious, spiritual, and cultural rituals or practices as 
desired by patient and family, especially at and after the time of death. 
6. Cultural 
1. The palliative care program serves each patient, family, and community in a culturally and 
linguistically appropriate manner.  
 
2. The palliative care program strives to enhance its cultural and linguistic competence.  
  
1
5
 
Table 2 (continued) 
 
Domain Guideline 
7. End-of-Life 
1. The interdisciplinary team identifies, communicates, and manages the signs and symptoms 
of patients at the end of life to meet the physical, psychosocial, spiritual, social, and cultural 
needs of patients and families. 
 
2. The interdisciplinary team assesses and, in collaboration with the patient and family, 
develops, documents, and implements a care plan to address preventative and immediate 
treatment of actual or potential symptoms, patient and family preferences for site of care, 
attendance of family and/or community members at the bedside, and desire for other 
treatments and procedures.  
 
3. Respectful postdeath care is delivered in a respectful manner that honors the patient and 
family culture and religious practices.  
 
4. An immediate bereavement plan is activated postdeath.  
8. Ethical/Legal 
1. The patient or surrogate’s goals, preferences, and choices are respected within the limits of 
applicable state and federal law, current accepted standards of medical care, and 
professional standards of practice. Person-centered goals, preferences, and choices form the 
basis for the plan of care.  
 
2. The palliative care program identifies, acknowledges, and addresses the complex ethical 
issues arising in the care of people with serious or life-threatening illness. 
 
3. The provision of palliative care occurs in accordance with professional, state and federal 
laws, regulations and current accepted standards of care. 
 
Note. Adapted from “National Consensus Project for Quality Palliative Care. C. Dahlin, Ed. Clinical Practice Guidelines for Quality Palliative Care. 3rd ed. 
Pittsburgh, PA: National Consensus Project for Quality Palliative Care; 2013.” Copyright 2013 by the National Consensus Project for Quality Palliative Care. 
Adapted with permission.
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Evolution of Palliative Care 
The evolution of palliative care in the U.S. healthcare system was highly influenced by 
historical changes in defining and conceptualizing the role of death and dying. This can be 
illustrated by the changing role of curative treatment and palliative care along the continuum of 
care or illness trajectory spanning from the time of diagnosis to death.  
In Western societies, including the United States, changes in perceptions of death and 
dying have been accompanied and influenced by scientific, medical, pharmacological, and 
technological advancements. Until the mid-19th century, there was little medicine could do to 
prolong life or cure diseases. Dying often occurred with minimal medical involvement and was 
largely considered the responsibility of the family, community or religious institutions (Institute 
of Medicine, 1997). In addition, life expectancy was relatively low and most deaths occurred at 
home in the care of family members. While the first U.S. hospitals established in the 18th century 
functioned like hospices to provide care for the sick and dying and shelter for the poor, the 
preferred place of care for the upper and middle class was at home throughout most of the 19th 
century (Starr, 1982).  
As medical practice advanced steadily and industrialization continued to evolve, health 
care became increasingly professionalized and institutionalized. By the early-20th century, 
hospitals had transformed into modern health care facilities with a focus on recovery and cure 
employing professional staff and medical technology and techniques, such as aseptic surgery and 
x-rays (Starr, 1982). In 1946, the Hospital Survey and Construction Act (or Hill-Burton Act), 
initiated considerable hospital growth by providing substantial financial support to expand 
community hospitals in the United States. In addition, the Public Health Service Act of 1944 
shaped medical research in the post-World War II era by providing federal funds that triggered 
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the expansion of the National Institutes of Health (NIH) and facilitated growth of medical 
knowledge and fostered scientific discovery. Scientific breakthroughs, particularly in medicine, 
generated a universal confidence and hopefulness toward medicine’s ability to prolong life and 
conceivably defeat death (Byock, 2014). As more Americans died in institutional settings than in 
their own homes, the role of medicine and medical institutions at the end of life became 
increasingly prominent. The focus of medicine was primarily on curing diseases and postponing 
death in the early to mid-20th century. Death was largely viewed as the inability to cure a disease, 
which commonly led to inattention to patients’ suffering, including pain at the end of life 
(Wheat, 2009). In addition, patients were typically not included in the medical decision-making 
process and little attention was paid to patients’ preferences and values (Byock, 2014).  
Medical advances also led to a steep decrease in infant mortality and a gradual increase in 
life expectancy (Institute of Medicine, 1997). Concerns about how to care for the elderly and 
terminally-ill arose among health care professionals and the public. During the early 1950s, 
Europeans began focusing their attention on end-of-life or hospice care. In particular, the modern 
use of the term hospice can be traced back to England (Clark, 2014). Considered among the most 
important landmarks of the modern hospice and palliative care movement is the establishment of 
the first modern hospice, St. Christopher’s Hospice in 1967 in London, UK, by nurse, medical 
social worker, and physician Dame Cicely Saunders (Wheat, 2009). Saunders is considered one 
of the movement’s pioneers, as she was among the first to identify and focus on the special needs 
of patients at the end of life (Richmond, 2005). The decade preceding the foundation of St. 
Christopher’s played a crucial role in shaping and developing the modern idea of hospice and 
palliative care (Buck, 2011; Clark, 1998).  
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Saunders first discussed the idea of creating a home for the dying with one of her 
terminally-ill patients, a Polish Jewish refugee named David Tasma, during Saunders’s work as a 
medical social worker at Archway Hospital in Northern London in 1948 (Richmond, 2005). 
Hoping to expand her nursing work with terminally-ill patients, she was advised to become a 
physician to better influence the care provided to the dying. She started her medical training at 
St. Thomas Hospital shortly after, followed by a research scholarship to study pain management 
at St. Mary’s Hospital in London (Richmond, 2005). During that time, she also volunteered at St. 
Joseph’s Hospice between 1958 and 1965, a home for the dying poor run by nuns located in 
London, where she used her medical knowledge and research findings to improve quality of care 
(Saunders, 2001). Extensive anecdotal and empirical evidence of the use of pain and symptom 
management were collected at St. Joseph’s Hospice to reveal the inadequacies of care for the 
dying in the British welfare state and raise awareness for the idea of specialized care for the 
dying (Saunders, 2001).  
In 1959, Saunders had prepared a 10-page proposal outlining her concept for a terminal-
care home, which she shared and later refined with support from key constituents in the clinical 
field in Britain and the United States (Clark, 1998; Saunders, 2001). Publishing papers became 
an important and effective medium for disseminating her ideas and connecting with constituents 
around the world (Clark, 1998).  Her first paper in 1957, entitled “Dying of Cancer,” in which 
Saunders discussed many of the elements comprising the core elements of modern idea of 
hospice care, generated affirmative feedback and valuable connections with supporters and 
associates dedicated to her cause. But it took several years to evoke serious interest among 
professionals in the medical field (Clark, 1998).  
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As her professional network grew, Saunders developed an interest in exploring terminal 
care in the United States. She began lecturing about her work and research with terminally-ill 
patients at St. Joseph’s Hospice in medical institutions in the United States in 1963 (Buck, 2011). 
Her approach to medical care was in stark contrast to the then pre-dominant emphasis on using 
medicine to cure diseases, such as cancer, rather than alleviate suffering caused by such diseases 
(Wheat, 2009). Her lectures made a profound impression on Florence Wald, then Dean of the 
School of Nursing at Yale University, who eventually invited her to become a visiting faculty 
member in the school in 1965 (National Hospice and Palliative Care Organization, 2015).  
As awareness of the need for specialized care for terminally-ill patients rose steadily, 
numerous studies demonstrating inadequate pain management and lack of emotional, 
psychosocial, spiritual and psychological support for patients with terminal illnesses and their 
families in the United States were published (Buck, 2011). Specifically, several studies published 
in the 1950s and early 1960s played an important role in shifting the attention to suffering and 
poor care conditions among patients dying of cancer at home and in charitable homes (Clark, 
2014; Saunders, 2001). For example, Elisabeth Kübler-Ross’ book “On Death and Dying” 
published in 1969 became an international bestseller, in which the author introduced the five 
stages of grief based on numerous interviews with dying patients and emphasized the patient’s 
right to participate in the end-of-life decision-making process (National Hospice and Palliative 
Care Organization, 2015).  
While the medical mainstream remained largely reluctant, nursing educators began 
proposing and teaching alternative approaches to care for the dying, including strategies to 
address ethical, spiritual, and emotional issues related to end-of-life care (Buck, 2011). After the 
establishment of St. Christopher’s Hospice in 1967 and sabbatical visits to study that hospice’s 
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care for terminally-ill patients, Wald founded the first modern hospice in North America, the 
Connecticut Hospice in Branford, Connecticut in 1974 (National Hospice and Palliative Care 
Organization, 2015; Saunders, 2001), shortly followed by the establishment of the International 
Work Group in Death, Dying, and Bereavement (IWG) (Buck, 2011).  
In 1978, following a series of meetings of hospice advocates during the prior three years, 
the National Hospice Organization (NHO) was founded. This organization published the first 
Standards of a Hospice Program of Care in the following year (Connor, 2007). Concurrently, 
the IWG published the document Assumptions and Principles Underlying Standards for 
Terminal Care (1979). Both organizations were actively involved in developing and advocating 
for a guiding framework for hospice and palliative care (Buck, 2011).  
National policy makers became increasingly aware of the potential benefits of hospice 
care for the elderly population. The Centers for Medicare and Medicaid Services (CMS), 
formerly known as the Health Care Financing Administration (HCFA), initiated 26 
demonstration programs in hospices nationwide to assess their care delivery models, structure, 
and cost effectiveness in an effort to facilitate a federal reimbursement system for hospice care. 
As a result, the Medicare Hospice Benefit (MHB), established in 1983 and made permanent in 
1985, was included in the Tax Equity and Fiscal Responsibility Act (TEFRA) of 1982 to cover 
end-of-life services to eligible individuals aged 65 and older. During this time, The Joint 
Commission (TJC), formerly known as the Joint Commission on Accreditation of Healthcare 
Organizations (JCAHO), started developing standards for hospice accreditation. While the 
nursing profession had long accepted and promoted hospice and palliative care for terminal 
patients, the medical profession began to follow suit (Connor, 2007). Although palliative care 
began to be recognized as a critical part of health care delivery, it remained largely separate from 
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curative and life-prolonging therapies. Palliative care was primarily considered end-of-life care 
and thus largely provided through hospice programs to actively dying patients after life-
prolonging or curative treatments had been exhausted, as displayed in Figure 1 (Meier & 
McCormick, 2015).  
 
Figure 1. Paradigm of Medical Care with Hospice Care 
 
Adapted from “Living Well at the End of Life: Adapting Health Care to Serious Chronic Illness in Old Age,” by J. 
Lynn, D. M. Adamson, 2003, RAND Health White Paper WP-137, p. 10. Copyright 2003 by RAND Corporation. 
Adapted with permission. 
 
 The definition and application of palliative care began to broaden in the 1990s, when the 
focus was on the integration of palliative care and curative treatment. The 1995 SUPPORT study 
jump-started this paradigm shift by demonstrating a substantial lack of such integration. 
Specifically, the study revealed that the majority of hospital patients experienced untreated 
physical pain at the end of life, that physicians lacked awareness of patients’ preferences of care 
and that patients’ preferences (when known) did not significantly impact processes of care. 
Additionally, two reports published by the Institute of Medicine (IOM) reports, Approaching 
Death (1997) and Crossing the Quality Chasm (2001), emphasized the need to combine the 
traditional model of medical care and palliative care into a comprehensive approach to care 
focused on increasing the quality of life for patients with serious illnesses and regardless of 
disease progression. Sepulveda et al. (2002) suggested that “this change in thinking emerged 
from a new understanding that problems at the end of life have their origins at an earlier time of 
the trajectory of disease” (p. 92)  
Curative Treatment 
Diagnosis CONTINUUM OF CARE Death
HOSPICE
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Palliative care became increasingly recognized as an integral part of high-quality health 
care delivery appropriate and potentially beneficial to patients at the time of diagnosis, not only 
to patients at the end of life through the channel of hospice care. This paradigm shift was evident 
through a variety of developments in health care delivery, practice and research. For example, in 
2000, the NHO changed its name to the National Hospice and Palliative Care Organization 
(NHPCO) in recognition of the need to expand the application of palliative care. Also, the World 
Health Organization’s (WHO) definition of palliative care was considerably modified in 2002. 
The WHO initially regarded palliative care as an approach to care that is focused on pain relief 
and targeted toward cancer patients who do not respond to curative or life-prolonging treatments. 
The updated definition, however, emphasized that palliative care may not be limited to patients 
at the end of life, but instead, may be appropriate and beneficial for all patients with serious or 
life-threatening illnesses and at any stage of the illness trajectory (World Health Organization, 
2002). The new definition broadened its focus to consider the treatment of all disease-related 
symptoms, such as physical, social, psychological, and spiritual needs, and attend to the patient’s 
family members’ well-being and health both during the patient’s illness and after the patient’s 
death by means of bereavement support (Sepulveda et al., 2002).  
In 2001, palliative care leaders met at a conference organized by the Center to Advance 
Palliative Care (CAPC) to discuss the current state of palliative care in the United States, which 
eventually led to the foundation of the National Consensus Project for Quality Palliative Care 
(NCP) (NCP, 2013). The NCP first published its Clinical Guidelines for Quality Palliative Care 
in 2004, which included the core concepts and structures of quality palliative care and eight 
domains of practice, as presented in the previous section. In the 2006 report A National 
Framework and Preferred Practices for Palliative and Hospice Care Quality, the National 
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Quality Forum (NQF) endorsed and included NCP’s clinical guidelines and domains of practice, 
which were used as a foundation to develop a set of preferred practices developed to improve 
palliative care. The guidelines have been updated in 2009 and 2013 to reflect the current state of 
research and practice. The modern paradigm of medical care that recognized the need to 
integrate palliative care early in the illness trajectory is presented in Figure 2.  
 
Figure 2. Paradigm of Medical Care with Palliative Care, Hospice Care, and Bereavement  
 
Adapted from “Living Well at the End of Life: Adapting Health Care to Serious Chronic Illness in Old Age,” by J. 
Lynn, D. M. Adamson, 2003, RAND Health White Paper WP-137, p. 10. Copyright 2003 by RAND Corporation. 
Adapted with permission. 
 
 Recognizing the need to provide access to palliative care to patients regardless of age, 
stage of illness, and health care setting has translated into a wide-variety of quality-improvement 
projects, which are concerned with improving palliative care in hospital settings (e.g., ICUs, 
emergency rooms), in other health care settings (e.g., ambulatory clinics, home health), and for 
certain patient populations (e.g., neonatal/pediatric patients, AIDS/HIV patients). The following 
section defines and describes the different delivery models of palliative care relevant to this 
study’s research focus. 
Delivery Models of Palliative Care 
Palliative care is provided in a range of health care settings, including hospitals, the 
patient’s home (e.g., the patient’s residence, nursing homes, or assisted-living facilities), 
hospices, and ambulatory or outpatient clinics (e.g., physician’s offices, transitional care 
facilities, or cancer centers). In the United States, palliative care is predominately delivered at 
Hospice Bereavement
Curative Treatment 
Diagnosis CONTINUUM OF CARE Death
Palliative Care
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home, in hospices, and in the hospital setting. This study centers on the provision of palliative 
care in the hospital setting.  
There are four major delivery models for hospital-based palliative care, including 
integrative models, inpatient palliative care consultation services, inpatient palliative care units, 
and hospice programs. Integrative models, or primary palliative care, focus on incorporating 
palliative care principles into the daily practices of hospital care (Nelson et al., 2010). The 
primary goal is to educate clinical staff involved in the patient’s routine care on how to address 
basic palliative care needs. Conversely, inpatient palliative care consultation services, inpatient 
palliative care units, and hospice programs may be classified as specialty palliative care provided 
by palliative care experts who are trained to manage patients with complex symptoms, family 
dynamics, and care decisions (Meier, 2011; von Gunten, 2002). 
The diffusion of hospital-based integrative models is difficult to examine due to data 
limitations. The focus of this study is therefore on specialty palliative care, which is described in 
the following paragraphs. 
Inpatient palliative care consultation services. 
Inpatient palliative care consultation services, the prevailing model of palliative care 
delivery in the hospital setting, provide palliative care consultations to patients and families 
within the hospital. Such services typically involve an advanced practice registered nurse 
(APRN) or physician as the primary provider who is trained in palliative care and has access to a 
palliative care-trained interdisciplinary team comprising nurse practitioners, pharmacists, 
psychologists, chaplains, social workers, therapists, and volunteers (Nelson et al., 2010; Wiencek 
& Coyne, 2014). The goal is to provide support to the referring physician to address the needs of 
patients and their families through recommendations relating to pain and symptom management, 
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goals of care, and coordination of care, while the referring physician typically holds the primary 
responsibility for the patient (Meier & McCormick, 2015). The AHA Annual Survey of 
Hospitals defines inpatient palliative care consultation services (also referred to as palliative care 
programs) as “an organized program providing specialized medical care, drugs, or therapies for 
the management of acute or chronic pain and/or the control of symptoms administered by 
specially trained physicians and other clinicians; and supportive care services, such as counseling 
on advanced [sic] directives, spiritual care, and social services, to patients with advanced disease 
and their families.”  
Inpatient palliative care units. 
 Inpatient palliative care units are designated units or clusters of beds where specialized 
medical care with an emphasis on comfort, symptom control, and quality of life is provided. 
Such units distinguish themselves by centralized palliative care expertise, a family-patient-
focused setting, and expert care and support for patients at the end of life and their families 
(Wiencek & Coyne, 2014). Inpatient palliative care units typically care for patients who have 
complex symptoms, are imminently dying, and/or cannot be treated in other hospital settings in 
an optimal manner. These units serve not only these patients but also their family members. The 
referring physician may transfer the patient’s primary care responsibility to the unit’s palliative 
care clinicians or keep it after the patient’s transfer to the unit (Meier & McCormick, 2015). 
Inpatient palliative care units may provide both curative treatment and palliative care, although 
the focus is primarily on comfort care. The AHA Annual Survey of Hospitals defines palliative 
care inpatient units as “a physically discreet, inpatient nursing unit where the focus is palliative 
care. The patient care focus is on symptom relief for complex patients who may be continuing to 
undergo curative treatment. Care is provided by palliative medicine specialists.” 
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Hospice programs. 
 Another form of specialty palliative care includes hospice units and programs, designed 
to care for patients with terminal illnesses and a life expectancy of six months or less who chose 
to forgo life-prolonging treatments. The AHA Survey of Hospitals does not distinguish between 
designated hospice units and hospice consultation services. Instead, it describes hospice 
programs as “a recognized clinical program with specific eligibility criteria that provides 
palliative medical care focused on relief of pain and symptom control and other services that 
address the emotional, social, financial, and spiritual needs of terminally ill patients and their 
families.” 
Diffusion of Palliative Care Delivery Models 
Figure 3 demonstrates the diffusion of palliative care services based on inpatient 
palliative care consultation services (PAL), inpatient palliative care units (IPAL), hospice 
programs (HOSPC) and NONE (i.e., no PAL, IPAL, or HOSPC present) for urban, non-federal, 
short-term, and acute care hospitals nationwide and across the study sample for the time period 
2007-2011. Note that the study sample includes hospitals located in Arizona, California, Florida, 
Maryland, New Jersey, and New York, which were in operation throughout the study period and 
had complete information for the study’s key and control variables (n=348). The national sample 
consisted of all hospitals present in the 2007-2011 AHA Annual Hospital Survey data (n=1,687). 
According to Figure 3, the national sample suggests an increase of palliative care in hospitals 
nationwide, with 54.2% of hospitals having at least one of the three palliative care services in 
place in 2007 compared to 57.9% of hospitals in 2011. Additionally, while the prevalence of 
PAL and IPAL rose between 2007 and 2011, the presence of HOSPC decreased over the study 
period. 
 27 
 
 
Figure 3. Comparison of Hospital-based Palliative Care in National and Study Sample 
 
Note. Categories do not add up to 100% as hospitals may have multiple palliative care services in place. 
IPAL=Inpatient palliative care units. HOSPC=Hospice programs. NONE= no PAL, IPAL, or HOSPC present. 
PAL=Inpatient palliative care consultation services.  
 
This development suggests a gradual shift away from HOSPC toward IPAL and PAL. 
This development may be in part explained by the similarities between these services and by the 
fact that IPAL may provide services to a broader patient population, including hospice patients.  
Although similar patterns are present among the hospitals in the study sample, several 
differences are noteworthy. First, hospitals with PAL in the study sample are more prevalent 
throughout the study period compared to the national sample. While 52.3% and 61.8% of 
hospitals in the study sample had a PAL in place in 2007 and 2011 respectively, 44.7% and 
51.9% of hospitals nationwide had this service in place, respectively. The prevalence of hospitals 
with IPAL is also higher in the study sample throughout the study period compared to the 
prevalence of this service in hospitals nationwide. Among hospitals in the study sample, 15.8% 
and 19% had an IPAL in place in 2007 and 2011, respectively. Among hospitals nationwide, 
45.8% 44.6% 44.0% 43.9% 42.1% 41.4% 39.9% 37.9% 36.8% 34.2%
44.7% 47.1% 49.3% 50.0% 51.9% 52.3% 54.3% 58.6% 59.8% 61.8%
28.0% 27.5% 26.8% 26.7% 25.1% 27.3% 26.4%
24.7% 23.0% 22.7%
12.7% 12.9% 13.5% 13.6% 14.6%
15.8% 16.7% 18.1% 18.1% 19.0%
2007 2008 2009 2010 2011 2007 2008 2009 2010 2011
National Sample
NONE PAL HOSPC IPAL
 28 
 
only 12.7% and 14.6% of hospitals had this service in place in 2007 and 2011, respectively. It 
follows that the study sample has fewer hospitals without any palliative care services (i.e., 
NONE) compared to the national sample throughout the study period. In other words, the study 
sample over-represents hospitals with palliative care services. The study’s sample selection 
approach is described in more detail in Chapter 4.  
Relevance of Key Variables 
 Palliative care services have expanded because of the perceived need for these types of 
services and empirical evidence that they are linked to hospital performance. This study focuses 
on determining the benefits to hospitals and patients, including lower hospital costs, shorter 
hospital stays, lower in-hospital mortality, and higher rates of hospice transfers.  
 From a hospital perspective, providing a service-mix that optimizes both economic 
viability and quality of care is an important management strategy. Specifically, hospital costs and 
hospital length of stay are considered key economic indicators of hospital performance. Whereas 
lower hospital costs may increase hospitals’ profit margins, shorter lengths of stay can facilitate 
patient turnover and care efficiency. From a patient perspective, lower in-hospital mortality and 
higher rates of hospice transfers may be viewed as positive outcomes, as most patients prefer to 
die at home or at least outside of the hospital setting.  
 The following paragraphs discuss in more detail the relevance of hospital costs, hospital 
length of stay, in-hospital mortality, and transfer to hospice in the context of hospital 
performance.  
Dependent variable hospital cost. 
In 2010, 5% of Medicare beneficiaries generated 39% of Medicare spending. These 
“costly” beneficiaries include patients with multiple chronic conditions, who utilize inpatient 
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hospital services, and who are at the end of life. Palliative care programs, particularly those that 
are based in hospitals, target this patient population and are thus uniquely qualified to reduce 
health care spending due to over- or misuse of health care services and inefficient care 
coordination. Prior research has shown that palliative care programs can prevent health care costs 
associated with expensive and preventable hospital services, such as hospital readmissions, 
prolonged ICU stays, emergency department visits, and futile use of hospital resources (Meier, 
2011). In particular, May et al. (2014) systematically reviewed empirical evidence regarding the 
financial impact of hospital-based palliative care and identified consistent savings in hospital 
costs, ranging from 9% to 25%. Morrison et al. (2011) examined the effect of palliative care 
consultations on hospital costs among Medicaid enrollees and found that patients who received a 
palliative care consultation incurred, on average, $6,900 less in hospital costs, spent less time in 
the ICU, were less likely to die in the ICU, and were more likely to receive hospice referrals than 
patients who received usual care.  
Dependent variable length of stay. 
Hospital length of stay (LOS) typically describes the number of days a patient was 
hospitalized in an inpatient facility. Inpatient days are calculated by subtracting the day of 
admission from the day of discharge. In health services research, hospital LOS is a widely used 
indicator of hospital performance. While many factors influence LOS in the hospital (Gruenberg 
et al., 2006), hospital LOS also provides insight into a hospital’s use of resources, and thus may 
function as a proxy for efficiency concerning costs, capacity, and quality of care (Kroch, Duan, 
Silow-Carroll, & Meyer, 2007).  
Hospital LOS is a main determinant of hospital costs; that is, cost efficiency is often 
equated with shorter hospital LOS, holding patient diagnosis and primary treatments constant. 
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Medicare’s inpatient prospective payment system (IPPS), implemented in 1984, and many 
commercial insurers have mechanisms in place to incentivize shorter hospital LOS (Cassel, Kerr, 
Pantilat, & Smith, 2010b). Specifically, under Medicare’s IPPS, hospitals receive a fixed 
payment per patient admission (Feder, Hadley, & Zuckerman, 1987). For each patient admission 
within a given diagnosis-related group (DRG), the hospital payment is based on a historically-
determined average of hospital costs of all patients within that particular DRG (Averill et al., 
2009). While hospitals typically expect to remain in close proximity to the average costs across 
all patients within a given DRG, mechanisms to improve cost efficiency (i.e., to reduce hospital 
LOS) without compromising quality of care are generally in the best interest of a hospital’s 
financial performance.  
Minimizing hospital LOS is also viewed as a central approach to improve a hospital’s 
capacity management and patient flow. Hospitals operating at or close to maximum capacity are 
likely to consider hospital LOS as an essential tool to avoid patient diversion to other hospitals 
(Bazzoli, Brewster, Liu, & Kuo, 2003; Cassel et al., 2010b). If a hospital deviates from its 
optimal capacity due to changes in demand, it is likely to adjust its supply of services to maintain 
economic viability (Bazzoli et al., 2006). A hospital may also consider changing its management 
of patient flow by streamlining the care continuum from admission to discharge of a patient.  
Prior research has also linked quality of care with hospital LOS. However, the 
relationship between hospital LOS and quality of care is complex. It is influenced by a variety of 
factors, including factors related to “organisational culture and hospital bed availability, through 
availability of ‘step down’ or intermediate care services, to the customs and cultures of the local 
populace” (Clarke, 2002, p. 209). In addition, the various dimensions of quality of care 
complicate a simple relational depiction. A widely used measure to capture quality of care in the 
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hospital setting is hospital readmission rates. Hospital readmissions may happen due to 
insufficient planning of discharge, severe illness progression, or inadequate allocation of follow-
up care (Jencks, Williams, & Coleman, 2009). Despite inconclusive findings on the relationship 
between hospital LOS and hospital readmissions, strategies have been employed to reduce 
hospital readmission rates and hospital LOS simultaneously. Accordingly, hospital-based 
palliative care may be a means to avoid unplanned hospital readmissions and reduce hospital 
LOS by offering a systematic approach to determine patient-centered goals of care based on 
diagnosis, prognosis, available treatments, and patient preferences and to facilitate efficient 
patient flow and timely transitions to the most appropriate care settings (Fine, 2004).  
Dependent variable in-hospital mortality. 
Hospital mortality rates have been a widely used indicator of quality of care and patient 
safety among hospitals in the United States. For a given hospital, the hospital mortality rate is 
typically defined as the proportion of patients who die during hospitalization (i.e., in-hospital 
mortality) or shortly after hospital discharge (i.e., 30-day mortality) (Borzecki, Christiansen, 
Chew, Loveland, & Rosen, 2010). These types of hospital mortality rates may be reported for the 
entire patient population (i.e., all-cause hospital mortality) or for patients with specific medical 
conditions (i.e., condition-specific hospital mortality). If variation in hospital mortality is due to 
variation in hospitals’ structural or procedural environments, lower hospital mortality rates may 
indicate higher quality of care (Goodacre, Campbell, & Carter, 2015). More precisely, it may 
provide evidence of clinical advances in diagnosing and treating patients, changes in discharge 
patterns, and which structural or procedural characteristics of care can circumvent or minimize 
preventable patient deaths (Kroch et al., 2007; Tourangeau, Cranley, & Jeffs, 2006). However, 
variation in hospital mortality is also driven by variation in patient population; that is, higher 
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mortality rates may be associated with a higher proportion of more complex or sicker patients for 
a given hospital (Goodacre et al., 2015). Risk-adjustment also needs to take into account how 
diagnoses and comorbidities are coded and how hospital readmissions are handled (Goodacre et 
al., 2015; Nicholl, 2007). Given appropriate and sufficient risk-adjustment, variation in hospital 
mortality rates are assumed to be attributable to suboptimal care (Girling et al., 2012).  
A variety of national quality improvement efforts have focused on hospital mortality 
rates, including public reporting and pay-for-performance (P4P) efforts. For example, the 
Centers for Medicare and Medicaid Services (CMS) and the Hospital Quality Alliance (HQA) 
started publicly reporting 30-day risk-standardized mortality rates for three common medical 
conditions, namely for acute myocardial infarction and congestive heart failure in 2007 and for 
pneumonia in 2008 (Centers for Medicare and Medicaid Services, 2015c). Nonetheless, the 
practicality of mortality rates to reflect quality of care has been a matter of debate. Cassel et al. 
(2010a) challenge the use of hospital mortality as a quality of care measure, as it equates patient 
deaths with medical failure. Patient-specific factors, such as goals of care, are important 
confounders of mortality for patients with serious chronic illnesses or at the end of life (Cassel et 
al., 2010a). Hence, if death is inevitable and focus on comfort care is part of the patient’s 
treatment plan, patient death is an unpreventable and expected outcome for that patient. While 
hospitals with a greater proportion of such patients may experience higher risk-adjusted mortality 
rates, they may not necessarily provide inferior quality of care. The use of risk-adjusted mortality 
rates as a quality measure is based on the assumption that this measure includes a sufficiently 
large proportion of preventable deaths to explain variation in risk-adjusted hospital mortality 
(Goodacre et al., 2015). Yet recent studies have found weak associations between risk-adjusted 
hospital mortality rates and preventable mortality rates, deeming risk-adjusted hospital mortality 
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rates poor indicators of quality of care (Girling et al., 2012; Hogan et al., 2015). Hogan et al. 
(2015) suggest that instead of relying on risk-adjusted mortality rates to assess a hospital’s 
quality of care, “reviews of individual deaths should focus on identifying ways of improving the 
quality of care, whereas the use of standardized mortality ratios should be restricted to assessing 
the quality of care for conditions with high case fatality for which good quality clinical data 
exist.” (p. 1) That is, risk-adjusted mortality measures may not be suitable for hospitals with a 
large proportion of patients with serious, chronic, and terminal illnesses – patients who would 
greatly benefit from palliative care.  
Despite arguable evidence, it is unlikely that mortality rates will vanish from outcomes-
related quality domains (Cassel et al., 2010a; Reed, 2010). Cassel et al. (2010a) discusses several 
approaches to adjust for palliative care-specific circumstances, such as mandating hospitals to 
publish all diagnoses assigned to a patient. That is, palliative care involvement is typically listed 
low among secondary diagnoses and, depending on the amount of secondary diagnoses, may not 
appear at all. Finally, the authors propose to limit mortality analyses to patients undergoing high-
risk procedures and patients with acute illnesses. If information on goals of care is not available 
or not considered, a focus on acute illnesses and high-risk procedures may be an appropriate way 
to recognize differences in hospital’s patient population and corresponding quality of care. While 
this approach may support the notion that patients with non-acute illnesses (e.g., cancer) are 
expected to die and patients with acute illnesses (e.g., pneumonia) are expected to live 
(Holloway & Quill, 2007), objective comparison of mortality rates across hospitals are only fair 
if differences in goals of care are sufficiently recognized.  
In summary, the controversial application of hospital mortality to measure quality of care 
emphasizes two important issues to consider when using mortality rates in such context. First, it 
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is crucial to control for all relevant patient-level factors influencing mortality, including goals of 
care (if available). This does not necessarily mean excluding all patients who receive palliative 
care. While end-of-life or hospice care focuses on patients with a terminal illness, palliative care 
is appropriate for all patients with a serious illness, regardless of acuity level. Nevertheless, 
certain patient populations are more likely to have palliative care needs (e.g., cancer patients, 
older patients) than others, which emphasizes the need to control for such confounding factors. 
Second, attending to structure and process of care measures when analyzing a hospital’s quality 
of care is essential. Besides difficulties in discriminating between hospitals based on hospital 
mortality rate alone, the level of mortality rates does not suggest any practical improvement 
activities (Shih & Schoenbaum, 2007). Hence, hospitals with palliative care services in place 
may indicate a commitment to high-quality care with the patient’s well-being at its core. In 
addition, palliative care services with appropriate structural and procedural formats are designed 
to facilitate patient-centered care planning by determining a patient’s preference concerning life-
prolonging treatment and palliative care, including developing appropriate discharge planning 
plans, supporting efficiency of care, and avoiding unnecessary hospital readmissions.   
Dependent variable transfer to hospice. 
The facilitation of hospice transfers may have positive associations with both patient and 
organizational outcomes. Specifically, for patients at the end of life, a transfer to hospice care 
may be a more appropriate and desirable alternative to prolonged hospitalization or in-hospital 
death. Place of death has been proposed as a quality indicator for end-of-life care based on the 
concept and empirical evidence that most patients prefer to die at home or at least outside of the 
hospital setting (Bell, Somogyi-Zalud, & Masaki, 2009; Higginson & Sen-Gupta, 2000). In 2013, 
the majority of patients who received hospice care (66.6%) died in their place of residence (i.e.., 
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private residence, nursing home, and residential facility). The remaining hospice patients died in 
hospice inpatient facilities (26.4%), and acute care hospitals (7%) (National Hospice and 
Palliative Care Organization, 2014). Thus, patient preferences to die at home may be realized 
under hospice care for most patients at the end of life. 
 Moreover, discharge management, including the facilitation of hospice transfers, may 
also influence hospital utilization at the end of life with noteworthy implications for quality of 
care, resource utilization, and health care spending. In particular, there is evidence that hospice 
enrollment at the end of life among nursing home residents is linked to better pain management, 
fewer physical restriction, and improved family satisfaction compared to nursing home residents 
without hospice enrollment (Mukamel et al., 2012). In addition, inpatient care, particularly in the 
critical care setting, is costly, often perceived as futile, and does not align with all patient and 
family preferences at the end of life (Barrett, Smith, Elixhauser, Honigman, & Pines, 2014; 
Huynh et al., 2013; Stricker, Rothen, & Takala, 2003). Still, one in three patients aged 65 and 
older dies in the hospital, despite a steady decline in hospital inpatient deaths between 1989 and 
2007 (Health, 2011). Teno et al. (2013) examined changes in sites of death, places of care, and 
health care transitions for Medicare decedents in 2000, 2005, and 2009. The researchers found 
that, while more Medicare patients died at home in 2009 compared to 2005, roughly 10% more 
patients were admitted to the hospital in the last 90 days prior to death (69.3%) and about 20% 
more patients were admitted to the ICU in the last 30 days (29.2%) during this period.  
In summary, strategies to facilitate care transitions to other health care settings, such as 
home hospice services or hospice medical facilities, promise to improve both organizational and 
patient outcomes. Hospital-based palliative care may provide a unique opportunity for hospitals 
to determine optimal patient-centered tools to assist care transitions, which align with a patient’s 
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goals of care, optimize resource use, and reduce unnecessary health care spending by minimizing 
ineffective treatment strategies. 
Hospital Adoption of Palliative Care 
 Existing studies exploring the adoption of hospital-based palliative care services usually 
focused on describing organizational and environmental factors that may be related to the 
adoption of such services. A summary of their findings is provided in Table 3. 
Nine studies, published between 2001 and 2015, examined the relationship between 
market or hospital characteristics and the adoption of hospital-based palliative care services. The 
studies vary by focus, empirical approach, and sample selection, definition of palliative care 
services, theory application, and data structure.  
 The majority of studies (n=6) focused on hospital-based inpatient palliative care 
consultation services. One study examined organizational and market factors associated with 
hospital-based hospice programs (Harrison et al. 2005). Pan et al. (2001) focused on the two 
palliative care-related services that were introduced into the AHA Survey of Hospitals in 1998, 
namely hospital-based end-of-life services and pain management. White, Cochran, and Patel 
(2002) created an end-of-life care index, ranging from 0 to 3 representing the presence of no to 
all of three palliative care services, including end-of-life, hospice, or pain management services. 
The authors examined the association between hospital and market characteristics on the number 
of palliative care services provided by the hospital, hospital system, network, or joint venture.  
 In addition, most studies used cross-sectional hospital samples consisting of U.S. non-
federal acute care hospitals. Billings and Pantilat (2001) limited their study sample to a 100 
randomly selected academic U.S. hospitals in operation in 1999. Morrison, Maroney-Galin, 
Kralovec, and Meier (2005) studied the growth of hospital-based inpatient palliative care 
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Table 3 
3Summary of Palliative Care Adoption Studies 
Table 3 (continued) 
 
Study Study Sample Research Method DV(s) Key Findings 
Dumanovsky et al. 
(2015) 
 
United States 
2293 hospitals 
for 2013 
Descriptive 
Statistics, 
multivariate logistic 
regression 
Binary variable:  
Presence of PAL 
(hospital-based, 
provided by health 
system/network/joi
nt venture) 
Hospitals with more beds are more likely to provide 
PC; public, Catholic Church-operated, and not-for-
profit hospitals are more likely to provide PC than 
for-profit hospitals; SCP hospitals are less likely to 
provide PC; 
Hospitals with ACGME accreditation, ACS-approved 
cancer program, hospice affiliation, and AAMC 
membership are more likely to provide PC; hospitals 
with higher mean % in county graduating from 4-year 
college are more likely to provide PC; hospitals 
located in the East South Central and West South 
Central are less likely to provide PC than hospitals 
located in the Mid-Atlantic; hospitals located in the 
Pacific region are more likely to provide PC than 
hospitals located in the Mid-Atlantic region.  
Morrison  
et al. (2011)  
 
United States 
2,489 hospitals 
for 2009 
Descriptive 
Statistics  
Binary variable:  
Presence of PAL 
(hospital-based, 
provided by health 
system/network/joi
nt venture) 
No statistical analysis employed/reported. 
Goldsmith  
et al. (2008) 
 
United States 
2,452 hospitals 
for 2006 
Descriptive 
Statistics 
Multivariate 
logistic regression 
Binary variable:  
Presence of PAL 
(hospital-based, or 
provided by health 
system, network, or 
joint venture) 
For-profit and public hospitals are less likely to 
provide PC than not-for-profit hospitals; 
SCP hospitals, hospitals with hospice affiliation and 
ACS-approved cancer program are more likely to 
provide PC; hospitals located in counties with higher 
% of bachelor’s degree are more likely to provide PC; 
Hospitals located in the Midwest and West are more 
likely to provide PC than hospitals located in the 
Northeast. 
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Table 3 (continued) 
 
Study Study Sample Research Method DV(s) Key Findings 
Harrison  
et al. (2005) 
 
United States 
4,032 hospitals 
for 2001 
Descriptive 
Statistics 
Correlation 
Analysis 
Multivariate 
logistic regression 
Binary variable: 
Presence of 
hospital-based 
HOSPC 
 
Hospitals with more services and operating 
expense per patient discharge are more likely to 
offer HOSPC; hospitals located in counties with 
higher per capita income and percentage of 
residents 65 and older are more likely to offer 
HOSPC; hospitals located in counties with higher 
unemployment rate and HMO penetration are 
less likely to offer HOSPC. 
Morrison  
et al. (2005) 
 
United States 
4,156 hospitals 
for 2000; 
4,064 for 2001 
4,163 for 2002 
4,226 for 2003 
 
Descriptive 
Statistics (2000-
2003) 
Multivariate 
logistic regression 
(using 2003 data) 
Binary variable:  
Presence of 
hospital-based PAL 
Hospitals with more beds, critical care beds are 
more likely to provide PC; public, for-profit, and 
federal/non-VA hospitals are less likely to 
provide PC than not-for-profit hospitals; VA 
hospitals are more likely to provide PC than not-
for-profit hospitals; hospitals with ACS-approved 
cancer program, AAMC membership, and 
hospice affiliation are more likely to provide PC; 
hospitals located in the census regions Middle 
Atlantic, South Atlantic, East North Central, 
West North Central, West South Central, and 
Pacific are less likely to provide PC than 
hospitals located in census region New England. 
Stover  
(2005) 
 
United States 
4,616 hospitals 
for 2000 
Descriptive 
Statistics 
Correlation 
Analysis 
Multivariate 
Logistic regression 
Binary variable: 
Presence of 
hospital-based PAL 
Hospitals with ACS-approved cancer program, 
health system/network membership, more beds, 
higher percentage of Medicare patients, and 
COTH membership are more likely to provide 
PC; for-profit hospitals are less likely to provide 
PC than not-for-profit hospitals; catholic 
hospitals are more likely to provide PC than not-
for-profit hospitals.  
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Table 3 (continued) 
 
Study Study Sample Research Method DV(s) Key Findings 
White  
et al. (2002) 
 
United States 
3,939 hospitals 
for 1998 
Descriptive 
Statistics 
EOL care index 
ranging between 0 
and 3 based on 
presence of EOL 
services, PM, 
and/or hospice 
services (hospital-
based, or provided 
by health system, 
network, or joint 
venture); 0=no 
service present,1=1 
service present, 
2=2 services 
present; 3=3 
services present  
Catholic hospitals provide more EOL services than 
hospitals with other ownerships; hospitals with more 
beds offer more EOL services; hospitals located in 
the census regions South Atlantic, East South Central, 
West South Central, and Pacific provide fewer EOL 
services than hospitals located in New England.  
Billings & Pantilat 
(2001) 
 
United States 
100 hospitals 
for 1999 
Descriptive 
Statistics 
Binary variable: 
Presence of 
hospital-based 
PAL, IPAL, 
HOSPC, and PM 
No statistical analysis employed/reported. 
Pan  
et al. (2001) 
 
United States 
1,120 hospitals 
for 1998/1999 
Descriptive 
Statistics 
T-Tests 
Binary variable: 
Presence of 
hospital-based 
EOL services and 
PM 
The average hospital with PC had more beds, critical 
care beds, admissions, Medicare discharges, but less 
full-time residents. 
 
Note. AAMC=American Association of Medical Colleges. ACGME=Accreditation Council of Graduate Medical Education. ACS=American College of 
Surgeons. COTH=Council of Teaching Hospitals. DV=Dependent variable. EOL=End-of-life. HMO=Health maintenance organization. HOSPC=Hospice 
program. IPAL=Inpatient palliative care unit. PAL=Inpatient palliative care consultation service. PC=Palliative care. PM=Pain management. SCP=Sole 
community provider. VA=Veterans Affairs. 
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consultation services in federal and non-federal acute care U.S. hospitals between 2000 and 
2003. Pan et al. (2001) included all U.S. hospitals in their study sample. Three studies focused on 
the associations between hospital-based palliative care provision and hospital characteristics 
(Billings & Pantilat, 2001; Morrison et al. 2005; Pan et al., 2001), while the remaining six 
studies examined the impact of hospital and market characteristics on hospital-based palliative 
care provision. “Markets” in these cases were typically defined as counties within a given state. 
Most studies (n=6) employed multivariate logistic regressions models, while the 
remaining three studies reported descriptive statistics only (Billings et al., 2001; Morrison et al., 
2005; Pan et al., 2001). However, only one study acknowledged and accounted for 
heteroscedasticity bias at the county-level by clustering standard errors by county (Stover, 2005). 
Additionally, one study Morrison et al. (2011) reported the variation in the number of board-
certified palliative care physicians by Medicare deaths in a given state to indicate a lack of access 
to palliative care. Most studies (n=6) also included controls for nine census regions (i.e., Mid-
Atlantic, New England, South Atlantic, East-North Central, East-South Central, West-North 
Central, West-South Central, Mountain, and Pacific) in their descriptive statistics or multivariate 
logistic regression models to control for regional variation in palliative care provision. 
The primary datasets used in the studies were the Area Health Resources Files (AHRF) to 
collect market characteristics and the AHA Annual Survey of Hospitals to identify hospitals with 
or without palliative care services and gather additional hospital characteristics, such as bed size, 
ownership type, and teaching status. Billings et al. (2001)’s study was the only study that 
randomly selected and surveyed hospitals in the Council of Teaching Hospitals (COTH) 
directory to collect such information. This is likely due to the fact that the AHA Annual Survey 
of Hospitals first inquired about hospital-based palliative care services in 2000 (Stover, 2005). 
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One of the nine studies applied organizational theories to derive specific research 
questions and hypotheses (Stover, 2005). The remaining eight studies focused largely on 
providing a general overview of the prevalence of hospital-based palliative care services and 
describing the organizational and environmental differences between hospitals with and without 
palliative care services rather than using a theoretical or conceptual framework to explain why 
such differences exist. Five of the nine studies belong to a series of reports published in five-year 
intervals to give an account on the state of hospital-based palliative care programs in non-federal 
acute care hospitals in the United States (Dumanovsky et al., 2015; Morrison et al., 2011; 
Goldsmith, Dietrich, Du, & Morrison, 2008; Morrison et al., 2005; Pan et al., 2001). Several of 
the nine studies found significant relationships between hospital-based palliative care services 
and hospital or environmental characteristics. Hospital characteristics, including teaching status, 
hospital size, hospice affiliation, and not-for-profit ownership had a positive association with the 
probability of hospital provision of palliative care services. Environmental characteristics, 
including educational level in a county and census region, were typically good predictors of 
hospital-based palliative care services. 
Hospital Performance Effects of Palliative Care 
 Fifty-six studies evaluating the effect of hospital-based palliative care on the study’s four 
dependent variables, published between 1988 and 2015, have been reviewed in this study. A 
summary of the empirical findings is presented in Table 4.  
 Note that several published reviews have previously summarized the empirical evidence 
on the association between palliative care services and this study’s dependent variables. 
Specifically, ten reviews synthesized empirical findings regarding the relationship between 
palliative care services and hospital and ICU costs (Higginson et al., 2002; Douglas et al., 2003; 
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Table 4 
4Summary of Outcome Evaluation Studies 
Table 4 (continued) 
 
Study PC Type Setting/Sample 
Research 
Design/Method 
Relevant 
Outcomes 
Key Findings 
Ahrens  
et al. (2003) 
 
United States 
Type:  
PAL 
 
 
Setting: ICU 
  
Sample: 
43 PC 
108 UC 
Single-center, 
Non-RCT, 
prospective, cohort 
study 
Hospital 
charges; 
ICU LOS; 
Hospital 
LOS; 
In-hospital 
mortality 
Lower (~35%) mean hospital variable direct 
charge per patient (p = .01), lower (~37%) 
hospital variable indirect charges per patient 
(p = .007), lower (~37%) fixed charges per 
patient (p = .006) for PC than UC; 
Lower (~31%) hospital LOS (p = .03), 
lower (~36%) ICU LOS (p = .09) for PC 
than UC; in-hospital mortality not 
statistically different. 
Albanese  
et al. (2013) 
 
United States 
Type:  
IPAL 
 
 
 
Setting: IPAL 
 
Sample: 
209 PC 
55 UC 
Single-center, 
Observational 
Hospital costs Lower (~69%) mean daily direct costs for 
IPAL who died in IPAL than UC (p not 
reported). 
Andereck  
et al. (2014) 
 
United States 
Type:  
PAL 
 
 
Setting: ICU 
 
Sample: 
240 PC 
238 UC 
Single-center, 
RCT 
Hospital 
costs; 
Hospital 
LOS; 
ICU LOS; 
 
Live discharges: 
ICU LOS, hospital LOS, and mean hospital 
costs not statistically different. 
Decedents: 
ICU LOS, hospital LOS, and mean hospital 
costs not statistically different. 
Azoulay et al. 
(2002) 
 
France 
Type: 
Integration 
 
 
Setting: ICU 
 
Sample: 
87 PC 
88 UC 
Multi-center, 
Cluster RCT, 
prospective 
blinded 
ICU LOS; 
ICU mortality 
ICU LOS and ICU mortality not statistically 
different. 
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Table 4 (continued) 
 
Study PC Type Setting/Sample 
Research 
Design/Method 
Relevant 
Outcomes 
Key Findings 
Back  
et al. (2005) 
 
United States  
Type:  
PAL 
 
Setting: Mixed 
 
Sample: 
82 PC 
183 UC 
Single-center, 
Observational 
Hospital 
LOS; 
In-hospital 
mortality 
Lower (~24%) mean hospital LOS for PC 
than UC (p < .05); 
Fewer PC patients (21%) died in acute care 
setting than UC patients (64%) (p < .05). 
Bakitas  
et al. (2009) 
 
United States 
Type:  
PAL 
Setting: Mixed 
 
Sample: 
161 PC 
161 UC 
Single-center, 
RCT 
Hospital 
LOS; 
ICU LOS; 
Hospice 
transfer; 
In-hospital 
mortality 
Mean hospital LOS, ICU LOS, referrals to 
hospice, and survival not statistically 
different between PC and UC patients. 
Bendaly  
et al. (2008) 
 
United States 
Type:  
PAL 
 
Setting: Mixed 
 
Sample: 
61 PC 
55 UC 
Single-center, 
Observational 
Hospital 
charges; 
Hospital LOS 
Lower (~16%) median total charges for PC 
than UC (p = .001);  
Mean hospital LOS not significantly 
different. 
Binney  
et al. (2014) 
 
United States 
Type: 
HOSPC 
Setting: 
Hospice 
 
Sample: 
167 PC (died)  
99 UC (died)  
Multi-center, 
Observational 
Hospital 
costs; 
Hospital 
LOS; 
ICU LOS; 
 
Mean LOS in HOSPC of 3.5 days translates 
into 585 ICU days avoided and $1,384,110 
saved (2011 currency); 
Lower mean hospital LOS for HOSPC  
(10.3 days) than ICU patients (13.6 days)  
(p < .05), higher mean ICU LOS for 
HOSPC (9.8 days) than ICU patients  
(7.2 days) (p < .05). 
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Table 4 (continued) 
 
Study PC Type Setting/Sample 
Research 
Design/Method 
Relevant 
Outcomes 
Key Findings 
Campbell  
et al. (2003) 
 
United States 
Type: 
PAL 
 
 
Setting: ICU 
 
Sample: 
Multi-organ 
system failure 
(MOSF): 
21 PC 
22 UC 
 
Global cerebral 
ischemia 
(GCI): 
20 PC 
18 UC 
Single-center 
Observational, 
historical controls 
Hospital 
costs; 
Hospital 
LOS; 
ICU LOS 
 
MOSF patients: 
Higher (~113%) mean daily cost savings 
after DNR order for PC patients than UC if 
CMO elected (p < .05);  
Lower (~27%) mean hospital LOS for PC 
patients than UC, mean ICU LOS not 
statistically different. 
GCI patients: 
Difference in mean daily cost savings after 
DNR order not statistically different; 
Lower (~45%) mean hospital LOS (p < 
.001) and lower (~48%) ICU LOS (p < .01) 
for PC patients than UC. 
Campbell  
et al. (2004) 
 
United States 
Type:  
PAL 
Setting: ICU 
 
Sample: 
26 PC 
26 UC 
Single-center, 
Observational, 
historical controls 
Hospital 
LOS; 
ICU LOS; 
In-hospital 
mortality 
Lower (~39%) mean hospital LOS  
(p < .007), lower (~49%) mean ICU LOS  
(p < .004) for PC than UC; 
Mean in-hospital mortality not statistically 
different. 
Carlson  
et al. (1988) 
 
United States 
Type:  
PAL 
 
 
 
Setting: ICU 
 
Sample: 
93 patients 
Single-center, 
Observational, 
pre-post  
Hospital 
charges; 
Hospital 
LOS; 
ICU LOS; 
In-hospital 
mortality; 
Lower (~31-64%) mean hospital charges for 
PC than UC (p < .05); lower (~33-70%) 
mean hospital LOS for PC than UC (p < 
.05); 
ICU LOS and in-hospital mortality not 
statistically different. 
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Table 4 (continued) 
 
Study PC Type Setting/Sample 
Research 
Design/Method 
Relevant 
Outcomes 
Key Findings 
Cassel  
et al. (2010c) 
 
United States  
Type:  
PAL 
Setting: Mixed 
 
Sample: 
91 PC patients 
20 PC patients 
Single-center 
Observational, 
before-and-after 
study 
Hospital 
charges; 
Hospice 
transfers; 
In-hospital 
mortality 
Lower (~25%) mean hospital charges for 
PC than UC (p not reported); 
More transfers to hospice for PC than UC (p 
not reported);  
No increase in-hospital mortality (p not 
reported). 
Cheung  
et al. (2010) 
 
United States 
Type:  
PAL 
Setting: ICU 
 
Sample: 
10 PC patients 
10 UC patients 
Single-center, RCT Hospital 
LOS; 
ICU LOS; 
In-hospital 
mortality 
Median hospital LOS, median ICU LOS, 
hospital and ICU mortality not statistically 
different. 
Ciemins  
et al. (2007) 
 
United States 
Type:  
PAL 
Setting: Mixed 
 
Sample: 
27 PC patients 
128 UC patients 
Single-center, 
observational, 
interrupted time-
series, matched 
cohort design 
Hospital 
costs; 
Hospital LOS 
Lower (~13%) mean daily costs for PC than 
UC (p < .01); lower (~16%) mean costs per 
admission for PC than UC (p < .00001); 
Mean/Median hospital LOS not 
significantly different. 
Cowan  
(2004) 
 
United States 
 
 
Type:  
PAL 
Setting: Mixed 
 
Sample:164 PC 
patients 152 UC 
patients 
Single-center, 
observational, 
cohort study 
Hospital 
charges; 
 
 
Lower (~6%) mean daily charges for PC 
than UC (p = .006); 
PC reduces hospital LOS for patients with 
hospital LOS ≥ 7 (0.55–3.55 days). 
Curtis  
et al. (2008) 
 
United States 
Type: 
Integration 
 
 
Setting: ICU 
 
Sample: 
337 PC patient 
(post-PAL) 
253 UC patients 
(pre-PAL) 
Single-center, 
observational, pre-
post study 
Hospital 
LOS; 
ICU LOS; 
Lower (~19%) mean ICU LOS for PC 
(post-PAL) than UC (pre-PAL) (p = .01), 
lower (~20%) mean hospital ICU for PC 
(post-PAL) than UC (pre-PAL) (p = .02). 
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Table 4 (continued) 
 
Study PC Type Setting/Sample 
Research 
Design/Method 
Relevant 
Outcomes 
Key Findings 
Curtis  
et al. (2011) 
 
United States 
Type: 
Integration 
 
 
Setting: ICU 
 
Sample: 
669 PC patients 
570 UC patients 
Multi-center, RCT ICU LOS ICU LOS not statistically different. 
Daly  
et al. (2010) 
 
United States 
Type: 
Integration 
 
 
Setting: ICU 
 
Sample: 
354 PC patients 
135 UC patients 
Multi-center, 
observational, 
pre-post study 
Hospital 
LOS; 
ICU LOS; 
In-hospital 
mortality 
Mean hospital LOS, ICU LOS, hospital 
mortality, and ICU mortality not statistically 
different. 
Davis  
et al. (2005) 
 
United States 
IPAL N/A Multi-center, 
observational 
Hospital 
charges 
Higher (~9%) mean total charges in IPAL 
than national mean charges (no p reported), 
Lower (~33%) mean pharmacy and 
laboratory charges in IPAL than national 
mean charges (no p reported). 
Detering  
et al. (2010) 
 
Australia 
Type:  
PAL 
Setting: Mixed 
 
Sample: 
154 PC patients 
155 UC patients 
Single-center, RCT In-hospital 
mortality 
Lower ICU mortality for PC (0%) than UC 
(15%) (p = .03); hospital mortality not 
statistically different. 
 
Digwood  
et al. (2011) 
 
United States 
Type:  
IPAL 
Setting: ICU 
 
Sample:  
2,319 (pre-
IPAL) 
2,716 (post-
IPAL) 
Single-center, 
observational, 
pre-post 
ICU LOS; 
ICU 
mortality; 
 
Lower mean ICU LOS after IPAL opening 
(4 days) than before (4.6 days) (p = .014); 
Lower (~24%) ICU mortality after IPAL 
opening than prior to opening (p = .003). 
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Table 4 (continued) 
 
Study PC Type Setting/Sample 
Research 
Design/Method 
Relevant 
Outcomes 
Key Findings 
Dowdy  
et al. (1998) 
 
United States  
 
 
Type:  
PAL 
Setting: Mixed 
 
Sample: 
31 PC patients 
68 UC patients 
Single-center, non-
RCT 
Hospital 
charges; 
ICU LOS 
In-hospital 
mortality 
In-hospital mortality and hospital charges 
not statistically different. 
Live discharges: 
Lower ICU LOS for PC than UC (p not 
reported).  
Decedents: 
Lower (minus 13 days) ICU LOS for PC 
than UC (no p reported). 
Elsayem  
et al. (2004) 
 
United States 
Type: IPAL Setting: IPAL 
in cancer center 
 
Sample: 
320 IPAL 
patients 
Single-center, 
observational 
Hospital 
charges; 
In-hospital 
mortality; 
In-hospital mortality between before and 
after IPAL opening not different (no p 
reported); 
Lower (~38%) mean daily charges in IPAL 
than in entire hospital (no p reported) 
Elsayem  
et al. (2006) 
 
United States  
Type: IPAL Setting: IPAL 
 
Sample: 
N/A 
Single-center, 
observational, 
longitudinal (1999-
2004), IPAL 
established in 1999 
In-hospital 
mortality; 
ICU mortality 
 
In-hospital mortality remained constant over 
time (p > .2);  
ICU mortality decreased from 38% (1999) 
to 28% (2004). 
Field et al. 
(1989) 
 
United States 
Type: PAL Setting: ICU 
 
Sample: 
20 patients (pre 
consult) 
20 patients 
(post-consult) 
Single-center, 
observational, 
pre-post  
In-hospital 
mortality; 
Hospital 
LOS; 
ICU LOS; 
In-hospital mortality and hospital LOS not 
statistically different (no p reported); 
Lower ICU LOS after intervention (6 days) 
than before (12 days) (p < .01). 
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Table 4 (continued) 
 
Study PC Type Setting/Sample 
Research 
Design/Method 
Relevant 
Outcomes 
Key Findings 
Foreman  
et al. (2015) 
 
Canada 
Type:  
PAL 
Setting: Mixed 
 
Sample: 
65 PC patients 
35 UC patients 
Single-center, 
observational 
Hospital 
costs; 
Lower (~80%) medical-imaging costs  
(p =.01), lower (~36%) laboratory costs  
(p = .024), lower (~48%) total healthcare 
costs (p = .001), and higher (~28%) 
physician costs (p = .05) for PC than UC.  
Gade  
et al. (2008) 
 
United States 
Type:  
PAL 
Setting: Mixed 
 
Sample: 
275 PC patients 
237 UC patients 
Multi-center, RCT Total health 
care costs; 
Hospital 
LOS; 
In-hospital 
mortality; 
Hospice 
transfers 
Lower (~31%) mean total healthcare costs 
for PC than UC (p = .001); 
Mean hospital LOS not statistically 
significant; 
Higher (~114%) in-hospital mortality for 
PC than UC (p = .002); 
Patients admitted to hospice not statistically 
significant. 
Hall et al. 
(2004) 
 
Canada 
Type: 
Integration 
Setting: ICU 
 
Sample: 
138 patients 
(pre PC) 
168 patients 
(post PC) 
Single-center, 
observational, 
pre-post 
 
Hospital 
LOS; 
ICU LOS; 
Reduced hospital LOS (16.4 to 10.5 days) 
(p = .005) 
ICU LOS not statistically different. 
Hanson  
et al. (2008) 
 
United States 
Type: PAL Setting: Mixed 
 
Sample: 
104 PC patients 
1,813 UC 
patients 
Single-center, 
observational 
Hospital 
costs; 
ICU mortality 
Lower (~11%) daily variable costs for PC 
than UC (p = .03); more (~20%) cost 
savings if PC for more than 50% of hospital 
LOS 
Holloran et al. 
(1995) 
 
United States 
Type: 
Integration 
Setting: ICU 
 
Sample: 
N/A 
Single-center, 
observational, 
pre-post 
 
ICU LOS Decreased LOS for SICU patients (p  < .05).  
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Table 4 (continued) 
 
Study PC Type Setting/Sample 
Research 
Design/Method 
Relevant 
Outcomes 
Key Findings 
Hsu-Kim  
et al. (2014) 
 
United States 
Type:  
PAL 
Setting: ICU 
Sample: 
41 PC patients 
80 UC patients 
Single-center, 
observational 
Hospital 
costs; 
Hospital 
LOS; 
ICU LOS; 
In-hospital 
mortality 
Mean daily costs not statistically different; 
Higher (~73%) hospital LOS, higher 
(~100%) ICU LOS, and higher (~414%) in-
hospital mortality (p < .01) for PC than UC.  
Jung  
et al. (2012) 
 
South Korea 
Type: IPAL Setting: IPAL 
 
Sample: 
126 IPAL 
patients 
461 UC patients 
Single-center, 
observational 
Hospital costs Lower (~27%) total medical costs for IPAL 
than UC (p < .001); increasingly lower 
(~33%) medical costs 1-2 months prior to 
death for PC than UC (p = .001). 
Lamba  
et al. (2012) 
 
United States 
Type:  
PAL 
Setting: ICU 
 
Sample: 
Live discharges 
58 Pre PC 
73 Post PC 
Decedents 
21 Pre PC 31 
(post PC) 
Single-center, 
observational, pre-
post 
Hospital 
LOS; 
ICU LOS 
Decedents: 
Mean ICU LOS and mean hospital LOS  
Not statistically different 
 
Lautrette  
et al. (2007)  
 
France 
Type: 
Integration 
Setting: ICU 
 
Sample: 
63 PC patients 
63 UC patients 
Multi-center, RCT Hospital 
LOS; 
ICU LOS 
Mean hospital and ICU LOS not statistically 
different. 
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Table 4 (continued) 
 
Study PC Type Setting/Sample 
Research 
Design/Method 
Relevant 
Outcomes 
Key Findings 
Lilly  
et al. 
(2000,’03)  
 
United States 
Type: 
Integration 
Setting: ICU 
 
Sample: 
396 Post PC 
134 Pre PC 
(2,361 PC 
patients in 4-
year follow-up) 
Single-center, 
observational, 
pre-post 
ICU LOS; 
ICU mortality 
Lower median ICU LOS for PC (3 days) 
than UC (4 days) (p =.01); ICU LOS 
remains 3 days for PC patients in follow-up 
period. 
Decedents: 
Lower median ICU LOS for PC patients 
with highest risk of mortality (3 days) than 
UC patients with highest risk of mortality (5 
days) (p = .02); 
Lower ICU mortality for PC (22.7%) than 
UC (31.3%) (p = .01), lower ICU mortality 
for PC in follow-up period (18%). 
Lo  
et al. (2002) 
 
Taiwan 
Type: 
HOSPC 
Setting: N/A 
 
Sample: 
912 hospice 
patients 
25,544 UC 
patients 
Observational 
(based on 
insurance claims 
data) 
Healthcare 
costs 
Lower total healthcare costs for PC than UC 
patients (p = .01). 
Lustbader  
et al. (2011) 
 
United States 
Type: PAL Setting: ICU 
 
Sample: 
Decedents 
693 PC patients 
515 UC patients 
Single-center, 
observational, 
historical controls  
Hospital 
LOS; 
ICU LOS; 
ICU mortality 
Shorter median hospital LOS for PC  
(11 days) than UC (12 days) (p < .0106); 
ICU LOS not statistically different; 
Lower (~34%) ICU mortality for PC than 
UC (p < .0005). 
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Table 4 (continued) 
 
Study PC Type Setting/Sample 
Research 
Design/Method 
Relevant 
Outcomes 
Key Findings 
Morrison  
et al. (2008) 
 
United States 
 
 
Type: PAL Setting: Mixed 
 
Sample: 
Live discharges 
2,630 PC patients 
18,427 UC 
patients 
 
Decedents: 
2,278 PC patients 
2,124 UC 
patients 
Multi-center, 
observational  
Hospital costs Live discharges: 
Lower (~14%) total costs (p = .02), lower 
(~19%) daily total costs (p < .001), lower 
(~15%) direct costs per admission (p = .004), 
lower (~21%) daily direct costs (p < .001), 
lower (~35%) laboratory costs, lower (~73%) 
ICU costs (p < .001) for PC than UC 
Decedents: 
Lower (~18%) total costs (p = .001), lower 
(~22%) daily total costs (p < .001), lower 
(~22%) direct costs per admission (p = .003), 
lower (~45%) daily direct costs (p < .001), 
lower (~34%) laboratory costs, lower (~27%) 
pharmacy costs, lower (~45%) ICU costs  
(p < .001) for PC than UC. 
Morrison  
et al. (2011) 
 
United States 
Type: PAL Setting: Mixed 
 
Sample: 
Live discharges: 
290 PC patients 
1,427 UC 
patients 
Decedents: 
185 PC patients 
149 UC patients 
Multi-center, 
observational 
Hospital 
costs;  
ICU costs, 
ICU LOS; 
Hospice 
transfer 
ICU mortality 
Live discharges: 
Lower (~11%)  mean total costs per admission 
(p < .05), lower (~18%) mean daily costs  
(p < .001), and lower ICU costs (p < .001) for 
PC than UC; 
More PC patients (30%) than UC patients (1%) 
were discharged to hospice (p < .001); 
Mean ICU LOS not statistically different. 
Decedents: 
Lower mean (~11%) total costs per admission (p 
< .05), lower (~9%) mean daily costs (p < .01), 
lower (~21%) mean pharmacy costs  
(p < .05); 
Mean ICU LOS shorter (~26%) for PC than UC 
(p < .05); 
Fewer PC patients (34%) than UC patients 
(58%) died in the ICU (p < .05). 
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Table 4 (continued) 
 
Study PC Type Setting/Sample 
Research 
Design/Method 
Relevant 
Outcomes 
Key Findings 
Mosenthal et 
al. (2008) 
 
United States 
Type: 
Integration 
Setting: ICU 
 
Sample: 
Live discharges 
244 Pre PC 
321 Post PC 
Decedents 
42 Pre PC 
46 Post PC 
Single-center, 
observational, 
pre-post 
Hospital 
LOS; 
ICU LOS; 
In-hospital 
mortality 
Decedents: 
Shorter mean ICU LOS for PC (6.1 days) 
than UC (7.6 days) (no p reported), shorter 
mean hospital LOS for PC (6.5 days) than 
UC (14.4 days) (no p reported); 
Lower in-hospital mortality for PC (14%) 
than UC (15%) (no p reported). 
Norton  
et al. (2007)  
 
United States 
Type: PAL Setting: ICU 
 
Sample: 
126 PC patients 
65 UC patients 
Single-center, 
quasi-experimental 
Hospital 
LOS; 
ICU LOS 
In-hospital 
mortality; 
Mean hospital LOS not statistically 
different, lower (~45%) ICU LOS for PC 
patients than UC patients (p = .0001); 
Mean ICU mortality not statistically 
different, PC patients who died in the ICU 
had significantly shorter ICU LOS. 
O’Mahony  
et al. (2005) 
 
United States 
Type: PAL Setting: Mixed 
 
Sample: 
77 PC patients 
(post PC) 
77 UC patients 
(pre PC) 
Single-center, 
observational, pre-
post 
 
Hospital 
charges; 
Hospital 
LOS; 
Lower median number of ventilator charges 
for patients post PC (n=4) than patients 
prior to PC (n=0) (p < .0001), lower (~63%) 
median total ventilator charges  
(p < .0001); 
Lower median LOS for patients transferred 
to hospice after PC (9 days) than prior to PC 
(12 days) (p < .05). 
Penrod et al. 
(2006) 
 
United States 
 
 
Type: 
Integration 
Setting: Mixed 
 
Sample: 
82 PC patients 
232 UC patients 
Multi-center, 
observational 
Hospital 
costs; 
Hospital 
LOS; 
ICU LOS 
 
 
Lower (~31%) daily direct costs for PC than 
UC (p = .0001); 
Mean hospital LOS not significantly 
different between PC and UC (p = .44); 
Mean ICU LOS shorter (~57%) for PC 
patients than UC patients (p = .007). 
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Table 4 (continued) 
 
Study PC Type Setting/Sample 
Research 
Design/Method 
Relevant 
Outcomes 
Key Findings 
Penrod  
et al. (2010) 
 
United States 
Type: 
Integration 
Setting: Mixed 
 
Sample: 
606 PC patients 
2,715 UC 
patients 
Multi-center, 
observational  
Hospital 
costs; 
Hospital 
LOS; 
ICU LOS; 
Lower daily direct hospital costs, nursing, 
radiology, pharmacy, and laboratory costs 
for PC than UC; 
Mean hospital LOS higher (~79%) for PC 
than UC; mean ICU LOS higher (~94%) for 
PC than UC; PC less likely (~44%) to be 
admitted to ICU than UC (no p reported). 
Quenot  
et al. (2011) 
 
France 
Type: 
Integration 
Setting: ICU 
 
Sample: 
678 expired 
(pre PC) 
823 expired 
(post PC) 
Single-center, 
observational, 
pre-post 
In-hospital 
LOS; 
ICU LOS 
Among patients who withheld or withdrew 
life-prolonging therapy, fewer median ICU 
days after intervention (7 days) than before 
(13 days) (p < .05) until death in ICU, fewer 
median hospital days after intervention (10 
days) than before intervention (14 days) 
until death in hospital (p < .05). 
Schneiderman  
et al. (2000) 
 
United States 
Type: PAL Setting: ICU 
 
Sample: 
35 PC patients 
35 UC patients 
Single-center, 
RCT, 
Prospective 
ICU LOS; 
In-hospital 
mortality 
In-hospital mortality not statistically 
different. 
Decedents: 
Lower (~68%) mean ICU LOS for ethics 
patients than UC (p = .03). 
Schneiderman  
et al. (2003) 
 
United States 
Type: PAL Setting: ICU 
 
Sample:  
276 PC patients 
270 UC patients 
Multi-center, RCT, 
Prospective 
Hospital 
LOS; 
ICU LOS; 
In-hospital 
mortality 
In-hospital mortality not statistically 
different. 
Decedents: 
Lower (~25%) mean hospital LOS for ethics 
patients than UC (p = .01) and lower 
(~18%) mean ICU LOS for PC than UC  
(p = .03). 
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Table 4 (continued) 
 
Study PC Type Setting/Sample 
Research 
Design/Method 
Relevant 
Outcomes 
Key Findings 
Shelton  
et al. (2010)  
 
United States 
Type: PAL Setting: ICU 
 
Sample: 
187 PC patients 
(post PC) 
190 UC patients 
(pre PC) 
Single-center, 
observational, 
pre-post 
Hospital 
costs; 
Hospital LOS 
Mean costs and hospital LOS not 
statistically different. 
Simoens 
et al. (2010a) 
 
Belgium 
Type: PAL Setting: Mixed 
 
Sample:  
88 PC patients 
53 UC patients 
Multi-center, 
observational 
Hospital costs Higher (~24%) mean daily costs for PC than 
UC (p = .002); Lower (~17%) mean daily 
costs for PC patients in ICU than UC 
patients (p = .025). 
Smith  
et al. (2003) 
 
United States 
Type: IPAL Setting: IPAL 
 
Sample: 
38 PC patients 
(died in IPAL) 
38 UC patients 
(died in UC) 
Single-center, 
observational 
Hospital 
costs; 
ICU LOS 
 
Lower mean direct costs (p = .004) and 
lower mean total costs (p = .0009) for PC 
than UC;  
ICU LOS not statistically different between 
PC and UC. 
Stover (2005) 
 
United States 
Type: PAL Setting: Mixed 
 
Sample:  
555,521 
patients 
Multi-center, 
observational 
Hospital 
charges; 
In-hospital 
mortality 
Hospitals with PAL do not have statistically 
lower hospital charges or in-hospital 
mortality. 
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Table 4 (continued) 
 
Study PC Type Setting/Sample 
Research 
Design/Method 
Relevant 
Outcomes 
Key Findings 
The 
SUPPORT 
Principal 
investigators 
(1995) 
 
United States 
Type: PAL Setting: Mixed 
 
Sample: 
2,652 PC 
patients 
2,152 UC 
patients 
Multi-center, 
cluster RCT 
Hospital 
charges; 
In-hospital 
mortality; 
ICU mortality 
 
For alive discharges, no difference in 
resource use (in US$1993) (no p reported); 
Lower median hospital charges for PC 
($27,000) than UC ($33,000) (no p 
reported); 
Mean hospital and ICU mortality not 
different (no p reported).  
Treece et al. 
(2004) 
 
United States 
Type: 
Integration 
Setting: ICU 
 
Sample: 
41 UC patients 
(pre PC) 
76 PC patients 
(post PC) 
Single-center, 
observational, 
Pre-post 
 
Hospital 
LOS; 
ICU LOS 
Median hospital LOS and median ICU LOS 
not statistically different. 
Weckmann  
et al. (2013) 
 
United States 
Type: 
HOSPC 
Setting: Mixed 
 
Sample: 
7 hospice 
patients 
202 UC patients 
Single-center, 
observational 
Hospital 
costs; 
Hospital 
LOS; 
Decedents: 
Lower hospital costs for HOSPC patients 
than UC (p < .001);  
Lower hospital LOS for HOSPC patients 
than UC (p = .02); 
Lower (~28%) costs for patients who 
received PC consult than patients who did 
not (p < .04). 
White  
et al. (2006) 
 
United States 
Type: IPAL Setting: IPAL 
 
Sample: 
1,774 PC 
patients (died in 
IPAL) 
520 UC patients 
(died in UC) 
Single-center, 
observational 
Hospital costs Lower (~72%) mean direct costs for PC 
patients than UC patients in the ICU (p not 
reported), lower (~30%) mean direct costs 
for PC patients than UC patients in other 
settings (no p reported).  
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Table 4 (continued) 
 
Study PC Type Setting/Sample 
Research 
Design/Method 
Relevant 
Outcomes 
Key Findings 
Whitford  
et al. (2014) 
 
United States  
Type: PAL Setting: Mixed 
 
Sample: 
Live discharges 
1,177 PC 
patients 
3,531 UC 
patients 
 
Decedents 
300 PC patients 
900 UC patients 
Multi-center, 
observational 
Hospital 
costs; 
Hospital 
LOS; 
Hospice 
transfers 
More hospice transfers for PC (31%) than 
UC (1%); hospital LOS not statistically 
different. 
Live discharges: 
Lower (~5%) mean total hospital costs for 
PC than UC (p < .05);  
Higher procedure costs, evaluation and 
management, image costs, and pharmacy 
costs for PC than UC (no % or p reported). 
Decedents: 
Lower (~31%) mean total hospital costs  
(p < .05); lower procedure, evaluation and 
management, image, pharmacy costs for PC 
than UC (no % or p reported). 
 
Note. CMO=Comfort measures only. DNR=Do not resuscitate. GCI=Global cerebral ischemia. HOSPC=Hospice program. ICU=Intensive care unit. 
IPAL=Inpatient palliative care unit. LOS=Length of stay. MOSF=Multi-organ system failure. N/A=Not available. PAL=Inpatient palliative care consultation 
service. PC=Palliative care. RCT=Random controlled trial. SICU=Surgical intensive care unit. UC=Usual care. 
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Higginson et al., 2003; Zimmermann et al., 2008; Smith & Cassel, 2009; Higginson & Evans, 
2010; Simoens et al., 2010b; El-Jawahri et al., 2011; Smith, Brick, O'Hara, & Normand, 2014; 
May et al., 2014). Three reviews focused on synthesizing empirical evidence regarding the 
association between palliative care services and hospital and/or ICU LOS (Cassel et al., 2010b; 
Aslakson et al., 2014; Khandelwal et al., 2015).  
 Overall, most studies (n=32) evaluated inpatient palliative care consultation services, of 
which approximately half (n=15) took place in ICUs. The remaining studies assessed the effects 
of integrative models (i.e., primary palliative care) (n=13), inpatient palliative care units (n=8), 
and hospice programs (n=3). The majority of integrative models embedded palliative care in the 
ICU setting (n=11), while only two embedded palliative care in mixed hospital units (Penrod et 
al., 2006; Penrod et al., 2010). Finally, the vast majority (n=46) were retrospective or prospective 
observational cohort studies, ten studies applied a randomized controlled trial (RCT) design (e.g., 
Andereck et al., 2014; Bakitas et al., 2009).   
Of 32 studies that evaluated hospital costs, charges or healthcare costs, most studies 
(n=26) identified significantly fewer hospital costs, charges or healthcare costs for patients who 
received palliative care compared to patients who did not. Six studies did not find any significant 
differences between patients who received palliative care and patients who did not receive 
palliative care (Andereck et al., 2014; Dowdy et al., 1998; Hsu-Kim et al., 2015; Shelton et al., 
2010; Stover, 2005; The SUPPORT Principal Investigators, 1995). Four studies reported mixed 
findings regarding hospital costs (Foreman et al., 2015; Simoens et al., 2010a; Whitford et al., 
2014; Davis et al., 2005). More than a third of the studies (n=11) used hospital charges to 
evaluate the economic impact of palliative care, although hospital charges are viewed as 
inadequate proxies for hospital expenditures. In particular, hospital charges are merely the 
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amount the hospital bills to the insurer or patient, not the actual costs the hospital incurred for a 
certain procedure or service. Hospital charges also vary widely by hospital and are therefore not 
suitable for comparing results across hospitals. The majority of studies (n=21) evaluated hospital 
costs, a more accurate representation of hospital expenditures. Of those 21 studies, the majority 
used the hospital’s cost-accounting system to retrieve cost measures. Two studies applied cost-
to-charge ratios (CCR) to convert hospital charges into costs (Andereck et al., 2014; Whitford et 
al., 2014). Two studies used alternative measures of costs (Gade et al., 2008; Lo, 2002). In 
particular, Gade et al. (2008) examined all healthcare costs incurred within the six months after 
hospitalization, while Lo (2002) used insurance payments from the Taiwanese National Health 
Insurance claims database as a proxy for healthcare expenditures within one year prior to the 
patient’s death. Overall, the results show that palliative care reduces hospitalization costs, which 
is consistent with conclusions of similar recent reviews (May et al., 2014; Simoens et al., 2010b; 
Smith et al., 2014). However, heterogeneous patient populations, particularly in non-RCT 
studies, may result in selection bias and thus hinder the ability to compare the economic impact 
of palliative care across studies.  
More than half of the reviewed studies (n=30) examined hospital LOS. While 13 studies 
were unable to find a difference in hospital LOS between palliative care and usual care patients 
(e.g., Ciemins et al., 2007; Lamba et al., 2012; Penrod et al., 2006), 15 studies identified lower 
hospital LOS for patients who received palliative care compared to patients who received usual 
care (e.g., Carlson et al., 1988; Lustbader et al., 2011; Mosenthal et al., 2008). The remaining 
two studies reported higher hospital LOS (Hsu-Kim et al., 2015; Penrod et al., 2010). Similarly, 
31 studies measured ICU LOS, 14 of which found shorter ICU LOS (e.g., Penrod et al., 2006), 
14 found no difference (e.g., Carlson et al., 1988), and two reported higher ICU LOS (Binney et 
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al., 2014; Hsu-Kim et al., 2015) for patients who received palliative care than patients who 
received usual care. Overall, empirical evidence on hospital and ICU LOS is inconclusive. The 
variability in findings may be explained by multiple factors, including the use of research 
designs. Cassel et al. (2010b) discussed many of these studies in regard to the relationship 
between inpatient palliative care consultation services and hospital LOS in their literature 
review. The researchers found that studies that revealed reduced hospital LOS were quasi-
experimental designs or randomized controlled trials, which focused on ICU-based palliative 
care consultations and primarily examined hospital LOS of deceased patients (Cassel et al., 
2010b). Particularly in observational studies, the ability to detect differences in hospital LOS 
may also be influenced by the fact that palliative care consultations often occur relatively late in 
the hospitalization period, which may result in Type II errors (Cassel et al., 2010b). Similarly, 
concerns regarding simultaneity bias or reverse causation arise, as prolonged hospital/ICU LOS 
may result in initiation of palliative care consultations. Cassel et al. (2010b) suggested 
employing proactive palliative care consultations on a predetermined day of hospitalization or at 
the time of hospital admission may mitigate these problems. Furthermore, the authors 
recommended analyzing and reporting the effect of palliative care services on LOS for living and 
deceased patients separately due to substantial interpretive and consequential differences of 
reduced LOS for those two patient groups. Another systematic review that summarized studies 
published between 1995 and March 2014 found more consistent evidence of reduced ICU LOS 
(Khandelwal et al., 2015). Specifically, 11 of 16 studies reported reduced ICU LOS, while five 
demonstrated no significant change. Two of the studies without significant changes in ICU LOS 
examined the effect of a system-level palliative care interventions (e.g., addition of a family 
support coordinator to the surgical ICU). Khandelwal and her colleagues (2015) concluded in 
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their systematic review that effects may be easier to detect if palliative care interventions take 
place at the patient level, because the effective palliative care consultations hinge on adapting 
care plans to the needs of an individual patient. The mean reduction in ICU LOS across all 
studies estimating ICU LOS was 26% with a standard deviation of 23% (Khandelwal et al., 
2015). Similar to Cassel et al. (2010b)’s supposition, the researchers attributed the observed 
variability in ICU LOS partially to the distinction between alive and deceased patients in their 
study sample.  
Twenty-six studies evaluated in-hospital mortality, including hospital and ICU mortality. 
Most of the studies (n=19) found no significant difference in hospital mortality between patients 
who received palliative care and patients who received usual care. However, the studies 
demonstrated consistently lower ICU mortality for patients who received palliative care 
compared to patients who received usual care (e.g., Digwood et al., 2011; Lilly et al., 2000; Lilly 
et al., 2003). These results suggest that palliative care facilitates the transition to lower levels of 
care, which may also be reflected in lower hospital costs. Finally, a small number of studies 
(n=4) evaluated the effects of hospital-based palliative care on hospice transfers (Cassel et al., 
2010c; Gade et al., 2008; Morrison et al., 2011; Whitford et al., 2014), three of which 
demonstrated more transfers or referrals to hospice care for patients who received palliative care 
compared to patients who received usual care (Cassel et al., 2010c; Morrison et al., 2011; 
Whitford et al., 2014) and one found no significant difference in hospice transfers between 
patients who received palliative care and patients who received usual care (Gade et al., 2008).  
Study Contribution 
This study aims to contribute to prior literature by using multiple measures of hospital-
based palliative care and robust analytical methodology. Specifically, this study takes a more 
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comprehensive look at the nature of palliative care services and their effects on selected 
outcomes than previous work by focusing on the provision of three types of hospital-based 
specialty palliative care services, namely inpatient palliative care consultation services, inpatient 
palliative care units, and hospice programs. All of these services are focused on providing end-
of-life care. The service descriptions, as identified in this chapter, emphasize symptom and pain 
management and supportive care to address emotional, psychological, spiritual, financial, legal, 
and social needs of seriously ill patients and their families.  
While the definitions highlight the similarities of the nature of these services, there are 
also two noteworthy differences. First, while hospice programs serve patients with certain 
eligibility criteria only (i.e., patients with a terminal illness, life expectancy of six months or less, 
and willingness to forgo curative treatment), inpatient palliative care consultation services and 
inpatient palliative care units typically provide services to all patients with serious illnesses 
regardless of stage of illness, prognosis, and continuation of curative treatments. Second, an 
inpatient palliative care unit distinguishes itself from the other two services by being a 
“physically discreet” ward. Conversely, hospice programs provide their services in the hospital, 
at home, or in other freestanding care facilities. An inpatient palliative care consultation service 
typically focuses on providing palliative care in the hospital, such as in general wards, ICUs, or 
other specialized care units.  
The similarities between these three services justify the assumption that the factors 
causing a hospital to provide one type of palliative care service are the same as the factors 
causing a hospital to offer the other two types of palliative care services; that is, this study 
models the provision of each of these services jointly in research question one.  
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On the other hand, each of these services may have a different impact on patient and 
organizational outcomes. Therefore, this study examines the effect of each of these services on 
selected outcomes separately in research questions two and three. For example, from a hospital's 
perspective, it may be critical to know if having an inpatient palliative care unit has a greater 
impact on economic viability and quality of care compared to the other two palliative care 
services. Answers to questions, such as “Is an inpatient palliative care unit positively associated 
with selected outcomes in the presence of a palliative care program and/or a hospice program?” 
may be useful to hospital managers when deciding to expand, reduce, or modify end-of-life care-
related service mixes.  
This study also distinguishes between and accounts for the source of palliative care 
services; that is, whether palliative care services are hospital-based or not-hospital-based. 
Hospital-based palliative care services are owned/provided by the hospital or its subsidiary. 
Palliative care services that are provided by a health system, network, or joint venture in a 
hospital’s local community are considered not-hospital-based in this study. The first research 
question focuses on the provision of at least one of the three hospital-based palliative care 
services as a dependent variable, and the corresponding analytical model controls for whether 
not-hospital-based palliative care services are available to hospitals. The availability of not-
hospital-based palliative care services is viewed as an important predictor of hospital-based 
palliative care services. Similarly, for research questions two and three, in addition to three 
binary variables indicating the presence of hospital-based palliative care services, a control 
variable for whether a not-hospital-based palliative care service is available is included in the 
analysis to account for its potential effect on organizational and patient outcomes.  
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Overall, this study aims to shed light on the differentiating effects of the types (i.e., 
inpatient palliative care consultation services, inpatient palliative care unit, and hospice program) 
and sources (hospital-based or not-hospital-based) of palliative care services on selected 
outcomes. A question of interest is “Do hospital-based palliative care services have significant 
effects on outcomes when not-hospital-based palliative care services are present?” If findings 
suggest otherwise, a hospital may not need to invest in hospital-based palliative care services 
and, instead, take advantage of resources available through their networks, health systems, or 
joint ventures in their local community.  
In sum, although previous research has studied the nature and effect of hospital-based 
palliative care services, a broader and more inclusive analysis of hospital-based palliative care 
services is a natural extension of previous studies and is likely to carry more relevance in 
decision-making processes at the hospital administrative level. Furthermore, no research study 
has explored whether hospitals with more experience in providing palliative care services have 
improved organizational and patient outcomes, as this study attempts to answer under research 
question three.  
This study also uses longitudinal data from several states, located in three of four census 
regions to assure geographic diversity, to predict the association of hospital and market 
characteristics with the provision of hospital-based palliative care. This study employs a 
longitudinal analysis using data on patients, hospitals, and counties from years 2007 through 
2011. While cross-sectional designs are limited to estimating correlations between variables, 
longitudinal designs are able to account for hospital and market characteristics over time. 
Moreover, this study includes a more inclusive set of control and independent variables derived 
from organizational theory.  
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Additionally, hierarchical generalized linear models (HGLM) and hierarchical linear 
models (HLM) are employed to address this study’s research questions and test the 
corresponding hypotheses. Although most research on health service organizations deals with 
some form of nested data (e.g., patients nested within hospitals nested within counties nested 
within states), the majority of studies on hospital adoption of health services and their effects on 
organizational and patient outcomes have not properly accounted for the complexity of 
hierarchical data. This study uses HGLM and HLM to estimate effects of variables measured at 
different levels (i.e., patient, hospital, and county) on a hospital-level outcome (i.e., research 
question one) and four patient-level outcomes (i.e., research questions two and three). In the 
context of hierarchical data, this statistical approach has several advantages compared to 
conventional estimation methods. Some conventional models ignore the hierarchical structure by 
analyzing higher- and lower-level predictors in the same way. For example, county- and 
hospital-level variables are included into the conventional, non-hierarchical, single-level model 
to predict an outcome at the hospital level. Alternatively, patient-, hospital-, and county-level 
variables are included in a single-level model to predict an outcome at the patient level. In these 
approaches, standard errors are generally too small since they do not take into account the 
clustering of the lower-level units within the higher-level units (Raudenbush & Bryk, 2002b). 
Hence, these models are likely to induce Type I errors. In this study, the hierarchical nature of 
the data is emphasized and modeled accordingly. Conversely, some studies aggregate lower level 
information to a higher-level and include the aggregated information with other higher level 
variables as predictor variables into the single-level model. For instance, patient-level 
information, such as age, gender, or primary diagnosis, is averaged at the hospital level and 
included as an explanatory variable. These models may suffer from inefficient regression 
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estimates if the number of nested units within higher-level units varies significantly (Raudenbush 
& Bryk, 2002b). 
Summary 
 This chapter began with a review of the concept of palliative care, its evolution, and 
delivery models. It continued with a description of the relevance of key variables in the context 
of hospital performance and outlined existing evidence on the effects of hospital and market 
characteristics on palliative care provision and the impact of hospital-based palliative care on 
hospital costs, hospital length of stay, in-hospital mortality, and transfer to hospice.  
 The following chapter provides an overview of the theoretical framework used in this 
study and develops propositions and corresponding hypotheses to address the study’s research 
questions.  
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The underlying conceptual framework for this study is based on organizational theories 
and frameworks that have been used by other health services researchers to explain the nature of 
hospital service adoption and how it potentially influences hospital performance. Five 
propositions and hypotheses are derived from Resource Dependence Theory (RDT) and 
Institutional Theory (IT) corresponding to research question one: which organizational and 
environmental forces are associated with the provision of hospital-based palliative care services? 
Donabedian’s (1980) Structure-Process-Outcome framework for quality assessment is applied to 
derive one proposition and four hypotheses corresponding to research questions two and three, 
respectively: do hospitals that provide palliative care services have improved organizational and 
patient outcomes compared to those not providing such services?; and: Is a hospital’s experience 
in providing palliative care services associated with improved organizational and patient 
outcomes? 
This chapter is divided into two main sections. The first section provides an overview of 
Resource Dependence Theory (Pfeffer & Salancik, 1978), Institutional Theory (DiMaggio & 
Powell, 1983; Meyer & Rowan, 1977), and how Oliver’s (1991) model of organizational 
responsiveness combines both theories. Five propositions and hypotheses from these conceptual 
perspectives are then developed to explain palliative care adoption in hospitals. The second 
section discusses Donabedian’s (1980) Structure-Process-Outcome framework and establishes 
two propositions and eight corresponding hypotheses relating palliative care services with the 
Chapter 3: Theoretical Framework 
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study’s patient and organizational outcomes: hospital costs, length of stay, in-hospital mortality, 
and care transition to hospice. The last section concludes this chapter with a brief summary. 
Hospital Adoption of Palliative Care 
 To address research question one, five propositions and corresponding hypotheses are 
derived based on the theoretical perspectives of Resource Dependence Theory (Pfeffer & 
Salancik, 1978) and Institutional Theory (DiMaggio & Powell, 1983; Meyer & Rowan, 1977).  
Resource Dependence Theory is an open-system approach to organizational behavior. 
According to this theory, a hospital’s survival is contingent on two major determinants: the 
availability of internal resources and the ability to acquire and maintain critical resources from 
the environment (Scott & Davis, 2007). Critical resources include economic resources, 
reputation, and knowledge. This theory posits that organizations are not self-sufficient and must 
therefore engage in exchanges with other organizations, stakeholders, and the environment to 
acquire the resources necessary for their survival (Pfeffer & Salancik, 1978). If a hospital is not 
entirely in control of all conditions or resources necessary to achieve a desired goal or outcome, 
a certain degree of dependence between actors arises (Casciaro & Piskorski, 2005; Pfeffer & 
Salancik, 1978). The act of exchanging resources creates power and dependence relations, which 
make hospitals vulnerable to the demands of resource providers. Dependence is a measure of 
how potent external constituents in a hospital’s environment are and to what degree they need to 
be taken into consideration in the decision-making process (Pfeffer & Salancik, 1978). Then, in 
order to secure a stable flow of critical resources, reduce dependence, and maximize autonomy, 
hospitals may choose between a variety of strategies and tactics to coordinate these relations 
(Scott & Davis, 2007).  
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Institutional Theory, like Resource Dependence Theory, is an open-natural approach to 
organizational behavior. This theory argues that organizations are shaped and constituted by their 
institutional environments and corresponding pressures (Scott & Davis, 2007). At the center of 
this theory lies the concept of institutionalization. Institutionalization has been defined as a 
means or process to infuse intrinsic value to organizational structures or activities to promote 
organizational self-maintenance (Scott, 1987). These organizational structures or activities are 
viewed as adaptive systems formed in response to internal participants and external demands 
(Selznick, 1996). Once these structures or activities become valued, they are replicated by other 
organizations over time and are assigned similar meaning within a given society – they become 
institutionalized (Scott, 1987). These institutional demands or pressures can be viewed as highly 
rationalized myths that are binding for some organizations.  
Oliver’s (1991) model of organizational responsiveness combines the theoretical views of 
Institutional Theory and Resource Dependence Theory (Oliver, 1991). Both theories have been 
used successfully in prior research studies to explain why, how, and when hospitals respond to 
external demands, pressures, and expectations (Campbell & Alexander, 2005; Proenca, Rosko, & 
Zinn, 2000; Zinn, Weech, & Brannon, 1998). The basic argument to justify this combined 
approach is that both these open-system approaches to organizational behavior focus on the 
organization’s exchange with the environment (Scott & Davis, 2007). The theories assume that 
organizational strategic choice and response are restricted and shaped by multiple external 
demands, pressures, and expectations to which organizations must respond to secure survival, 
stability, and predictability (Oliver, 1991). Organizational responses to institutional pressures 
imposed by the environment may vary between complying with and resisting such demands. 
While RDT suggests that powerful constituents are those who control scarce resources, 
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institutional theorists assume that power resides in those who shape and enforce institutional 
rules, norms, and beliefs, such as government agencies, interest groups, and public opinion 
(Oliver, 1991; Proenca et al., 2000). Organizational responsiveness to demands of external 
constituents then varies according to the different assumptions about the degree of choice, 
awareness of pressures, and self-interest. Resource Dependence Theory assumes an active role of 
management (i.e., that organizational change is intentional) and that organizations seek to 
maintain autonomy and obtain resources for survival. Institutional Theory adopts a more passive 
role of management. It posits that organizations seek legitimacy for survival by conforming to 
collective norms and beliefs. Yet institutional theorists started to acknowledge explicitly the role 
of agency, organizational interest, and strategic choice in explaining the variation in 
organizational responses to institutional environments (Goodrick & Salancik, 1996; Oliver, 
1991; Pache & Santos, 2010; Scott, 1987). Research has suggested that organizational interest 
and discretion is greater when institutional rules are uncertain, unclear, conflicting, or 
inconsistent with technical requirements (Goodrick & Salancik, 1996; Pache & Santos, 2010). 
Conflicting institutional demands typically arise in environments where multiple, uncoordinated 
actors with different views on what is effective and legitimate coexist (i.e., fragmentation) and 
where these actors have the ability to enforce their demands (i.e., centralization) (Pache & 
Santos, 2010). The health care environment is indeed inherently complex, uncertain and highly 
dynamic, manifested by fragmented health care delivery, ambiguous policies and values, 
incompatible financial incentives, and multifaceted regulatory systems, (Proenca et al., 2000). 
This diverse environment is likely to pose different, potentially competing demands on hospitals, 
so that their responsiveness is likely to vary according to type, relative intensity of external 
pressures, and organizational goals and interests.  
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Hospitals are increasingly providing palliative care services to their patient population. 
The hospital’s environment may pose demands, expectations, and norms onto a hospital, to 
which it may respond through providing palliative care services. Both the internal (i.e., 
organizational factors) and external environment (i.e., market factors) determine how the hospital 
functions. According to RDT and IT, organizational and environmental factors may explain why 
hospitals decide to provide palliative care services. The combined approach by Oliver (1991) is 
appropriate to explain why hospitals decide for or against providing palliative care services. In 
this model, five drivers of strategic responses to institutional pressures to conform to norms, 
demands, or expectations are presented: cause, constituents, control, context, and content. These 
five categories will function as an overarching conceptual framework for the first five 
propositions and the corresponding hypotheses to address research question one.  
The first antecedent of strategic responsiveness relates to the cause of institutional 
pressures, which refers to “the rationale, set of expectations, or intended objectives that underlie 
external pressures for conformity” (Oliver, 1991, p. 161). This factor refers to the reason that a 
focal hospital is pressured to conform to norms, demands, or expectations. A related factor is 
control, which relates to the method or means by which a hospital is pressured to conform to 
external pressures. Due to its similarity, control will not be discussed separately (Fareed, 2013). 
The decision to conform or not depends on how much a hospital agrees with and values the 
objectives and intentions of institutional constituents who try to pressure hospitals to be more 
economically and socially accountable. Integrating palliative care into the hospital’s service mix 
is said to improve quality of care and increase a hospital’s economic viability through cost-
savings when provided to patients who are most likely to benefit from palliative care services 
(Center to Advance Palliative Care, 2014). In particular, the National Quality Forum (NQF) 
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developed quantifiable quality indicators for palliative care in the hospital setting; the Joint 
Commission provides an advanced certification for palliative care; and the National Consensus 
Project for Quality Palliative Care (NCP) promotes evidence-based practices to optimize 
palliative care programs. An industry-wide emphasis on the importance of palliative care in 
providing high-quality care may be viewed as an institutional pressure, which, in turn, may 
influence a hospital with similar values and objectives to provide palliative care services in hope 
of reaching or maintaining legitimacy and economic health (Oliver, 1991; Proenca et al., 2000). 
This is particularly true for large hospitals, as their size increases their visibility and public 
exposure. From an economic perspective, a positive relationship between hospital size and 
palliative care provision may also imply the existence of economies of scope. Therefore, it is 
proposed,  
 Proposition 1: Hospital size is positively associated with the provision of palliative care 
services. 
 Hypothesis 1: Hospitals with more staffed and set-up beds are more likely to provide 
palliative care services compared to hospitals with fewer staffed and set-up beds, 
ceteris paribus.  
Another antecedent of strategic responsiveness relates to the environmental context, in 
which institutional pressures are exercised. According to RDT, the level of market competition is 
an essential external factor that influences organizational change (Zinn et al., 1998). Greater 
competition increases the demand on a shared pool of resources (Fareed & Mick, 2011; Zinn et 
al., 1998). Hospitals must compete for the same resources, which makes inputs scarcer and 
pressures hospitals to differentiate themselves from competitors (Kazley & Ozcan, 2007). 
Providing hospital-based palliative care services may be seen as a method to attract patients and 
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manage organizational interdependence (Scott & Davis, 2007). In areas with a higher density of 
competitors, more hospitals compete for the same patient population (e.g., patient referrals). 
Providing hospital-based palliative care services may be a visible indicator of the hospital’s 
effort to accommodate the internal and external stakeholders. In competitive markets, hospitals 
may argue that the provision of palliative care services makes them more attractive to potential 
patients, who have a wider variety of health care settings to choose from compared to less 
competitive markets (Kazley & Ozcan, 2007). Offering hospital-based palliative care services 
may establish a competitive advantage in securing the flow of resources needed for 
organizational success (Zinn et al., 1998). Thus, 
Proposition 2: Market competition is positively associated with the provision of palliative 
care services. 
 Hypothesis 2: Hospitals in more competitive markets (i.e., counties) are more likely 
to provide palliative care services compared to hospitals in less competitive markets 
(i.e., counties), ceteris paribus.  
 Interconnectedness is another context-related predictor of organizational conformity 
(Oliver, 1991). Organizations in highly interconnected environments are predicted to be more 
likely to comply with the values, norms, or expectations of the environment, facilitated by 
voluntary or regulatory diffusion of information and best-practice guidelines (DiMaggio & 
Powell, 1983; Meyer & Rowan, 1977; Pfeffer & Salancik, 1978). Hospitals affiliated with a 
health system typically have access to greater internal resources (e.g., capital to invest in 
palliative care services) to respond to environmental pressures (Banaszak-Holl, Zinn, & Mor, 
1996). On the other hand, the availability of alternative sources for key resources may also 
moderate the need to comply with such pressures (Zinn, Weimer, Spector, & Mukamel, 2010). 
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That is, having access to palliative care services through a health system, network, or joint 
venture in the local community provides an alternative source of such services. Hospitals 
affiliated with a health system, network, or joint venture offering palliative care services at 
another location may be less likely to provide their own palliative care services. Therefore, it is 
proposed, 
 Proposition 3: The availability of alternative sources for palliative care services is 
negatively associated with the provision of palliative care services.  
 Hypothesis 3: Hospitals that have access to palliative care services through a health 
system, network, and/or joint venture in their local community are less likely to 
provide palliative care services in-house, ceteris paribus.  
 Constituents are stakeholders who express expectations, norms, or demands, to which 
hospitals may feel pressured to conform (Oliver, 1991). Providing cost-effective care is one of 
the primary demands of public payers, such as Medicare. Palliative care practices in the hospital 
setting have been shown to contain hospital costs, reduce length of stay in the hospital and ICU, 
decrease the use of unnecessary treatments, and decrease 30-day hospital readmissions (Nelson, 
Chand, Sortais, Oloimooja, & Rembert, 2011). Providing hospital-based palliative care services 
may be viewed as a means to meet demands related to the provision of cost-effective care. In 
addition, Medicare patients are typically good candidates for palliative care services, as they are 
older and tend to spend an extended period of time in the hospital at the end of life. Hospitals 
with a greater Medicare share of inpatient days are more likely to depend on Medicare 
reimbursements for economic survival than hospitals with a lower proportion of Medicare 
patients. Thus, it is proposed,  
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 Proposition 4: Medicare dependence is positively associated with the provision of 
palliative care services. 
 Hypothesis 4: Hospitals with a greater Medicare share of inpatient days are more 
likely to provide palliative care services compared to hospitals with a smaller 
Medicare share of inpatient days, ceteris paribus. 
 The final antecedent of strategic responsiveness, content, relates to which particular 
expectations, norms, or demands the hospital needs to conform. In other words, content refers to 
the nature of environmental pressures (Oliver, 1991). If such pressures are consistent with the 
hospital’s internal goals, values, and mission, a hospital is more likely to conform. Hospital 
teaching status may reflect a hospital’s internal goals, values, and mission. Teaching hospitals 
are dedicated to providing clinical care, conducting research, and teaching the future workforce. 
Teaching hospitals may view the provision of palliative care services as an important part of 
teaching and providing comprehensive care. Specifically, the education and training of medical 
students may be viewed as essential to provide quality palliative care to an aging population that 
increasingly deals with serious chronic illnesses, such as cancer. Therefore, it is proposed,  
 Proposition 5: Teaching status is positively associated with the provision of palliative 
care services.  
 Hypothesis 5: Hospitals that are COTH (Council of Teaching Hospitals) members are 
more likely to provide palliative care services compared to hospitals that are non-
COTH members, ceteris paribus.  
Hospital Performance Effects of Palliative Care 
 To address research questions two and three, two propositions and eight corresponding 
hypotheses are derived based on Donabedian’s (1980) Structure-Process-Outcome (SPO) 
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framework for quality assessment. Donabedian identifies three categories of quality measures, 
namely structure, process, and outcomes of care. Structural characteristics affect the process of 
care, which, in turn, affect outcomes of care. Structure is described as “the attributes of the 
setting in which care occurs” (Donabedian, 1988, p. 1745). The main proposition of the 
structural component is that high-quality care can only occur in the “appropriate” setting. 
Structural attributes of a hospital setting may be described in terms of environmental, 
organizational, and patient characteristics. Process refers to the actual provision of care. Finally, 
outcome denotes “the effects of care on the health status of patients and populations” 
(Donabedian, 1988, p. 1745). This model provides a conceptual framework to test whether 
hospital-based palliative care services have an association with organizational and patient 
outcomes. 
This study views palliative care services as a structural component of care, as palliative 
care services provide hospitals with a “systematic approach” to coordinate and manage care for 
complex patients and assist with appropriate transitioning between health care settings (Center to 
Advance Palliative Care, 2014). Studies have found that palliative care services lead to cost 
containment due to decreased hospital and ICU length of stay (Campbell & Guzman, 2003; 
2004), and more appropriate utilization of health care services, such as laboratory tests, and 
radiological tests (Lautrette et al., 2007; O'Mahony et al., 2010).  
In this study, it is proposed that hospitals that provide palliative care services produce 
improved organizational and patient outcomes compared to hospitals that do not provide 
palliative care services. Furthermore, hospitals that are more experienced in providing palliative 
care services have better outcomes than hospitals that are less experienced in providing palliative 
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care services. The two propositions and their corresponding hypotheses related to organizational 
patient outcomes are formally stated as follows: 
 Proposition 6: The provision of palliative care services is associated with improved 
patient and organizational outcomes.  
 Hypothesis 6a: Patients treated in hospitals that provide palliative care services incur 
lower hospital costs than patients treated in hospitals that do not provide such 
services, ceteris paribus. 
 Hypothesis 6b: Patients treated in hospitals that provide palliative care services have 
shorter hospital LOS than patients treated in hospitals that do not provide such 
services, ceteris paribus. 
 Hypothesis 6c: Patients treated in hospitals that provide palliative care services are 
less likely to die during hospitalization than patients treated in hospitals that do not 
provide such services, ceteris paribus. 
 Hypothesis 6d: Patients treated in hospitals that provide palliative care services are 
more likely to transfer to hospice than patients treated in hospitals that do not provide 
such services, ceteris paribus. 
 Proposition 7: Greater experience in providing palliative care is associated with improved 
patient and organizational outcomes.  
 Hypothesis 7a: Patients treated in hospitals that are more experienced in providing 
palliative care services incur lower hospital costs than patients treated in hospitals that 
are less experienced, ceteris paribus. 
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 Hypothesis 7b: Patients treated in hospitals that are more experienced in providing 
palliative care services have shorter hospital LOS than patients treated in hospitals 
that are less experienced, ceteris paribus. 
 Hypothesis 7c: Patients treated in hospitals that are more experienced in providing 
palliative care services are less likely to die during hospitalization than patients 
treated in hospitals that are less experienced, ceteris paribus. 
 Hypothesis 7d: Patients treated in hospitals that are more experienced in providing 
palliative care services are more likely to be transferred to hospice than patients 
treated in hospitals that are less experienced, ceteris paribus. 
Summary 
 This chapter established a theoretical framework by drawing on Institutional Theory, 
Resource Dependence Theory, and Donabedian’s Structure-Process-Outcome framework to 
explain the impact of hospital and market factors on palliative care provision and the effects of 
palliative care services on patient and organizational outcomes. Based on the theoretical 
framework, seven propositions and 13 corresponding hypotheses were derived. The next chapter 
describes this study’s research methodology, including research design, data sources, study 
sample, variable measurement, empirical methodology, and sensitivity analyses.  
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 This chapter explains the research methods used to explore the nature of hospital-based 
palliative care provision and the relationship between hospital-based palliative care provision 
and hospital costs, hospital length of stay, in-hospital mortality, and transfer to hospice.  
The first section identifies the research design; the next four sections describe the data 
sources, study sample, variable measurement, and the empirical methodology employed to 
investigate the study’s research questions. The last section outlines the set of sensitivity analyses 
used to evaluate the robustness of the empirical results. The chapter concludes with a summary. 
Research Design 
 This study, observational and retrospective in nature, aims to examine the relationship 
between hospital and market characteristics and hospital-based palliative care provision (research 
question one) and the association between hospital-based palliative care provision and patient 
and organizational outcomes (research questions two and three).  
To test the seven propositions and 13 hypotheses presented in the previous section, this 
study analyzes a longitudinal data set, which encompasses a five-year (2007-2011) time frame 
and six U.S. states (Arizona, California, Florida, Maryland, New Jersey, and New York). A two-
level hierarchical generalized linear model (HGLM) is used to analyze the five hypotheses 
proposed under research question one. Four three-level HGLM or hierarchical linear models 
(HLM) are estimated to test the hypotheses proposed under research questions two and three.  
Chapter 4: Methodology 
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General, short-term, acute care, non-federal, and urban hospitals in the U.S. are units of 
analysis nested within counties for research question one. Hospital i is the lower level unit nested 
within the higher level unit county j (i.e., level-2 unit). Independent and control variables were 
obtained or constructed at the hospital or county level. For research questions two and three, the 
lowest level units of analysis are hospital visits of patients aged 18 and older with one of eight 
primary diagnoses deemed most likely to benefit from palliative care. Further detail is provided 
in a later section of this chapter. Patient i is a level-1 unit nested within hospital j (i.e., level-2 
unit) nested within county k (i.e., level-3 unit). Independent and control variables were obtained 
or constructed at the patient, hospital, or county level.  
Two additional empirical specifications are noteworthy. First, all analytical models in this 
study are estimated using a balanced sample of hospitals; that is, hospitals that consistently 
provided hospital information across the five-year study period. A balanced panel was used to 
facilitate the construction of palliative care adoption patterns for hospitals across the study 
period. Finally, years (i.e., time points) are not modelled as an additional hierarchical level in any 
of the analytical models outlined in the previous paragraph. Specifically, for research question 
one, level-1 units consist of hospitals with five observations for the years 2007 through 2011. For 
research questions two and three, level-2 units constitute hospitals with five observations for the 
years 2007 through 2011.  
Data Sources 
Administrative data are obtained and merged from a variety of sources to acquire wide-
ranging information about market and hospital characteristics, hospitals’ patterns of palliative 
care provision, and measures of hospital performance. The two primary data sources for this 
study are the AHA Annual Survey of Hospitals and State Inpatient Databases (SID) for Arizona, 
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California, Florida, Maryland, New Jersey, and New York from 2007 to 2011. The AHA Annual 
Survey of Hospitals is conducted on a yearly basis by the American Hospital Association and 
collects information from over 6,400 hospitals nationwide with an annual response rate of more 
than 75%. Participating hospitals respond to approximately 1,000 questions spanning a variety of 
categories, including organizational structure, demographics, staffing, service utilization, 
facilities and services, and managed care affiliations (American Hospital Association, 2014).  
The SID are assembled by the Healthcare Cost and Utilization Project (HCUP), which is 
sponsored by the Agency for Healthcare Research and Quality (AHRQ). A wide range of clinical 
and non-clinical data elements are available for each inpatient discharge record, including patient 
demographics, primary and secondary diagnoses, hospital length of stay, payer source, hospital 
charges, and disposition at discharge (Agency for Healthcare Research and Quality, 2015).  
The study also includes data from four supplemental administrative databases: the Area 
Health Resources Files (AHRF), the HealthLeader-Interstudy databases, the Medicare Hospital 
Cost Reports, and data provided by the American Nurses Credentialing Center (ANCC). These 
data are used to construct control variables at the hospital and county level. The AHRF, 
maintained by the National Center for Health Workforce Analysis (NCHWA), Bureau of Health 
Workforce within the Health Resources and Services Administration (HRSA), encompasses over 
6,000 current and historical data elements for counties nationwide, including population 
demographics, hospital utilization, health care professions, and health facilities. The 
HealthLeaders-InterStudy databases are used to obtain annual HMO and PPO enrollment data. 
The Healthcare Cost Report Information System (HCRIS), collected and maintained by the 
Centers for Medicare and Medicaid Services (CMS), provides a variety of financial performance 
data for Medicare-certified hospitals by fiscal year, including data elements from hospitals’ 
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income statements and balance sheets (Centers for Medicaid and Medicare Services, 2015b). 
Finally, information on hospitals recognized as a Magnet organization by the ANCC Magnet 
Recognition Program® in the years 2007 through 2011 are hand-collected from the ANCC’s 
website. Magnet organizations are acknowledged for their excellence in a variety of nursing 
processes and high-quality patient care (American Nurses Credentialing Center, 2014). 
Data from the AHA Annual Survey of Hospitals and SID are merged by the hospital’s 
AHA identification number. The merged dataset is then linked with the Medicare Hospital Cost 
Reports by the hospital’s Medicare provider number. Hospitals with a cost reporting period of 
less than 360 and more than 370 days are excluded. Hand-collected data on ANCC Magnet 
designation are manually added to the merged dataset by hospital name. Finally, market-level 
information from AHRF and HealthLeaders-InterStudy are merged by the hospital’s county 
federal information processing standard (FIPS) code.  
Study Sample 
Data from hospitals in the following six states are used to examine the three research 
questions: Arizona, California, Florida, Maryland, New Jersey, and New York. There are several 
reasons for choosing hospitals from the aforementioned states. First, these states provide 
consistent and comprehensive information on hospital characteristics and hospitalized patients 
over the study period required to investigate the study’s research questions. Hospitals within 
these states also experienced a growing trend in hospital-based palliative care provision over the 
study’s time period. Additionally, the included states are located in three of the four U.S. census 
regions and constitute approximately 19% of general medical and surgical hospitals nationwide. 
These states also have a sufficiently large number of hospitals within counties and patients 
within hospitals, which is necessary to estimate this study’s hierarchical models with random 
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effects at the county and hospital level. Finally, three of the states, California, Arizona, and 
Florida, are traditional retirement states. As the elderly are one of the primary target populations 
for palliative care, findings from this study may provide valuable insight for policy makers in 
states with a high proportion of elderly residents.  
Several additional sample exclusion criteria are employed to establish homogeneity of the 
study sample. First, specialty hospitals, such as prison hospitals, psychiatric hospitals, 
rehabilitation facilities, and hospitals that restrict admissions primarily to children, are excluded 
from the study sample. Specialty hospitals serve specific patient populations, to whom they 
provide a more limited array of services than general acute care hospitals. Patterns of palliative 
care adoption among specialty hospitals are therefore likely to be different from patterns at 
general acute care hospitals. Additionally, hospitals under federal control, such as Veterans 
Affairs (VA) hospitals, are also excluded from the study sample, because they are federally 
mandated to make a palliative care consult team available (Veterans Health Administration, 
2008). The study focuses on non-federal, general acute care hospitals in metropolitan counties. 
Among the study states, the percentage of inpatient discharge records in metropolitan areas 
ranges from 91.83% in California to 100% in New Jersey. Finally, hospitals that did not respond 
to the AHA Annual Survey of Hospitals consistently throughout the study’s time period and 
hospitals that had missing values for key or control variables were excluded from the study 
sample.  
Several additional patient-level exclusion criteria are employed in this study to establish a 
homogenous patient sample. First, SID inpatient discharge records are restricted to patients aged 
18 and older. While pediatric and adult palliative care are similar in nature, palliative care needs 
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of children with complex and serious illnesses often differ from palliative care needs of adult 
patients.  
Second, SID inpatient discharge records are also limited to patients who are assigned one 
of the following eight primary diagnoses deemed most likely to benefit from and receive 
palliative care services: acute cerebrovascular disease, acute myocardial infarction, cancer, 
congestive heart failure, chronic obstructive pulmonary disease, dementia, HIV infection, and 
dementia. The selection of primary diagnoses is based on the most frequent causes of death 
nationwide (Murphy et al., 2013) and prior literature (Santa-Emma, Roach, Gill, Spayde, & 
Taylor, 2002; Stover, 2005; Weissman & Meier, 2011). Disease categories generated by the 
Clinical Classification Software (CCS) for the International Classification of Diseases, 9th 
Revision, Clinical Modification (ICD-9-CM) are used to identify this study’s patient population. 
The CCS was developed by the Healthcare Cost and Utilization Project (HCUP) and is a 
standardized coding system, which places ICD-9-CM codes into manageable and clinically 
meaningful categories (Healthcare Cost and Utilization Project, 2015).  
By limiting the study’s patient sample to patients with the above-mentioned primary 
diagnoses, the analysis more clearly focuses on those individuals most likely to benefit from 
palliative care services. It may be noted that an inclusion criterion based on primary diagnosis 
may include inpatient discharge records from patients who did not receive palliative care 
services or, conversely, exclude inpatient discharge records from patients who received palliative 
care services. Hence, these sample selection criteria only approximate the hospital’s patient 
population most likely to benefit and receive palliative care services. Table 5 displays the CCS 
categories and corresponding ICD-9-CM diagnosis chapters that are associated with the study’s 
eight primary diagnoses. 
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Table 5 
5Primary Diagnosis, CCS Category, and ICD-9-CM Diagnosis Chapter 
Primary Diagnosis 
CCS 
Category 
ICD-9-CM Diagnosis Chapter 
Acute cerebrovascular disease 109 7 - Diseases of circulatory system 
Acute myocardial infarction 100 7 - Diseases of circulatory system 
Cancer 11-45 2 – Neoplasms 
Congestive heart failure 108 7 - Diseases of circulatory system 
COPD 127 8 - Diseases of respiratory system 
Dementia 653 5 - Mental illness 
HIV 5 1 - Infectious and parasitic diseases 
Pneumonia 122 8 - Diseases of respiratory system 
 
Note. CCS=Clinical classification software. COPD=Chronic obstructive pulmonary disease. HIV=Human 
immunodeficiency virus. ICD-9-CM=International Classification of Diseases, 9th Revision, Clinical Modification.  
 
 Approximating the study’s palliative care patient population is necessary, as ICD-9-CM 
codes uniquely identifying palliative care patients are largely absent or lack consistent 
application. Finally, inpatient discharge records with missing values for any dependent or control 
variable and inpatient discharge records with reported hospital lengths of stay greater than 30 
days are excluded from the study sample. Table 6 provides an overview of the number of 
patients, hospitals, and counties dropped based on this study’s sample exclusion criteria, missing 
or invalid values.  
 According to Table 6, 93.66% of patients, 66.11% of hospitals, and 51.95% of counties 
were dropped based on the study’s sample exclusion criteria, missing or invalid values for at 
least one of the study’s patient and hospital characteristics. Note that there was no missing 
information on any of the study’s county characteristics.  
 The majority of patients aged 18 and older (84.49%) did not have one of the study’s eight 
selected primary diagnoses. About one in every four urban, non-federal, general, acute care 
hospitals (22.84%) did not have information on the availability of at least one of the three 
palliative care services (PAL, IPAL, or HOSPC) for one or more study years. For a given   
  
8
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Table 6 
6Stepwise Removal Process of Study Observations Across All Study Years 
   Patient   Hospital   County  
Overall sample   59,315,052             5,134             1,155  
 Sample criteria       
 Patient:   Patients aged < 18 years     9,783,840                 12                   0  
 Patient:   Primary DX not ACD, AMI, cancer, CHF, COPD, dementia,   
                 HIV, or pneumonia   41,848,720                176                   0   
 Patient:   Length of stay > 30 days        124,338                    4                   0   
 Hospital: Federal, non-urban, long-term, and specialty hospitals        533,942             1,230                410  
 Missing/inconsistent values        
 Key Variables        
 PAL, IPAL, and/or HOSPC (missing)     1,127,506                848                  60  
 PAL, IPAL, and/or HOSPC (unrealistic implementation patterns)     1,266,206                859                  80  
 Number of set-up and staffed beds (Hypothesis 1)                   0                    0                    0   
 1 minus Herfindahl-Hirschman Index (Hypothesis 2)                   0                    0                    0   
 Presence of PC services in health system/network/JV (Hypothesis 3)                  0                    0                    0   
 Share of Medicare patients (%) (Hypothesis 4)                  0                    0                    0   
 Teaching hospital (Hypothesis 5)                   0                    0                    0   
 Control Variables        
 Hospital        627,701                265                  50  
 Patient        239,460  0 0 
 County                   0   0 0 
 Final sample     3,763,339             1,740                555  
 Annual average        752,668        348        111  
 % overall sample analyzed  6.34% 33.89% 48.05% 
 
Note. ACD=Acute cerebrovascular disease. AMI=Acute myocardial infarction. CHF=Congestive heart failure. COPD=Chronic obstructive pulmonary 
disease. DX=Diagnosis. HIV=Human immunodeficiency virus. HOSPC=Hospice program. IPAL=Inpatient palliative care unit. JV=Joint venture. 
PAL=Inpatient palliative care consultation service. PC=Palliative care. 
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palliative care service, information was missing both at random in a given study year for some 
hospitals and throughout the study period for other hospitals. 
 Moreover, 859 hospitals were excluded from the study sample because of unrealistic 
implementation patterns for PAL, IPAL, or HOSPC; that is, these hospitals repeatedly switched 
between having and not having a palliative care service during the five year study period. Note 
that consistent implementation patterns of palliative care services were an essential prerequisite 
for constructing the three key independent variables to address research question three, namely 
experience in providing PAL, IPAL, or HOSPC, as described later in this chapter. Regarding 
research question one, it is also important to avoid modeling false changes in palliative care 
provision over the study period, as within-hospital coding errors in the dependent variable are 
magnified in the context of modeling random effects.  
 In addition, imputations were performed for 27 hospitals. Specifically, 18 hospitals were 
categorized as hospitals with no palliative care service throughout the study period if they had no 
palliative care service in any study period except in one year between 2008 and 2010. Similarly, 
nine hospitals were categorized as hospitals with continuous provision of a palliative care service 
throughout the study period if they had a palliative care service in all study years except in one 
year between 2008 and 2010. 
Variable Measurement  
 The following sections are grouped into descriptions of key variables, including 
dependent variables, key independent variables, and control variables for the three research 
questions. Dependent variables and control variables for research questions two and three are 
discussed within one section, as they are the same for both research questions.  
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Research question one: dependent and key independent variables. 
Research question one examines which hospital and market characteristics are associated 
with the hospital provision of palliative care services. Five propositions and corresponding 
hypotheses have been proposed. Table 7 provides an overview of the dependent variable and five 
key independent variables constructed to model hospital-based palliative care provision. 
Research question one: control variables. 
 Hospital provision of palliative care may be influenced by other factors present in the 
hospital’s institutional environment. These factors are included as control variables in the 
analytical model and can be grouped into hospital and market characteristics.  
 Several hospital characteristics are included in the models to control for confounding 
factors associated with the provision of hospital-based palliative care. Specifically, lagged 
operating margin as a proxy for financial performance (measured as the ratio of net patient 
income and net profit revenue in the prior year), ANCC Magnet recognition as a proxy for higher 
quality of care, and ownership type as a proxy for a hospital’s mission, are potential confounders 
that may affect the hospital’s decision to adopt palliative care services. Binary variables, based 
on the information reported in the AHA Annual Survey of Hospitals, are used to denote the 
hospital’s type of ownership: for-profit, public, and not-for-profit (reference group). In regard to 
ANCC Magnet recognition, a binary variable is constructed, using hand-collected information 
from the ANCC website, to identify hospitals that were recognized as Magnet organizations.  
 Additionally, patient severity or complexity may influence a hospital’s decision to 
provide palliative care services. That is, hospitals with a higher case-mix index (CMI) may be 
more likely to offer palliative care services in order to meet patients’ palliative care needs. This 
index is constructed and provided by the Centers for Medicare and Medicaid Services (CMS) 
 88 
 
Table 7 
7A Description of Key Variables, Research Question One 
Construct Variable Measurement Unit  Database 
Dependent Variable 
Hospital-based 
PC provision 
Presence of PAL, 
IPAL, and/or 
HOSPC 
Binary variable;  
=1 if hospital has PAL, IPAL, 
and/or HOSPC; =0 otherwise 
Hospital 2007-2011 
AHA 
Annual 
Hospital 
Surveys 
Independent Variables 
H1: Size  
 
Hospital bed size 
 
Continuous variable; 
measured as the number of 
staffed and set-up beds (in 
10s). 
Hospital 2007-2011 
AHA 
Annual 
Hospital 
Surveys 
H2: Market 
competition 
1 – Herfindahl-
Hirschman Index 
(HHI) 
Continuous variable; 
constructed by subtracting the 
sum of the squares of market 
shares of admissions for all 
hospitals in the county from 
1; values range from 0 to 1. 
Values closer to 1 indicate 
higher levels of competition. 
County 
 
2007-2011 
AHA 
Annual 
Hospital 
Surveys 
H3: Availability 
of alternative 
palliative care 
resources 
Presence of PAL, 
IPAL, and/or 
HOSPC in a 
hospital’s health 
system, network, 
and/or joint 
venture. 
Binary variable;  
=1 if hospital has PAL, IPAL, 
and/or HOSPC in health 
system, network and/or joint 
venture; =0 otherwise. 
Hospitals in the same county 
belonging to the same health 
system are combined. 
Hospital 
 
2007-2011 
AHA 
Annual 
Hospital 
Surveys 
H4: Medicare 
dependence 
Share of 
Medicare patients 
Continuous variable; 
calculated by dividing 
Medicare inpatient days by 
total inpatient days. 
Hospital 2007-2011 
AHA 
Annual 
Hospital 
Surveys 
H5: Teaching 
status 
COTH 
membership 
Binary variable; =1 if hospital 
is COTH-member; =0 
otherwise. 
Hospital 2007-2011 
AHA 
Annual 
Hospital 
Surveys 
 
Note. AHA=American Hospital Association. COTH=Council of Teaching Hospitals. HHI=Herfindahl-Hirschman 
Index. HOSPC=Hospice program. IPAL=Inpatient palliative care program. PAL=Inpatient palliative care 
consultation service. 
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and represents a hospital’s average diagnosis-related group (DRG) relative weight. It is 
calculated by summing the DRG weights for all Medicare discharges and dividing the sum by 
the total number of discharges. Similarly, several additional characteristics of the hospital’s 
patient population may influence the hospital’s need or desire to provide palliative care services, 
including the percentage of patients with primary diagnoses most likely to benefit from palliative 
care, the percentage of patients aged 65 and older, the percentage of Hispanic patients, the 
percentage of black patients, and the hospital’s average length of stay. Moreover, a hospital’s 
nursing capacity may influence the likelihood of providing palliative care services. Nursing 
capacity is measured as a continuous variable by dividing the hospital’s number of full-time 
registered nurses by total nurses.  
Multiple demand-related county characteristics are included as control variables. 
Specifically, environmental uncertainty may affect the hospital’s managerial decision to conform 
to institutional demands (Oliver, 1990). Environmental uncertainty depends on the availability of 
critical resources in the environment (i.e., munificence) (Pfeffer & Salancik, 1978) and may 
influence the hospital’s decision or ability to provide palliative care services. The following 
variables are used in this study to account for munificence: the fraction of uninsured individuals 
aged between 18 and 64, market size (i.e., the number of total residents in the county), inflation-
unadjusted per capita income, the unemployment rate for individuals aged 16 and older, HMO 
penetration (i.e., the percentage of fully insured lives covered by HMO), and PPO penetration 
(i.e., the percentage of fully insured lives covered by PPO) in the hospital’s county. Finally, the 
area wage index is included to account for geographic cost differences or price factors. This 
index is computed and provided by CMS and comprises the ratio of the average hourly wage of a 
geographic area to the average hourly wage nationwide. Hospital geographic areas are defined in 
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accordance with the Core-Based Statistical Areas (CBSAs), established by the Office of 
Management and Budget. The national average hourly wage is calculated by dividing total wage 
costs by total hours for hospitals nationwide, whereas the average hourly wage for each 
geographic area is calculated by dividing total wage costs by total hours for hospitals in the 
geographic area. Therefore, hospitals located in the same geographic area are assigned the same 
values for the area wage index. 
To account for time-specific effects, dummy variables are included for each year with 
year 2007 as the reference. Lastly, this study accounts for geographic variation by including five 
state indicators, as prior research consistently demonstrated significant geographic variation in 
hospital-based palliative care provision (e.g., Dumanovsky et al., 2015). California is treated as 
the reference.  
Research questions two and three: dependent and key independent variables. 
Research question two investigates whether patients treated in hospitals with palliative 
care services incur lower hospital costs, have shorter hospital stays, are less likely to die during 
hospitalization, and are more likely to be transferred to hospice, corresponding to hypotheses 6a 
through 6d. Research question three explores whether patients treated in hospitals that are more 
experienced in providing palliative care services incur lower hospital costs, have shorter hospital 
stays, are less likely to die during hospitalization, are more likely to be transferred to hospice, 
corresponding to Hypotheses 7a through 7d. Table 8 presents the dependent and independent 
variables used to test these eight hypotheses. 
Four important features are noteworthy concerning the measurement of the key 
dependent and independent variables presented in Table 8. First, in regard to length of stay, the 
last day of hospitalization for patients transferred to hospice is determined by the day of hospice  
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Table 8 
8A Description of Key Variables, Research Questions Two and Three 
Construct Variable Measurement Unit  Database 
Dependent Variables – Research Questions Two and Three 
Organizational 
outcome 
Hospital costs  Continuous variable; 
measured in constant 
2007 U.S. dollars; log of 
total patient charges 
multiplied by hospital’s 
CCR and (PPI2007/PPI2007+) 
Patient 2007-2011 
SID for 
AZ, CA, 
FL, MD, 
NJ, & NY 
Patient  
outcome  
Hospital length of 
stay (LOS) 
Count variable; 
LOS is defined by the 
difference between day of 
admission and day of 
discharge or death 
Patient 2007-2011 
SID for 
AZ, CA, 
FL, MD, 
NJ, & NY 
Patient  
Outcome 
In-hospital mortality Binary variable; 
1=died during hospital 
stay; 0=otherwise. 
Patient 2007-2011 
SID for 
AZ, CA, 
FL, MD, 
NJ, & NY 
Patient  
Outcome 
Transfer to hospice Binary variable; 
1=discharged to home 
hospice or hospice 
facility; 0=otherwise. 
Patient 2007-2011 
SID for 
AZ, FL, NJ, 
& NY 
Independent Variables – Research Question Two 
H6a-d:  
Palliative care 
provision 
 
Presence of hospital-
based:  
1) PAL 
2) IPAL 
3) HOSPC 
Three binary variables; 
1) 1=hospital has PAL; 
       0=otherwise. 
2) 1=hospital has IPAL; 
       0=otherwise. 
3) 1=hospital has 
HOSPC; 0=otherwise. 
Hospital 2007-2011 
AHA 
Annual 
Hospital 
Surveys 
Independent Variables – Research Question Three 
H7a-d:  
Palliative care 
experience 
Years of experience 
providing hospital-
based: 
1) PAL 
2) IPAL 
3) HOSPC 
Three continuous 
variables; 
1) # of years PAL 
present (since 2006). 
2) # of years IPAL 
present (since 2006). 
3) # of years HOSPC 
present (since 2006). 
Hospital 2007-2011 
AHA 
Annual 
Hospital 
Surveys 
 
Note. AHA=American Hospital Association. AZ=Arizona. CA=California. CCR=Cost-to-charge ratio. FL=Florida. 
HOSPC=Hospice program. IPAL=Inpatient palliative care program. LOS=Length of stay. MD=Maryland, NJ=New 
Jersey. NY=New York. PAL=Inpatient palliative care consultation service. PPI=Producer-price index. SID=State 
inpatient database.  
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transfer regardless of whether the patient is transferred to a hospital-based or an outside hospice 
facility. 
Second, in regard to hospital costs, a hospital’s cost-to-charge ratio (CCR) is the ratio of 
a hospital’s total operating and capital-related expenses and total hospital charges using 
information from the Medicare Hospital Cost Reports. The ratio ranges from zero to one, where 
a value closer to zero constitutes a greater difference between hospital costs and hospital charges. 
The Agency for Healthcare Research and Quality provides CCR files for 2007 through 2011 
used to convert the patient’s hospital charges into their corresponding cost estimates. This study 
applies a hospital-specific all-payer inpatient CCR (APICC) if available. If APICC is not 
available, a weighted group-average all-payer inpatient CCR (GAPICC) is used, which is a 
weighted average of CCR for a hospital in a given group. A group is defined by state, urban/rural 
location, for-profit/not-for-profit ownership, and number of beds. The hospital’s proportion of 
beds in a given group are used as the weight for each hospital. 
Third, in regard to hospice transfers, transfers to home hospice include patients who were 
discharged to receive hospice care at their place of residence, which may include a patient’s 
private residence, nursing home, or assisted-living facility. Transfers to a hospice facility include 
discharges to hospital-based hospices and outside hospice facilities. 
 Finally, in regard to palliative care experience, note that hospitals with PAL, IPAL, or 
HOSPC present in 2007 are treated as hospitals with one year of experience in 2007. Hospitals 
that discontinued a palliative care service were assigned a “0” in years of and after 
discontinuation. Additionally, hospitals without a palliative care service throughout the study 
period were assigned a “0” for experience in all years. This specification assumes time has a 
linear effect. 
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Two additional sample restrictions warrant further explanation. First, to examine research 
questions two and three in regard to transfer to hospice, the analytical model excludes patients 
treated in California and Maryland, because neither state provides information on transfer to 
hospice. Second, separate analytical models for decedents and patients discharged alive are 
estimated to assess research questions two and three concerning length of stay. In the context of 
outcome evaluation, length of stay has a considerably different meaning for these two patient 
populations. In particular, the end of the hospital stay is the time of discharge for survivors, 
whereas the end of the hospital stay is determined by the patient’s death for decedents.  
Research questions two and three: control variables. 
All analytical models include the same set of control variables, which may be grouped 
into patient, hospital, and market characteristics. Also, all hospital and market characteristics 
included in the analytical model to investigate research question one, as described in the previous 
sections, are incorporated as control variables in the analytical models to explore research 
questions two and three. Note that one hospital control variable, a hospital’s average length of 
stay, is not included in the 3-level HGLM with length of stay as the dependent variable to assure 
model convergence.  
Several patient characteristics, including demographic and clinical factors that may affect 
hospital costs, length of stay, in-hospital mortality, and hospice transfers are included in the 
analytical models. Patient demographics include the patient’s age, gender, race or ethnicity, and 
payer type, income, residential location, and source of admission. This study focuses on patients 
aged 18 or older on the day of hospital admission. The patient’s age is categorized into five 
groups: 18-49 (the reference group), 50-64, 65-74, 75-84, and 85 or older. The patient’s gender is 
measured as a binary variable with male patients being the reference group. Individuals are 
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classified into one of the four race/ethnicity categories: non-Hispanic white (the reference 
group), non-Hispanic African-American, Hispanic, and other. The patient’s payer type is divided 
into five categories: Medicare (the reference group), Medicaid, private insurance, self-pay, or 
charity/other. The patient’s income is approximated by a four-level categorical variable that 
identifies in which state level income quartile the median household income in the patient’s zip 
code falls. Specifically, values between 1 and 4 are assigned to identify the poorest to wealthiest 
populations, respectively. The poorest population functions as the reference group. In addition, 
the patient’s residential location is divided into one of the following categories: central/fringe 
area with at least 1 million residents (the reference group), large metropolitan area with between 
50,000 and 999,999 residents, and micropolitan/rural areas with fewer than 50,000 residents. The 
patient’s source of hospital admission is divided into five categories: emergency room (the 
reference group), routine, another hospital, another healthcare facility, and court/law 
enforcement. Note that routine admissions include physician or HMO referrals and outpatient or 
clinic transfers. 
The following clinical indicators are also included in the analytical models. The patient’s 
Charlson-Comorbidity Index (CCI) and number of surgical procedures are measured as 
continuous variables and used to capture the patient’s medical severity. Furthermore, the 
patient’s primary diagnosis is accounted for by seven binary variables indicating whether the 
patient was assigned one of seven primary diagnoses using the Clinical Classifications Software 
(CCS) based on ICD-9-CM codes: acute cerebrovascular disease (ACD) (ccs code = 109), acute 
myocardial infarction (AMI) (CCS category = 100), congestive heart failure (CHF) (CCS 
category = 108), chronic obstructive pulmonary disease (COPD) (CCS category = 127), 
dementia (CCS category = 653), pneumonia (CCS category = 122), and HIV infection (CCS 
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category = 5). Cancer patients, identified by the CCS categories 11 through 45, are treated as the 
reference. Finally, a binary variable indicating whether a patient had a palliative care encounter 
is included by identifying the ICD-9 CM code V66.7 among the patient’s secondary diagnoses. 
Although patients can have palliative care encounters regardless of whether they are treated in 
hospitals with specialty palliative care services (i.e., PAL, IPAL, and HOSPC), hospitals with 
such services record about 30% more palliative care encounters than hospitals without such 
services. Note that including and excluding this variable suggested that the key parameter 
estimates in the models with hospital costs, length of stay, and transfer to hospice as dependent 
variables were robust to including and excluding this variable. However, the results of the model 
with in-hospital mortality as the dependent variable differ substantially and, thus, are discussed 
separately in Chapter 5.    
Empirical Methodology 
Preliminary analysis. 
Several preliminary analyses are performed. First, the data are analyzed carefully to 
identify outliers and missing values, as described in a previous section of this chapter. Study 
variables are assessed individually, over time and in different binary combinations to examine 
the quality of the data. Scatterplots, histograms, and box plots are used to identify extreme values 
to be excluded from the study sample. Distributive properties are examined to determine 
appropriate data transformations. Descriptive statistics are also used to decide on the unit of 
measurement. Data management is performed using Stata/MP for Windows (64-bit), Version 
14.0. Hierarchical linear modeling is conducted using MELOGIT command in Stata and the 
MIXED and GLIMMIX procedure in SAS for Windows (64-bit), Version 9.4.   
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Model assumptions. 
 In hierarchical modeling, several formal assumptions are required to be met to generate 
unbiased, consistent, and accurate estimates (Raudenbush & Bryk, 2002a). The first set of 
assumptions pertains to the unbiasedness of the coefficients estimating the effects of the 
covariates. Specifically, level-1 covariates are independent of the level-1 error term. Similarly, 
level-2 and level-3 covariates are independent of the level-2 and level-3 error terms, respectively. 
In addition, the covariates at each level are not correlated with the random effects at the other 
levels. The second set of assumptions relates to the random effects in the model and thus affects 
the consistency and accuracy of standard error estimation. In particular, in the case of continuous 
outcome models (i.e., hospital costs), each level-1 error term is normally distributed, 
independent, and has a mean of zero and variance of 𝜎2 for every level-1 unit. Furthermore, the 
random errors at higher levels are independent from each other. Note that in the case of binary 
outcome models (i.e., palliative care provision, in-hospital mortality, and transfer to hospice), the 
level-1 error variance has a mean of zero and a fixed variance at 𝜋2 3⁄ . Finally, in the case of 
count outcome models (i.e., length of stay), the level-1 error variance is assumed to be equal to 
the mean.  
Research question one: empirical model. 
 A two-level HGLM is employed to address research question one and the corresponding 
hypotheses 1 through 5. The empirical model is based on the notion that hospitals are nested 
within counties, meaning a hospital’s log-odds of having at least one of three palliative care 
services (i.e., PAL, IPAL, and/or HOSPC) in place may differ across counties. Hospital 
characteristics are modeled at the lowest level with subscript j and county characteristics at the 
higher level with subscript k. Each hierarchical level is provided with a level-specific model, in 
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which hospital characteristics predict palliative care provision and county characteristics predict 
the average county’s palliative care provision. The level-specific models are then joined into a 
combined model for hypothesis testing. The combined model may be expressed by the following 
equation, 
Empirical Model Research Question One, Palliative Care Provision 
(𝑃𝐶_𝑃𝑅𝑂𝑉)𝑗𝑘 = 𝛾00 + 𝛾10(𝑆𝐼𝑍𝐸)𝑗𝑘 + 𝛾20(𝐴𝐿𝑇)𝑗𝑘 + 𝛾30(𝑀𝐸𝐷𝐶_𝐼𝑁𝑃𝑆𝐻𝐴𝑅𝐸)𝑗𝑘 + 𝛾40(𝑇𝐸𝐴𝐶𝐻)𝑗𝑘
+ 𝛾50(𝐶𝑁𝑇𝑅𝐿𝑆1)𝑗𝑘 + 𝛾01(𝐶𝑂𝑀𝑃)𝑘 + 𝛾02(𝐶𝑁𝑇𝑅𝐿𝑆2)𝑘 + 𝛾03(𝑌𝐸𝐴𝑅)𝑘 + 𝑒𝑗𝑘 + 𝑢0𝑘. 
  
 where j = 1, 2, …, 𝑛𝑘 hospitals and k = 1, 2, …, N counties, (PC_PROV)𝑗𝑘 is hospital j’s 
log-odds of providing at least one of three palliative care services (i.e., PAL, IPAL, and/or 
HOSPC), and 𝛾00 is the average log-odds of having at least one of three palliative care services 
across all hospitals when all covariates equal zero. Furthermore, (𝑆𝐼𝑍𝐸)𝑗𝑘 is hospital j’s bed 
size, (𝐴𝐿𝑇)𝑗𝑘 is a binary variable (1 = hospital j’s has access to palliative care services through a 
health system, network, or a joint venture, 0 = otherwise), (𝑀𝐸𝐷𝐶_𝐼𝑁𝑃𝑆𝐻𝐴𝑅𝐸)𝑗𝑘 is hospital j’s 
share of Medicare patients, (𝑇𝐸𝐴𝐶𝐻)𝑗𝑘 is a binary variable (1 = hospital j is a member of 
COTH, 0 = otherwise), (𝐶𝑁𝑇𝑅𝐿𝑆1)𝑗𝑘 is a vector of hospital-specific control variables, 
(𝐶𝑂𝑀𝑃)𝑘 is county k’s level of hospital competition, (𝐶𝑁𝑇𝑅𝐿𝑆2)𝑘 is a vector of county-specific 
control variables, (𝑌𝐸𝐴𝑅)𝑘 is a vector of year dummies for years 2008 through 2011, 𝑒𝑗𝑘 is the 
error variance across patients with mean 0 and fixed variance, and 𝑢0𝑘 is the error variance 
across counties.  
 The five (alternative) hypotheses under research question one and their corresponding 
null hypotheses are stated below. Statistical significance is examined using individual t-tests.  
Null and Alternative Hypotheses, Hypothesis 1 
𝐻0: 𝛾10 = 0 ; 𝐻1: 𝛾10 > 0.   
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Null and Alternative Hypotheses, Hypothesis 2 
𝐻0: 𝛾01 = 0 ; 𝐻2: 𝛾01 > 0.  
Null and Alternative Hypotheses, Hypothesis 3 
𝐻0: 𝛾20 = 0 ; 𝐻3: 𝛾20 < 0.  
Null and Alternative Hypotheses, Hypothesis 4 
𝐻0: 𝛾30 = 0 ; 𝐻4: 𝛾30 > 0.  
Null and Alternative Hypotheses, Hypothesis 5 
𝐻0: 𝛾40 = 0 ; 𝐻5: 𝛾40 > 0.  
Research questions two and three: empirical models. 
Four three-level HGLM and HLM are employed to address research questions two and 
three and the corresponding hypotheses. The empirical models are based on the notion that 
patients are nested within hospitals, and hospitals are nested within counties. Specifically, patient 
characteristics are modeled at the first level with subscript i, hospital characteristics are modeled 
at the second level with subscript j, and county characteristics are modeled at the third level with 
subscript k. Each hierarchical level can be modeled separately. These models are then joined into 
combined models used for hypothesis testing for each of the four dependent variables, 
respectively. Specifically, the combined models for hospital costs, (COSTS)𝑖𝑗𝑘, length of stay, 
(LOS)𝑖𝑗𝑘, in-hospital mortality, (INH_MORT)𝑖𝑗𝑘, and transfer to hospice, (TR_HOSPC)𝑖𝑗𝑘, 
respectively are stated as follows, 
Empirical Model Research Questions Two and Three, Hospital Costs 
(COSTS)𝑖𝑗𝑘 = 𝛾000 + 𝛾100(𝐶𝑁𝑇𝑅𝐿𝑆1)𝑖𝑗𝑘 + 𝛾010(𝑃𝐴𝐿)𝑗𝑘 + 𝛾020(𝐼𝑃𝐴𝐿)𝑗𝑘
+ 𝛾030(𝐻𝑂𝑆𝑃𝐶)𝑗𝑘 + 𝛾040(𝑃𝐴𝐿_𝐸𝑋𝑃)𝑗𝑘 + 𝛾050(𝐼𝑃𝐴𝐿_𝐸𝑋𝑃)𝑗𝑘
+ 𝛾060(𝐻𝑂𝑆𝑃𝐶_𝐸𝑋𝑃)𝑗𝑘 + 𝛾070(𝐶𝑁𝑇𝑅𝐿𝑆2)𝑗𝑘 + 𝛾001(𝐶𝑁𝑇𝑅𝐿𝑆3)𝑘
+ 𝛾002(𝑌𝐸𝐴𝑅)𝑘 + 𝑒𝑖𝑗𝑘 + 𝑟0𝑗𝑘 + 𝑢00𝑘 . 
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where i = 1, 2… 𝑛𝑗𝑘 patients, j = 1, 2… 𝑛𝑘 hospitals, k = 1, 2… N counties, (COSTS)𝑖𝑗𝑘 
is patient i’s hospital costs, and 𝛾000 is the average hospital costs across all hospitals. In addition, 
(𝐶𝑁𝑇𝑅𝐿𝑆1)𝑖𝑗𝑘  is a vector of patient characteristics, (𝑃𝐴𝐿)𝑗𝑘 is a binary variable (1 = hospital j 
has an inpatient palliative care consultation service, 0 = otherwise), (𝐼𝑃𝐴𝐿)𝑗𝑘 is a binary variable 
(1 = hospital j has an inpatient palliative care unit, 0 = otherwise), (𝐻𝑂𝑆𝑃𝐶)𝑗𝑘 is a binary 
variable (1 = hospital j has a hospice program, 0 = otherwise), (𝑃𝐴𝐿_𝐸𝑋𝑃)𝑗𝑘 is hospital j’s years 
of experience in offering an inpatient palliative care consultation service, (𝐼𝑃𝐴𝐿_𝐸𝑋𝑃)𝑗𝑘 is 
hospital j’s years of experience in offering an inpatient palliative care unit, (𝐻𝑂𝑆𝑃𝐶_𝐸𝑋𝑃)𝑗𝑘 is 
hospital j’s years of experience in providing a hospice program, (𝐶𝑁𝑇𝑅𝐿𝑆2)𝑗𝑘  is a vector of 
hospital characteristics, (𝐶𝑁𝑇𝑅𝐿𝑆3)𝑘 is a vector of county characteristics, (𝑌𝐸𝐴𝑅)𝑘 is a vector 
of year dummies for years 2008 through 2011, 𝑒𝑖𝑗𝑘 is the error variance between patients, 𝑟0𝑗𝑘 is 
the error variance across hospitals, and 𝑢00𝑘is the error variance across counties.  
Empirical Model Research Questions Two and Three, Length of Stay 
(LOS)𝑖𝑗𝑘 = 𝛾000 + 𝛾100(𝐶𝑁𝑇𝑅𝐿𝑆1)𝑖𝑗𝑘 + 𝛾010(𝑃𝐴𝐿)𝑗𝑘 + 𝛾020(𝐼𝑃𝐴𝐿)𝑗𝑘 + 𝛾030(𝐻𝑂𝑆𝑃𝐶)𝑗𝑘
+ 𝛾040(𝑃𝐴𝐿_𝐸𝑋𝑃)𝑗𝑘 + 𝛾050(𝐼𝑃𝐴𝐿_𝐸𝑋𝑃)𝑗𝑘 + 𝛾060(𝐻𝑂𝑆𝑃𝐶_𝐸𝑋𝑃)𝑗𝑘
+ 𝛾070(𝐶𝑁𝑇𝑅𝐿𝑆2)𝑗𝑘 + 𝛾001(𝐶𝑁𝑇𝑅𝐿𝑆3)𝑘 + 𝛾002(𝑌𝐸𝐴𝑅)𝑘  + 𝑒𝑖𝑗𝑘 + 𝑟0𝑗𝑘 + 𝑢00𝑘. 
 
where i = 1, 2… 𝑛𝑗𝑘 patients, j = 1, 2… 𝑛𝑘 hospitals, k = 1, 2… N counties, (LOS)𝑖𝑗𝑘 is 
patient i’s hospital length of stay, 𝛾000 is the average hospital length of stay across all hospitals, 
and 𝑒𝑖𝑗𝑘 is the error variance across patients with a mean equal to the variance. The remaining 
variables have the same definitions as noted above.  
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Empirical Model Research Questions Two and Three, In-hospital Mortality 
(INH_MORT)𝑖𝑗𝑘
= 𝛾000 + 𝛾100(𝐶𝑁𝑇𝑅𝐿𝑆1)𝑖𝑗𝑘 + 𝛾010(𝑃𝐴𝐿)𝑗𝑘 + 𝛾020(𝐼𝑃𝐴𝐿)𝑗𝑘
+ 𝛾030(𝐻𝑂𝑆𝑃𝐶)𝑗𝑘 + 𝛾040(𝑃𝐴𝐿_𝐸𝑋𝑃)𝑗𝑘 + 𝛾050(𝐼𝑃𝐴𝐿_𝐸𝑋𝑃)𝑗𝑘
+ 𝛾060(𝐻𝑂𝑆𝑃𝐶_𝐸𝑋𝑃)𝑗𝑘 + 𝛾070(𝐶𝑁𝑇𝑅𝐿𝑆2)𝑗𝑘 + 𝛾001(𝐶𝑁𝑇𝑅𝐿𝑆3)𝑘
+ 𝛾002(𝑌𝐸𝐴𝑅)𝑘 + 𝑒𝑖𝑗𝑘 + 𝑟0𝑗𝑘 + 𝑢00𝑘. 
 
where i = 1, 2… 𝑛𝑗𝑘 patients, j = 1, 2… 𝑛𝑘 hospitals, k = 1, 2… N counties, 
(INH_MORT)𝑖𝑗𝑘 is patient i’s log-odds of in-hospital mortality, 𝛾000 is the average log-odds of 
in-hospital mortality across all hospitals, and 𝑒𝑖𝑗𝑘 is the error variance across patients with mean 
0 and fixed variance. The remaining variables have the same definitions as noted above. 
Empirical Model Research Questions Two and Three, Transfer to Hospice 
(TR_HOSPC)𝑖𝑗𝑘 = 𝛾000 + 𝛾100(𝐶𝑁𝑇𝑅𝐿𝑆1)𝑖𝑗𝑘 + 𝛾010(𝑃𝐴𝐿)𝑗𝑘 + 𝛾020(𝐼𝑃𝐴𝐿)𝑗𝑘 + 𝛾030(𝐻𝑂𝑆𝑃𝐶)𝑗𝑘
+ 𝛾040(𝑃𝐴𝐿_𝐸𝑋𝑃)𝑗𝑘 + 𝛾050(𝐼𝑃𝐴𝐿_𝐸𝑋𝑃)𝑗𝑘 + 𝛾060(𝐻𝑂𝑆𝑃𝐶_𝐸𝑋𝑃)𝑗𝑘
+ 𝛾070(𝐶𝑁𝑇𝑅𝐿𝑆2)𝑗𝑘 + 𝛾001(𝐶𝑁𝑇𝑅𝐿𝑆3)𝑘 + 𝛾002(𝑌𝐸𝐴𝑅)𝑘 + 𝑒𝑖𝑗𝑘 + 𝑟0𝑗𝑘 + 𝑢00𝑘. 
 
where i = 1, 2… 𝑛𝑗𝑘 patients, j = 1, 2… 𝑛𝑘 hospitals, k = 1, 2… N counties, 
(TR_HOSPC)𝑖𝑗𝑘 is patient i’s log-odds of hospice transfer, 𝛾000 is the average log-odds of 
hospice transfer across all hospitals, and 𝑒𝑖𝑗𝑘 is the error variance across patients with mean 0 
and fixed variance. The remaining variables have the same definitions as noted above. 
To test the four (alternative) hypotheses under research question two, joint hypothesis 
tests are used. Note that statistical significance of the three key parameters (i.e., dummy variables 
for PAL, IPAL, and HOSPC) cannot be tested using individual t-tests due to the nature of the 
palliative care experience variable used to address research question three. Specifically, hospitals 
with a palliative care service in a given year are coded having at least one year of experience 
providing this service. Individual t-tests are invalid in this set-up, as they test the statistical 
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significance of the key parameters when palliative care experience and other covariates is zero. 
Therefore, three joint hypothesis tests are conducted to address research question two, which 
evaluate a 1-year effect of PAL, IPAL, and HOSPC on hospital costs, length of stay, in-hospital 
mortality, and transfer to hospice, respectively.  
Null and Alternative Hypotheses 6a, Hospital Costs 
𝐻0: 𝛾010 + 𝛾040 = 0; 𝐻6𝑎: 𝛾010 + 𝛾040 < 0.   
𝐻0: 𝛾020 + 𝛾050 = 0; 𝐻6𝑎: 𝛾020 + 𝛾050 < 0.   
𝐻0: 𝛾030 + 𝛾060 = 0; 𝐻6𝑎: 𝛾030 + 𝛾060 < 0.   
Null and Alternative Hypotheses 6b, Length of Stay 
𝐻0: 𝛾010 + 𝛾040 = 0; 𝐻6𝑏: 𝛾010 + 𝛾040 < 0.   
𝐻0: 𝛾020 + 𝛾050 = 0; 𝐻6𝑏: 𝛾020 + 𝛾050 < 0.   
𝐻0: 𝛾030 + 𝛾060 = 0; 𝐻6𝑏: 𝛾030 + 𝛾060 < 0.   
Null and Alternative Hypotheses 6c, In-hospital Mortality 
𝐻0: 𝛾010 + 𝛾040 = 0; 𝐻6𝑐: 𝛾010 + 𝛾040 < 0.   
𝐻0: 𝛾020 + 𝛾050 = 0; 𝐻6𝑐: 𝛾020 + 𝛾050 < 0.   
𝐻0: 𝛾030 + 𝛾060 = 0; 𝐻6𝑐: 𝛾030 + 𝛾060 < 0.   
Null and Alternative Hypotheses 6d, Transfer of Hospice 
𝐻0: 𝛾010 + 𝛾040 = 0; 𝐻6𝑑: 𝛾010 + 𝛾040 > 0.   
𝐻0: 𝛾020 + 𝛾050 = 0; 𝐻6𝑑: 𝛾020 + 𝛾050 > 0.   
𝐻0: 𝛾030 + 𝛾060 = 0; 𝐻6𝑑: 𝛾030 + 𝛾060 > 0.   
 To address research question three, the effects of palliative care experience are tested 
using individual t-tests. The four (alternative) hypotheses and their corresponding null 
hypotheses are stated as follows, 
Null and Alternative Hypotheses 7a, Hospital Costs 
𝐻0: 𝛾040 = 0; 𝐻7𝑎: 𝛾040 < 0.   
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𝐻0: 𝛾050 = 0; 𝐻7𝑎: 𝛾050 < 0.   
𝐻0: 𝛾060 = 0; 𝐻7𝑎: 𝛾060 < 0.   
Null and Alternative Hypotheses 7b, Length of Stay 
𝐻0: 𝛾040 = 0; 𝐻7𝑏: 𝛾040 < 0.   
𝐻0: 𝛾050 = 0; 𝐻7𝑏: 𝛾050 < 0.   
𝐻0: 𝛾060 = 0; 𝐻7𝑏: 𝛾060 < 0.   
Null and Alternative Hypotheses 7c, In-hospital Mortality 
𝐻0: 𝛾040 = 0; 𝐻7𝑐: 𝛾040 < 0.   
𝐻0: 𝛾050 = 0; 𝐻7𝑐: 𝛾050 < 0.   
𝐻0: 𝛾060 = 0; 𝐻7𝑐: 𝛾060 < 0.   
Null and Alternative Hypotheses 7d, Transfer to Hospice 
𝐻0: 𝛾040 = 0; 𝐻7𝑑: 𝛾040 > 0.   
𝐻0: 𝛾050 = 0; 𝐻7𝑑: 𝛾050 > 0.   
𝐻0: 𝛾060 = 0; 𝐻7𝑑: 𝛾060 > 0.   
Sensitivity Analysis 
 Several sensitivity analyses are performed to evaluate the robustness of the empirical 
results regarding the associations between the five key independent variables and the probability 
of palliative care provision corresponding to research question one. Specifically, three alternative 
specifications using respectively the provision of inpatient palliative care consultation services, 
inpatient palliative care units, and hospice programs are used to determine whether the results are 
robust across alternative measures of palliative care provision. It is possible that the effects of 
key independent variables have different effects on the provision of the three different types of 
palliative care services.  
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 Several sensitivity analyses are conducted to examine the effects of palliative care on 
hospital performance. First, in regard to hospital costs, separate models for decedents and 
survivors are estimated to evaluate whether palliative care services have consistent effects on 
hospital costs across the two patient populations. Empirical evidence exists that patients who 
received a palliative care consultation and subsequently died during hospitalization incurred 
significantly lower hospital costs than survivors who received a palliative care consultation 
during their hospital stay (Whitford et al., 2014). Second, length of stay for patients who were 
transferred to hospice is examined to assess the effects of palliative care services on discharge 
timing when subsequent hospice transfers were initiated. Third, the effects of palliative care 
services on transfer to hospice are examined based on a patient sample, which includes patients 
who were transferred to hospice and patients who were discharged to home health care or a 
skilled nursing facility. This sensitivity analysis is performed to assess whether hospital-based 
palliative care services increases a patient’s probability of hospice transfer when compared to 
patients with the above-mentioned discharge statuses. Finally, the effects of palliative care 
services on in-hospital mortality are evaluated for each primary diagnosis individually to 
determine how sensitive the results are to the selection of different patient populations. 
Summary 
 This chapter identified the research design, data sources, study sample, variable 
measurement, the empirical methodology, and sensitivity analyses used in this study. This study 
employs a pooled, cross-sectional research design. Data elements from six different data sources 
are linked to create the study’s sample, including a variety of patient, hospital, and county 
information.  
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 The study’s three research questions are investigated with a balanced panel of hospitals 
from six states over a period of five years. A two-level HGLM is used to address research 
question one. Three-level HGLM and HLMs are used to investigate research questions two and 
three. The empirical findings of these analytical models and their corresponding sensitivity 
analyses are presented in Chapter 5. 
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 This chapter presents the study findings based on the data and methodology discussed in 
the previous chapter and is divided into four sections. The first section provides descriptive 
statistics on patients, hospitals, and counties for Arizona, California, Florida, Maryland, New 
Jersey, and New York during the study period 2007 to 2011. The second and third sections report 
the empirical results of the study’s analytical models and sensitivity analyses for each research 
question. The last section provides a brief summary. 
Results of Descriptive Analysis 
Number of patients, hospitals, and counties. 
 During the study period, a total of 59,315,052 patient visits across all hospitals in the 
study states were recorded in the SID discharge files. About 6.34% of those were included in the 
study, amounting to 3,763,339 patient records. As discussed earlier, patient records were 
included in the study sample only if they belonged to patients who were 18 years or older, had 
one of eight primary diagnoses, and were treated in urban, non-federal, general, and acute care 
hospitals. More than half of patients in the study sample were treated in California (30.49%) and 
Florida (23.14%). Patients in New York and New Jersey accounted for approximately 15% of the 
study sample, respectively. Arizona and Maryland had the smallest patient shares with 7.05% 
and 9.24%, respectively. The study’s patients received medical care in 348 hospitals located in 
111 counties across the six study states. The average state in the study sample is comprised of 19 
urban counties, with Arizona having the least (n=5) and California the most (n=28). The number 
Chapter 5: Results 
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of hospitals per county varied from one to 37, with a sample average of three. Specifically, 42 
counties had one hospital, 41 counties had between two and three hospitals, 17 counties had four 
to six hospitals, and 10 counties had seven to 14 hospitals. One county consisted of 37 hospitals. 
The average hospital had 2,163 patients meeting the sample criteria annually, with one reporting 
only 37 and another reporting 16,773 patients. 
Characteristics of patients. 
 Table 9 provides a comparison of patients across patient disposition. The majority of 
patients were 65 years and older (61.06%), and white (67.02%). The sample was almost evenly 
split between female and male patients. While the distribution of patient gender and 
race/ethnicity was similar across patient disposition, the average patient who expired during the 
hospital stay was five years older than the average patient discharged alive, with 73 and 68 years 
respectively. The median household income quartile by patient zip code as a proxy for patient 
income was relatively evenly distributed among the four quartiles. Relatively more patients 
belonged to the lowest quartile (26.72%) than the wealthiest quartile (22.02%). Most patients 
resided in central/fringe areas with at least one million residents (73.72%). The remaining 
patients lived in metropolitan areas with 50,000 to 999,999 residents (23.42%) or micro/rural 
areas with fewer than 50,000 residents (2.92%). Note that while the study examined urban 
hospitals only, patients who were treated in these hospitals may live in non-urban areas.  
Most patients were covered by Medicare (60.92%), followed by private insurance 
(22.52%), Medicaid (9.82%), self-pay (3.72%), and other means (3.02%). The distributions of 
patient income, urban/rural residence, and type of health insurance were comparable across 
patient disposition. The majority of patients were admitted through the emergency room 
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Table 9 
9Descriptive Statistics for Patient Characteristics by Patient Disposition, 2007-2011 
Table 9 (continued) 
 
Patient Characteristics 
 Patient Disposition  
Total 
Discharged Alive Died in Hospital 
 #  (%)  #  (%) # (%) 
Control Variables             
Gender             
Male  1,788,429 (49.82)       85,265  (50.42)  1,873,694  (49.82) 
Female  1,805,702  (50.22)       83,943  (49.62)  1,889,645  (50.22) 
Age             
18-49 (reference)     482,482  (13.42)       12,735    (7.52)     495,217  (13.22) 
50-64     941,314  (26.22)       32,328  (19.12)     973,642  (25.92) 
65-74     774,266  (21.52)       33,409  (19.72)     807,675  (21.52) 
75-84     843,400  (23.52)       48,534  (28.72)     891,934  (23.72) 
85+     552,669  (15.42)       42,202  (24.92)     594,871  (15.82) 
Race/Ethnicity             
White (reference)  2,403,946  (66.92)     116,865  (69.12)  2,520,811  (67.02) 
Black     511,582  (14.22)       19,370  (11.42)     530,952  (14.12) 
Hispanic     430,656  (12.02)       18,747  (11.12)     449,403  (11.92) 
Other      247,947    (6.92)       14,226    (8.42)     262,173    (7.02) 
Median HH Income (level: ZIP)             
Lowest quartile (reference)     963,620  (26.82)       42,879  (25.32)  1,006,499  (26.72) 
2nd lowest quartileb     906,482  (25.22)       42,831  (25.32)     949,313  (25.22) 
2nd highest quartileb     934,837  (26.02)       43,929  (26.02)     978,766  (26.02) 
Highest quartile      789,192  (22.02)       39,569  (23.42)     828,761  (22.02) 
Urban/Rural Residencec             
Central/Fringe (reference)  2,651,346  (73.82)     123,559  (73.02)  2,774,905  (73.72) 
Metro     839,217  (23.32)       40,732  (24.12)     879,949  (23.42) 
Micro/Ruralb     103,568    (2.92)         4,917    (2.92)     108,485    (2.92) 
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Table 9 (continued) 
 
Patient Characteristics 
 Patient Disposition  
Total 
Discharged Alive Died in Hospital 
 #  (%)  #  (%) # (%) 
Health Insurance 
Medicare (reference)  2,181,588  (60.72)     112,118  (66.32)  2,293,706  (60.92) 
Medicaid     357,106    (9.92)       13,443  (7.92)     370,549  (9.82) 
Private     814,570  (22.72)       32,255  (19.12)     846,825  (22.52) 
Self-pay     131,655    (3.72)         5,989  (3.52)     137,644  (3.72) 
Other      109,212    (3.02)         5,403  (3.22)     114,615  (3.02) 
Source of Admission             
Emergency room (reference)  1,838,797  (51.22)       98,704  (58.32)  1,937,501  (51.52) 
Another hospital     140,063    (3.92)       13,643    (8.12)     153,706    (4.12) 
Another HCF       85,786    (2.42)         7,370    (4.42)       93,156    (2.52) 
Court/Law enforcementb         2,076    (0.12)             84    (0.02)         2,160    (0.12) 
Routine  1,527,409   (42.52)       49,407  (29.22)  1,576,816   (41.92) 
Primary Diagnosis             
Cancer (reference)  1,035,008  (28.82)       51,520  (30.42)  1,086,528  (28.92) 
ACD     384,756  (10.72)       38,976  (23.02)     423,732  (11.32) 
AMI     416,531  (11.62)       25,171  (14.92)     441,702  (11.72) 
CHF     679,175  (18.92)       21,354  (12.62)     700,529  (18.62) 
COPD     404,673  (11.32)         6,558  (3.92)     411,231  (10.92) 
Dementia       65,411  (1.82)            976  (0.62)       66,387  (1.82) 
HIV       42,644  (1.22)         2,678  (1.62)       45,322  (1.22) 
Pneumonia     565,933  (15.72)       21,975  (13.02)     587,908  (15.62) 
Charlson-Comorbidity Indexa 2.50 (2.50)           3.16  (2.68) 2.53 (2.22) 
Number of surgical proceduresa 2.03 (2.71) 3.46 (3.77) 2.09 (2.78) 
Palliative care encounter             
No (reference)  3,538,455  (98.52)     125,997  (74.52)  3,664,452  (97.42) 
Yes       55,676  (1.52)       43,211  (25.52)       98,887  (2.62) 
Dependent Variables             
Length of staya           5.39  (4.60)           6.88  (6.57) 5.46 (4.72) 
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Table 9 (continued) 
 
Patient Characteristics 
 Patient Disposition  
Total 
Discharged Alive Died in Hospital 
 #  (%)  #  (%) # (%) 
Hospital costs (in 2007 US$)a       12,380  (12,948)       19,547  (23,426)       12,703  (13,675) 
Died in hospital             
No  -   -   -   -   3,594,131  (95.52) 
Yes  -   -   -   -      169,208  (4.52) 
Transferred to hospice             
No  2,768,815  (96.52)  -   -   2,178,845  (96.12) 
Yes     101,065  (3.52)  -   -        89,321  (3.92) 
Total  3,594,131  (100)     169,208  (100)  3,763,339  (100) 
 
Note. ACD=Acute cerebrovascular disease. AMI=Acute myocardial infarction. CHF=Congestive heart failure. COPD=Chronic obstructive pulmonary disease. 
HCF=Healthcare facility. HH=Household. HIV=Human immunodeficiency virus. ZIP=Zone improvement plan. Two-sample z-tests are used to compare the 
proportions across patient disposition.  
aMeans and standard deviations are reported for Charlson-Comorbidity Index, number of surgical procedures, length of stay, and hospital costs; t-tests are used 
to test differences in means across patient disposition. All differences across patient disposition are significant at the p<.05 level. bThe proportions by patient 
disposition are not statistically significant (p>.1). cCentral/Fringe: ≥1 million residents; Metro: 50,000-999,999 residents; Micro/Rural: <50,000 residents.  
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(51.52%) and more than a third of patients were admitted routinely (41.92%). A significantly 
higher percentage of expired patients were admitted from another hospital or healthcare facility 
(12.54%) compared with patients discharged alive (6.34%). Patients discharged alive were also 
more likely to be admitted routinely (42.52%) than expired patients (29.22%).  
 A total of 169,208 patients died during hospitalization (4.52%) and 89,321 of patients 
who lived to be discharged were transferred to hospice (3.92%). About a third of patients had a 
cancer-related primary diagnosis (28.92%). The second most common primary diagnosis was 
congestive heart failure (18.62%), followed by pneumonia (15.62%), acute myocardial infarction 
(11.72%), acute cerebrovascular disease (11.32%), COPD (10.92%), dementia (1.82%), and HIV 
(1.22%). Acute cerebrovascular disease was more prevalent among decedents (23.02%) 
compared with survivors (10.72%). In contrast, COPD was significantly less prevalent among 
expired patients (3.92%) than patients discharged alive (11.32%). Altogether, decedents were 
sicker than patients who were discharged alive. On average, decedents had a higher Charlson-
Comorbidity Index (3.16 versus 2.5) and more surgical procedures (3.46 versus 2.03). Decedents 
also stayed in the hospital longer and incurred higher hospital costs than survivors. The average 
decedent had a hospital LOS of 6.88 days and incurred $19,547 in hospital costs, whereas the 
average survivor was discharged after 5.39 days and incurred $12,380 in hospital costs. The 
differences were statistically significant. In addition, one in four decedents had a palliative care 
encounter (25.52%). Among survivors, very few had a palliative care encounter (1.52%).  
In summary, the majority of patients were white, at least 65 years old, covered by 
Medicare, and lived in urban areas. Most patients were admitted to the hospital through the 
emergency room and had a primary diagnosis related to cancer, congestive heart failure, or 
pneumonia. There were also noteworthy differences between patients who died during 
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hospitalization and patients who lived to be discharged. On average, expired patients were sicker 
than survivors with longer hospital LOS, more surgical procedures, and a higher Charlson-
Comorbidity Index. Decedents also incurred higher hospital costs, were more likely to have a 
palliative care encounter and to be admitted to the hospital for acute cerebrovascular disease.  
Characteristics of hospitals. 
 In Table 10, the hospitals in the study sample are compared with all general, acute care, 
short-term, non-federal, and urban hospitals present in the 2007-2011 AHA Annual Survey of 
Hospitals data. Each hospital-year combination was treated as an observation to calculate the 
averages and percentages presented in Table 10.  
Table 10 
10Comparison of Hospitals in the AHA Database and the Study Sample, 2007-2011 
Hospital Characteristics 
National Sample 
(n=1,687) 
Study Sample 
(n=348) 
Difference 
Bed size M (SD) 267 (229) 331 (234) *** 
Ownership n (%)          
For-profit 248 (14.70) 45 (12.93) *** 
Public 256 (15.17) 52 (14.95)  
Not-for-profit 1,183 (70.13) 251 (72.12) ** 
Teaching status n (%)          
COTH member 228 (13.51) 62 (17.82) *** 
Non-teaching 1,460 (86.54) 286 (82.18) *** 
PC provision n (%)      
           PAL, IPAL, and/or HOSPC          943 (55.89) 216 (61.95) *** 
           PAL  820 (48.60) 200 (57.36) *** 
           IPAL 227 (13.44) 61 (17.53)  *** 
           HOSPC   449 (26.60) 86 (24.83) * 
Years of experience with PC  
(since 2006) M (SD)         
 
PAL 1.38 (1.72) 1.64 (1.77) *** 
IPAL   0.34 (0.99) 0.45 (1.13) *** 
HOSPC    0.73 (1.41) 0.66 (1.35) ** 
 
Note. AHA=American Hospital Association. COTH=Council of Teaching Hospitals. HOSPC=Hospice program. IPAL= 
Inpatient palliative care unit. M=Mean. PAL=Inpatient palliative care consultation service. PC=Palliative care. SD=Standard 
deviation. t-tests were conducted to compare means of national and study samples for bed size and years of PC in place. Two-
sample z-tests of proportions were performed to compare proportions of national and study samples for all other variables.  
* p < .1 ** p < .05 *** p < .01. 
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 Note that results were computed and reported for hospitals with complete information 
only and for hospitals that were in operation throughout the study period. It is expected that 
hospitals with palliative care services are more prevalent in the study sample than in the national 
sample. Several of the states in the study sample have passed or introduced legislation or 
initiatives promoting increased access to palliative care, including California, Florida, Maryland, 
and New Jersey (Adondakis & Daniell, 2015; Center to Advance Palliative Care, 2016). In 
comparison to the national sample, these states may be more proactive in supporting palliative 
care than other states. Thus, hospitals with palliative care services are more likely to be located 
in these states. It is also expected that the average number of hospital beds is higher in the study 
sample than in the national sample, as every study state (except Arizona) has a higher population 
density than the national average and thus needs to be equipped to serve more patients. No 
notable differences in teaching status or hospital ownership are expected.  
 The average hospital in the study sample is larger than the average hospital in the 
national sample. The study sample has proportionately more not-for-profit and teaching 
hospitals, but fewer for-profit hospitals than the national sample. The two samples also differ 
significantly in regard to their palliative care adoption characteristics. As anticipated, the study 
sample has proportionately more hospitals with at least one of three palliative care services. 
Hence, the results from this study sample may only be generalizable across the study states or to 
states with similarly high hospital-based palliative care prevalence. 
 The distribution of the individual palliative care services also differs significantly. 
Specifically, the study sample has a significantly higher proportion of hospitals with inpatient 
palliative care consultation services and inpatient palliative care units, but significantly fewer 
hospitals that provide hospice programs. Similarly, the average hospital in the study sample has 
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inpatient palliative care consultation services and inpatient palliative care units in place longer 
and hospice programs in place shorter compared with the average hospital in the national sample. 
Characteristics of counties.  
 Table 11 compares urban counties in the study sample with urban counties in the national 
sample. Note that results are computed and reported for counties with non-missing information 
only. It is expected that market competition is higher in the study sample than in the national 
sample, as the study states have, on average, more hospitals located in urban counties than all 
U.S. states. Furthermore, it is expected that the average population size is larger among urban 
counties in the study sample than the national sample due to higher population density in the 
majority of study states compared to the national average. No noteworthy differences in the 
remaining county characteristics are expected.  
Table 11 
11Comparison of Urban Counties in the AHA Database and the Study Sample, 2007-2011 
County Characteristics 
National Sample (n=899) Study Sample (n=111) 
Difference 
Mean SD Mean SD 
Market competition  0.33 (0.30) 0.49 (0.29) *** 
Area wage index 0.96 (0.15) 1.12 (0.19) *** 
HMO penetration rate  6.5 (7.39) 12.89 (10.08) *** 
PPO penetration rate 13.4 (6.22) 13.32 (8.03)  
Per capita income            36,826  (9,143)            43,765  (13,453) *** 
Population size          283,918  (548,743)          762,012  (1,117,598) *** 
Unemployment rate 7.45 (2.88) 8.38 (3.87) *** 
Uninsured rate 19.34 (6.27) 20.42 (6.32) *** 
 
Note. AHA=American Hospital Association. HMO=Health maintenance organization. PPO=Preferred provider 
organization. SD=Standard deviation. t-tests were conducted to compare means. 
* p < .1 ** p < .05 *** p < .01. 
 
 While the differences in means for most county characteristics were statistically 
significant at the 1% level, the average PPO penetration rates were not statistically different 
between the two groups. Compared to counties in the national sample, counties in the study 
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sample were on average more competitive, had a higher area wage index, higher HMO 
penetration rate, higher per capita income, larger population, and higher unemployment rate.  
Descriptive statistics of key variables. 
 Table 12 presents the annual means and standard deviations of the dependent variable 
and the five key independent variables used to examine research question one. There was an 
increase in palliative care provision (i.e., hospitals with PAL, IPAL, and/or HOSPC) over the 
study period, with levels of palliative care provision ranging between 59% in 2007 and 66% in 
2011 (p = .051). In addition, hospitals experienced a slight increase in hospital beds. Specifically, 
the average hospital had 326 and 334 beds in 2007 and 2011, respectively. However, the increase 
was not statistically significant. Hospitals also experienced a small increase in Medicare 
inpatient days between 2007 and 2011, ranging from 46.4% in 2007 to 48.5% in 2011 (p < .036). 
This increase may be an indication of an aging patient population. Moreover, while 51% of 
hospitals had access to palliative care services through a health system, network, or joint venture 
in 2007, 56% of hospitals had such access in 2011. The difference was not statistically 
significant. There were no notable and statistically significant fluctuations in the number of 
teaching hospitals or market competition over the study period. Note that there was little within-
variation for teaching status and hospital beds. Therefore, the coefficients estimated for these 
variables are likely to derive from between-hospital variation.  
 Table 13 presents annual means and standard deviations of the four dependent variables 
and key independent variables used to examine research questions two and three. According to 
Table 13, the number of patients transferred to hospice and the log of inflation-adjusted hospital 
costs remained stable over the study period. On average, 4% of patients in the study sample were 
transferred to hospice annually.  
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Table 12 
12Descriptives Statistics of Key Variables by Year, Research Question One 
Variable 
2007 2008 2009 2010 2011 
Mean (SD) Mean  (SD) Mean (SD) Mean (SD) Mean (SD) 
 
Dependent Variable                     
Provision of PAL, IPAL, and/or HOSPC 0.59 (0.49) 0.60 (0.49) 0.62 (0.49) 0.63 (0.48) 0.66 (0.48) 
 
Independent Variables                     
   H1: Number of staffed and set-up beds 326 (227) 329 (234) 331 (235) 335 (238) 334 (236) 
   H2: 1 minus HHI 0.47 (0.31) 0.48 (0.29) 0.48 (0.29) 0.49 (0.29) 0.50 (0.28) 
   H3: Presence of PC in health   
         system/network/JV 0.51 (0.50) 0.52 (0.50) 0.53 (0.50) 0.54 (0.50) 0.56 (0.50) 
   H4: Share of Medicare inpatient days (%) 46.4 (13.8) 46.9 (13.3) 47.4 (13.3) 47.3 (13.6) 48.5 (13.2) 
   H5: Membership with COTH 0.18 (0.38) 0.18 (0.38) 0.18 (0.38) 0.18 (0.38) 0.18 (0.38) 
 
Note. COTH=Council of Teaching Hospitals. HHI=Herfindahl-Hirschman Index. HOSPC=Hospice program. IPAL=Inpatient palliative care unit. JV=Joint 
venture. PAL=Inpatient palliative care consultation service. PC=Palliative care. SD=Standard deviation.  
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Table 13 
13Descriptive Statistics of Key Variables by Year, Research Questions Two/Three 
Variable 
2007 2008 2009 2010 2011 
Mean (SD) Mean  (SD) Mean (SD) Mean (SD) Mean (SD) 
 
Dependent Variables 
(n=3,763,339)                     
In-hospital mortality 0.05 (0.22) 0.05 (0.21) 0.05 (0.21) 0.04 (0.20) 0.04 (0.20) 
Length of stay 5.60 (4.80) 5.54 (4.77) 5.44 (4.71) 5.39 (4.67) 5.32 (4.63) 
Transfer to hospice* 0.04 (0.19) 0.04 (0.20) 0.04 (0.20) 0.04 (0.20) 0.04 (0.20) 
Hospital costs  
(2007 US$) 
  
12,779  (13,695) 
  
12,676  (13,446) 
  
12,475  (13,412) 
  
12,679  (13,767) 
  
12,911 (14,045) 
Log of hospital costs  
(2007 US$) 9.09 (0.84) 
      
9.09 (0.82) 
      
9.07 (0.83) 
      
9.09 (0.83) 
      
9.11 (0.82) 
 
Independent Variables  
(n=348)                     
H7:     Presence of PAL 0.52 (0.50) 0.54 (0.50) 0.59 (0.49) 0.60 (0.49) 0.62 (0.49) 
 Presence of IPAL 0.16 (0.37) 0.17 (0.37) 0.18 (0.39) 0.18 (0.39) 0.19 (0.39) 
 Presence of HOSPC 0.27 (0.45) 0.26 (0.44) 0.25 (0.43) 0.23 (0.42) 0.23 (0.42) 
H8:    Years of experience    
 with PAL (since ‘06) 0.52 (0.50) 1.05 (0.98) 1.63 (1.44) 2.19 (1.90) 2.80 (2.35) 
 Years of experience    
 with IPAL (since ‘06) 0.16 (0.37) 0.31 (0.70) 0.45 (1.02) 0.61 (1.36) 0.74 (1.65) 
 Years of experience  
 with HOSPC (since ’06) 0.27 (0.45) 0.52 (0.87) 0.68 (1.23) 0.84 (1.59) 1.01 (1.94) 
 
Note. IPAL=Inpatient palliative care unit. HOSPC=Hospice program. PAL=Inpatient palliative care consultation service. SD=Standard deviation.  
* Means and deviations calculated based on patients treated in hospitals in Arizona, Florida, New Jersey, and New York (n=2,268,166). 
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 The average patient’s hospital costs fluctuated between $12,475 and $12,911 over the 
study period. The average length of stay decreased slightly over the study period, from 5.6 days 
in 2007 to 5.32 days in 2011 (p < .001). Similarly, the number of patients who died in the 
hospital declined from 5% in the first three study years to 4% in 2010 and 2011.  
 Table 13 also shows a steady growth in the number of hospitals with PAL. Specifically, 
while 52% of hospitals offered PAL in 2007, 62% of hospitals had such a service in place by 
2011. Hospitals also experienced an increase in IPAL, from 16% of hospitals in 2007 to 19% of 
hospitals in 2011. Conversely, HOSPC were less prevalent in 2011 compared to 2007, with 23% 
and 27% of hospitals, respectively reporting having such programs.  Not surprisingly, the 
average years of having PAL, IPAL, or HOSPC in place since 2006 increased over the study 
period. 
Descriptive statistics of control variables. 
 Table 14 reports means and standard deviations of all hospital and market control 
variables used for all three research questions averaged across the study period. Specifically, 
hospital control variables and state indicators were averaged across all hospitals and study years, 
while market control were averaged across all counties and study years. Natural log-
transformations were used for three variables, namely average length of stay, population size, 
and unemployment rate. 
 The majority of hospitals were not-for-profit (72%). The patient population of an average 
hospital consisted of 13.88% black patients, 18.97% Hispanic patients, and 36.05% patients aged 
65 years and older. On average, patients stayed in the hospital for 4.6 days (or 1.5 mean log). 
Note that calculations of means and standard deviations for patient characteristics in Table 14 are 
based on all hospital patients, whereas those in Table 9 are based on the study’s patient sample.  
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Table 14 
14Descriptive Statistics of Control Variables, All Research Questions 
Control Variables Mean (SD) 
Hospital Control Variables (n = 348)     
Operating margin (lagged)  -0.15 (0.12) 
Ownership     
For-profit 0.13 (0.34) 
Public 0.15 (0.36) 
Not-for-profit (reference) 0.72 (0.48) 
Magnet hospital 0.03 (0.17) 
Average length of stay (log)* 1.50 (0.19) 
Hospital patients with 1 of 8 primary DX (%)  13.61 (3.89) 
Hospital patients aged ≥ 65 (%) 36.05 (13.17) 
Hospital patients black (%) 13.88 (15.92) 
Hospital patients Hispanic (%) 18.97 (20.28) 
Ratio of RN to total nurses 0.80 (0.11) 
Hospital all-patient DRG case mix 1.51 (0.24) 
County Control Variables (n = 111)     
Area Wage Index 1.12 (0.19) 
HMO Penetration (%) 12.89 (10.07) 
PPO Penetration (%) 13.32 (8.03) 
Per capita income (in 1,000)  43.76 (13.45) 
Population size (in 10,000) (log) 3.81 (0.98) 
Unemployment rate (for ages ≥ 16 in county) (log) 2.03 (0.44) 
Rate of uninsured (for ages < 65 in county) (%) 20.42 (6.32) 
Year 2007 (reference) 0.20 (0.40) 
Year 2008 0.20 (0.40) 
Year 2009 0.20 (0.40) 
Year 2010 0.20 (0.40) 
Year 2011 0.20 (0.40) 
State     
Arizona 0.07 (0.25) 
California 0.39 (0.49) 
Florida 0.20 (0.40) 
Maryland 0.08 (0.28) 
New Jersey 0.12 (0.33) 
New York 0.14 (0.35) 
 
Note. DRG=Diagnosis-related group. DX=Diagnosis. HMO=Health maintenance organization. PPO=Preferred 
provider organization. RN=Registered nurse. SD=Standard deviation. 
* Not included in model with length of stay as a dependent variable. 
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 The average hospital served a patient population consisting of 13.61% patients with PC-
benefiting primary diagnoses, ranging from 3.04% to 35.28%. The spread indicates that some 
hospitals in the study sample serve relatively few patients with diagnoses likely to utilize and 
benefit from palliative care, whereas others serve relatively high numbers of such patients. In 
addition, hospital beds, teaching status, and ownership type did not have substantial within-
hospital variation over the study period.  
 On average, the study’s counties had PPO and HMO penetration rates of 13.32% and 
12.89%, respectively. In addition, the average county had an unemployment rate of 8.38% (or 
2.03 mean log), 20.42% uninsured rate, and about 43,760 US dollars per capita income across all 
study years. The majority of hospitals were located in California and Florida, amounting to 59% 
of hospitals in the study sample. In addition, area wage index, per capita income, and population 
size have little within-hospital variation. Overall, county characteristics hardly change over the 
study period. Finally, due to the study’s balanced sample, the number of hospitals in the sample 
was unchanged over time.  
Empirical Analysis: Research Question One  
 This section is divided into two parts. The empirical results of the main analytical model 
are first reported and discussed, followed by a presentation and summary of sensitivity analyses 
conducted to evaluate the robustness of the results generated by the main analytical model. Prior 
to estimating the full model, an unconditional model (i.e., a model without any covariates) is 
estimated to calculate the intra-class correlation coefficient (ICC), which is employed to identify 
how the total variance in the probability of palliative care provision is divided into between-
hospital variation and between-county variation. 
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Results of main analysis. 
 Table 15 reports the results generated from the two-level HGLM with hospital-based 
palliative care provision as the dependent variable. Note that the ICC indicated that a statistically 
significant proportion of the variation in the probability of palliative care provision was at the 
county level (22.66%).  
Table 15 
15Results of 2-Level Model for Palliative Care Provision 
Table 15 (continued)   
Variable Odds Ratio SE 
Key Independent Variables     
Number of set-up and staffed beds (in 10s) 1.0375*** 0.0068 
1 - Herfindahl-Hirschman Index 3.0801 2.9928 
Presence of PC services in health system/network/JV 0.5564*** 0.0971 
Share of Medicare patients (%) 0.9958 0.0089 
Teaching hospital 1.2330 0.3635 
Hospital Control Variables     
Operating margin (lagged) 0.4322 0.2912 
Public  0.2779*** 0.0799 
For-profit 0.1059*** 0.0282 
Magnet Hospital 1.3544 0.6922 
Ratio RN to total nurses 4.4536** 3.3621 
Hospital all-patient DRG case-mix 7.3099*** 3.3836 
Patients with 1 of 8 primary DX (%)  1.0043 0.0355 
Hospital patients Hispanic (%) 0.9825*** 0.0056 
Hospital patients Black (%) 0.9908 0.0079 
Hospital patients aged ≥ 65 (%) 0.9784 0.0134 
Average length of stay (log) 1.2021 0.6719 
County Control Characteristics     
Area Wage Index  1.8982 3.2079 
PPO penetration rate (%) 0.9950 0.0258 
HMO penetration rate (%) 1.0043 0.0298 
Per Capita Income (in 1,000 US$)  1.0317 0.0202 
Population size (in 10,000 residents) (log) 0.7672 0.2462 
Unemployment rate (log) 0.7146 0.6146 
Rate of uninsured aged 18 through 64 (%) 1.0733* 0.0450 
Year     
2008 1.2240 0.4322 
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Table 15 (continued)   
Variable Odds Ratio SE 
2009 1.5246 1.0548 
2010 1.5514 1.1593 
2011 1.7526 1.2440 
State      
Arizona 1.9942 2.6016 
Florida 0.2396 0.2397 
Maryland 3.2205 3.7562 
New Jersey 1.3769 1.2880 
New York 1.7324 1.7296 
Intercept 0.0056* 0.0176 
 
Note. DRG=Diagnosis-related group. DX=Diagnosis. HMO=Health maintenance organization. JV=Joint venture. 
PC=Palliative care. PPO=Preferred provider organization. RN=Registered nurse. SE=Standard error.  
* p < .1 ** p < .05 *** p < .01. 
 In support of Hypothesis 1, the results indicated that the ratio of the probability of 
providing palliative care services compared to the probability of not providing such services was 
3.75% higher for a 10-bed increase in hospital size (p < .01), controlling for other variables in the 
model. In reference to Hypothesis 2, the results suggested that market competition was not 
significantly associated with the likelihood of palliative care provision (p = .25), ceteris paribus. 
In favor of Hypothesis 3, the findings showed that the ratio of the probability of providing 
palliative care services compared to the probability of not providing such services was 44.36% 
lower if a hospital had access to palliative care services through a health system, network, or 
joint venture (p < .01), keeping other variables constant in the model. Against the predictions 
posited in Hypothesis 4 and 5, the results indicated that hospitals’ dependence on Medicare and 
teaching status were not significantly associated with the probability of palliative care provision 
(p > .1), ceteris paribus.  
 Five hospital control variables and one county control variable yielded statistically 
significant results. Specifically, the ratio of the probability of providing palliative care services 
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compared to the probability of not providing such services was 72.21% and 89.41% lower for 
public and for-profit hospitals, respectively, compared with not-for-profit hospitals (p < .01). In 
addition, the odds of providing hospital-based palliative care was positively associated with the 
ratio of registered nurses and total nurses (odds ratio: 4.45; p = .048) and hospital all-patient 
DRG case-mix (odds ratio: 7.31; p < .01). That is, an increase in the ratio of registered nurses to 
total nurses by one standard deviation (SD = 0.11) increases the odds of hospital-based palliative 
care provision by 18%, whereas an increase in case-mix by one standard deviation (SD = 0.24) 
increases the odds by 62.37%. Conversely, the odds of providing palliative care was significantly 
negatively associated with the percentage of Hispanic patients (odds ratio: 0.98; p < .01). Finally, 
a county’s rate of the uninsured (odds ratio: 1.07; p = .091) was positively associated with the 
odds of providing palliative care.  
Results of sensitivity analysis. 
 Table 16 presents the results of the sensitivity analyses using alternative measures for 
hospital-based palliative care provision. Three alternative models were employed to examine the 
effects of the study’s five key independent variables on the provision of inpatient palliative care 
consultation services, inpatient palliative care units, and hospice programs, respectively.  
 According to Table 16, hospital size had a consistently positive association with each of 
the three palliative care services. The odds ratios were larger than 1, indicating a 2.9% to 4.3% 
higher probability of providing PAL, IPAL, or HOSPC compared to the probability of not 
providing PAL, IPAL, or HOSPC for every 10-bed increase in hospital size. These empirical 
findings are consistent with the results produced in the main analytical model and with the 
relational expectation suggested in Hypothesis 1. In addition, market competition was not 
significant in any of the three alternative scenarios.  
 123 
 
Table 16 
16Sensitivity Analyses with Alternative Measures for Palliative Care Provision 
Variable 
PAL IPAL HOSPC 
Odds 
Ratio 
SE 
Odds 
Ratio 
SE 
Odds 
Ratio 
SE 
H1: Number of set-up and staffed 
beds (in 10s) 
1.043*** 0.007 1.029*** 0.006 1.037*** 0.007 
H2: 1 - HHI  2.545 2.572 0.204 0.220 1.028 1.327 
H3: Presence of PC services  
in health system/network/JV 
0.856 0.144 0.673** 0.123 0.081*** 0.018 
H4: Share of Medicare patients  0.999 0.009 1.022* 0.012 0.974*** 0.010 
H5: Teaching hospital 1.998** 0.594 0.541** 0.168 0.979 0.297 
 
Note. HHI=Herfindahl-Hirschman Index. HOSPC=Hospice program. IPAL=Inpatient palliative care unit. JV=Joint 
venture. PAL=Inpatient palliative care consultation service. PC=Palliative care. SE=Standard error.  
* p < .1 ** p < .05 *** p < .01. 
 
 The presence of palliative care services in a hospital’s health system, network, or joint 
venture was not significant in predicting the odds of providing PAL, but in predicting the odds of 
providing HOSPC (odds ratio: 0.081; p < .01) and IPAL (odds ratio: 0.673; p < .05). These 
findings partially supported the relationship depicted in Hypothesis 3 with two of three palliative 
care services being positively associated with the presence of palliative care services in a 
hospital’s local community. Although a hospital’s share of Medicare patients was not associated 
with the probability of providing PAL, this variable significantly predicted the odds of providing 
IPAL and HOSPC. While a hospital’s share of Medicare patients was positively (odds ratio: 
1.02; p < .05) associated with the odds of providing IPAL, it was negatively associated with the 
odds of providing HOSPC (odds ratio: 0.97, p < .01). These findings partially agreed with the 
predictions posited in Hypotheses 4. Finally, while a hospital’s teaching status was negatively 
associated with the odds of providing IPAL (odds ratio: 0.541, p < .05) and was not significantly 
associated with the odds of providing HOSPC, it was positively associated with providing PAL 
(odds ratio: 1.998, p < .01) as proposed in Hypothesis 5.  
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 Empirical analysis: research questions two and three  
This section is structured in a way similar to the previous section. After the empirical 
results of the main analytical model are presented, the findings of several sensitivity analyses are 
reported and summarized for each dependent variable separately. Unconditional models are 
estimated to calculate the ICC to identify how the total variance in hospital costs, in-hospital 
mortality, transfer to hospice, and length of stay, respectively, is distributed among the patient, 
hospital, and county level.  
Hospital costs.  
Results of main analysis. 
Table 17 presents the results generated from the three-level HGLM with hospital costs as 
the dependent variable. Note that the ICC suggested that a statistically significant proportion of 
the variation in hospital costs were at the patient (87.68%), hospital (7.39%), and county level 
(4.93%). 
Table 17 
17Results of 3-Level Model for Hospital Costs, 2007-2011 
Table 17 (continued)   
Variable Coefficient SE 
Research Questions Two and Three      
PAL -0.0087*** 0.0020 
IPAL -0.0163*** 0.0020 
HOSPC  0.0004 0.0021 
Years of PAL experience (since 2006)  0.0115*** 0.0005 
Years of IPAL experience (since 2006)  0.0018*** 0.0006 
Years of HOSPC experience (since 2006) -0.0034*** 0.0006 
Patient Control Variables     
Patient Age     
50-64  0.0300*** 0.0011 
65-74  0.0222*** 0.0013 
75-84  0.0275*** 0.0014 
85+  0.0155*** 0.0015 
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Table 17 (continued)   
Variable Coefficient SE 
Patient Gender     
Female -0.0135*** 0.0006 
Patient Ethnicity/Race     
Black -0.0057*** 0.0011 
Hispanic -0.0143*** 0.0011 
Other -0.0093*** 0.0013 
Median HH Income (level: ZIP)     
2nd lowest quartile  0.0083*** 0.0010 
2nd highest quartile  0.0048*** 0.0010 
Highest quartile  -0.0035*** 0.0011 
Patient Location     
Metro  0.0431*** 0.0017 
Micro/Rural  0.0638*** 0.0022 
Health Insurance     
Medicaid -0.0102*** 0.0013 
Private -0.0720*** 0.0010 
Self-pay -0.1094*** 0.0019 
Other  -0.0930*** 0.0020 
Admission Source     
Another hospital -0.1033*** 0.0017 
Another HCF  0.0041* 0.0021 
Court/Law enforcement -0.0923*** 0.0132 
Routine -0.0764*** 0.0009 
Primary Diagnosis     
HIV  0.0802*** 0.0031 
AMI -0.1560*** 0.0013 
ACD  0.2123*** 0.0013 
CHF  0.0292*** 0.0011 
COPD -0.0633*** 0.0013 
Pneumonia  0.0482*** 0.0012 
Dementia -0.1129*** 0.0025 
Charlson-Comorbidity Index  0.0314*** 0.0002 
Number of surgical procedures  0.1890*** 0.0001 
Palliative care encounter -0.1481*** 0.0020 
Hospital Control Variables     
Number of set-up and staffed beds (in 10s)  0.0014*** 0.0001 
Operating margin (lagged)  0.0652*** 0.0064 
Presence of PC services in health system/network/JV -0.0111*** 0.0016 
Share of Medicare patients (%) -0.0012*** 0.0001 
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Table 17 (continued)   
Variable Coefficient SE 
Teaching hospital  0.0544*** 0.0038 
Public   0.0119** 0.0060 
For-profit  0.0313*** 0.0058 
Magnet Hospital -0.0200*** 0.0017 
Ratio RN to total nurses -0.0329*** 0.0053 
Hospital all-patient DRG case-mix -0.0324*** 0.0064 
Patients with 1 of 8 primary DX (%) -0.0010* 0.0006 
Hospital patients Hispanic (%) -0.0007*** 0.0001 
Hospital patients Black (%) -0.0030*** 0.0004 
Hospital patients aged ≥ 65 (%) -0.0030*** 0.0003 
Average length of stay (log)  0.2263*** 0.0103 
County Control Characteristics     
1 - Herfindahl-Hirschman Index  -0.0367*** 0.0061 
Area Wage Index   0.5084*** 0.0155 
PPO penetration rate (%)  0.0010*** 0.0001 
HMO penetration rate (%) -0.0024*** 0.0003 
Per Capita Income (in 1,000 US$)  -0.0011*** 0.0002 
Population size (in 10,000 residents) (log)  0.0347*** 0.0133 
Unemployment rate (log)  0.0573*** 0.0057 
Rate of uninsured aged 18 through 64 (%) -0.0015*** 0.0002 
Year     
2008 -0.0230*** 0.0022 
2009 -0.0794*** 0.0047 
2010 -0.0755*** 0.0052 
2011 -0.0353*** 0.0050 
State      
Arizona -0.0462 0.0718 
Florida -0.1514*** 0.0425 
Maryland -0.1454*** 0.0555 
New Jersey -0.1261*** 0.0471 
New York -0.3635*** 0.0466 
Intercept  7.9857*** 0.0710 
 
Note. ACD=Acute cerebrovascular disease. AMI=Acute myocardial infarction. CHF=Congestive heart failure. 
COPD=Chronic obstructive pulmonary disease. DRG=Diagnosis-related group. DX=Diagnosis. HCF=Healthcare 
facility. HH=Household. HIV=Human immunodeficiency virus. HMO=Health maintenance organization. 
HOSPC=Hospice program. IPAL=Inpatient palliative care unit. PAL=Inpatient palliative care consultation service. 
PC=Palliative care. PPO=Preferred provider organization. RN=Registered nurse. SE=Standard error. ZIP=Zone 
improvement plan.  
* p < .1 ** p < .05 *** p < .01. 
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The point estimate for a 1-year-effect of IPAL was associated with 1.43% lower hospital 
costs (i.e., 𝑒−0.0163 + 0.0018 − 1 = −0.014, p < .01). Although the financial benefits of having an 
IPAL diminished over time, the point estimates for annual effects after the first year were 
consistently associated with lower hospital costs given that years of experience never exceeded 
five years. Specifically, the point estimates for hospitals with two to five years of IPAL 
experience ranged between 1.25% (i.e., 𝑒−0.0163 +2∗ 0.0018 − 1 = −0.0125, p < .01) and 0.7% 
(i.e., 𝑒−0.0163 + 5∗0.0018 − 1 = −0.007, p < .01) lower hospital costs, respectively. While the 
point estimate of a 1-year effect of HOSPC was statistically insignificant, each additional year of 
HOSPC experience significantly reduced hospital costs by 0.34% (p < .01). Taking this pattern 
of decline into account, after the first year in place, the presence of HOSPC was associated with 
significantly lower hospital costs, ranging between 1.67% and 0.65% lower hospital costs. 
Furthermore, the point estimate of a 1-year effect of PAL was not statistically significant (i.e., 
𝑒−0.0087+0.0115 − 1 = 0.003, p = .143). However, each additional year of PAL experience was 
associated with 1.16% higher hospital costs (p < .01), ceteris paribus. Thus, while IPAL and 
HOSPC were generally associated with lower hospital costs, PAL programs were generally 
associated with higher hospital costs.  
 The majority of patient characteristics significantly affected hospital costs, ceteris 
paribus. First, patient age had a positive association with hospital costs. Compared to the patients 
aged between 18 and 49, patients in age group 50-64, 65-75, 75-84, and 85 and older incurred 
3.05%, 2.24%, 2.79%, and 1.57% higher hospital costs, respectively. In addition, female patients 
incurred 1.34% lower hospital costs than male patients. Black, Hispanic, and other 
races/ethnicities had 0.57%, 1.42%, and 0.92% lower hospital costs compared to white patients. 
Compared to the patients in the lowest quartile of median household income, patients in the 
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second lowest and second highest quartiles accumulated between 0.83% and 0.49% higher 
hospital costs, respectively. Conversely, patients in the highest quartile incurred 0.34% lower 
hospital costs than patients in the lowest quartile. Patients from metro and micro/rural areas 
incurred significantly higher hospital costs (4.41% and 6.58%, respectively) compared to patients 
from central/fringe areas.  
 Compared to patients covered by Medicare, patients covered by Medicaid, private 
insurance, self-pay, and other means (e.g., charity), incurred 1.01%, 6.95%, 10.36%, and 8.88% 
lower hospital costs, respectively. Furthermore, patients who were transferred from another 
hospital, admitted by court or law enforcement, and patients who were admitted routinely 
incurred 9.81%, 8.82%, and 7.36% lower hospital costs respectively, compared to patients who 
were admitted through the emergency room. However, patients transferred from another health 
care facility incurred slightly higher hospital costs (0.41%) than patients who were admitted 
through the emergency room.  
 Moreover, compared to cancer patients, patients with HIV, ACD, CHF, and pneumonia 
incurred 8.35%, 23.65%, 2.96%, and 4.94% higher hospital costs. Patients with any of the 
remaining primary diagnoses had significantly lower costs compared to cancer patients. For 
example, patients with AMI incurred 14.44% lower hospital costs compared to cancer patients. 
Similarly, compared to cancer patients, dementia patients incurred 10.68% lower hospitals costs. 
The number of surgical procedures and Charlson-Comorbidity Index were positively associated 
with hospital costs. Specifically, one additional surgical procedure was associated with an 
increase in hospital costs of 20.8%.  An increase of Charlson-Comorbidity Index by one standard 
deviation (SD = 2.22) resulted in 7.2% higher hospital costs. Finally, patients with a documented 
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palliative care encounter had 13.77% lower hospital costs compared to patients without such a 
documented encounter.  
 At the hospital level, several control variables were significantly associated with hospital 
costs, although their effect sizes were small, ceteris paribus. Specifically, an increase in ten 
hospital beds and one-percentage point increase in lagged operating margin were associated with 
a 0.14% and 6.74% increase in hospital costs, respectively. Hospitals with access to palliative 
care services through a health system, network, or joint venture incurred 1.11% lower hospital 
costs compared to hospitals without such access. A one-percentage point increase in a hospital’s 
share of Medicare patients was associated with a 0.12% decrease in hospital costs. Teaching 
hospitals incurred 5.59% higher hospital costs compared to non-teaching hospitals. For-profit 
and public hospitals had 3.18% and 1.2% higher hospital costs compared to not-for-profit 
hospitals, respectively. Magnet hospitals incurred 1.98% lower hospital costs compared to 
hospitals without Magnet designation. A hospital’s all-patient DRG case-mix and ratio of 
registered nurses to total nurses were negatively associated with hospital costs, with coefficients 
of -0.03 respectively. A one percent increase in a hospital’s share of patients with one of the 
study’s eight primary diagnoses, percentage of Hispanic patients, percentage of Black patients, 
and percentage of patients aged 65 were also associated with somewhat lower hospital costs. 
Finally, a 10% increase in average length of stay was associated with a 2.18% increase in 
hospital costs.  
 All eight market control variables were significantly associated with hospital costs, 
keeping other variables constant in the model. Specifically, market competition, HMO 
penetration rate, per capita income, and the rate of uninsured were associated with somewhat 
lower hospital costs. On the other hand, the population size, unemployment rate, PPO 
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penetration rate, and area wage index were positively associated with hospital costs. For 
example, a 10% increase in county’s area wage index was associated with 7.49% higher hospital 
costs.  
Results of sensitivity analysis. 
 Table 18 reports the results of the sensitivity analyses for hospital costs. Separate models 
were employed for patients who died during hospitalization and patients who were discharged 
alive.    
Table 18 
18Sensitivity Analyses for 3-Level Model for Hospital Costs by Patient Disposition 
Variable 
Decedents Survivors 
Coefficient SE Coefficient SE 
Research Questions Two and Three         
PAL -0.0053 0.012 -0.0095*** 0.0020 
IPAL 0.0003 0.012 -0.0185*** 0.0020 
HOSPC -0.0308** 0.013 0.0020 0.0021 
Years of PAL experience (since 2006) 0.0175*** 0.003 0.0117*** 0.0005 
Years of IPAL experience (since 2006) 0.0034 0.004 0.0022*** 0.0006 
Years of HOSPC experience (since 2006) -0.0106*** 0.003 -0.0033*** 0.0006 
 
Note. HOSPC=Hospice program. IPAL=Inpatient palliative care unit. PAL=Inpatient palliative care consultation 
service. SE=Standard error.  
* p < .1 ** p < .05 *** p < .01. 
 
 Among decedents, the 1-year effects of PAL and IPAL on hospital costs were statistically 
insignificant, while a 1-year effect of HOSPC reduced hospital costs by 4.06% (i.e., 
𝑒−0.0308−0.0106 − 1 = −0.0406, p < .01). Among survivors, the 1-year effect of IPAL resulted in 
1.62% (i.e., 𝑒−0.0185+0.0022 − 1 = −0.0162, p < .01) reduced hospital costs, whereas the 1-year 
effects of PAL and HOSPC had no significant impact on hospital costs among survivors. 
 The effects of a hospital’s experience in providing PAL, IPAL, or HOSPC were similar 
across patient disposition. Among survivors, one additional year of PAL experience was 
associated with 1.18% higher hospital costs, whereas one additional year of PAL experience was 
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associated with 1.77% higher hospital costs for decedents. Furthermore, one additional year of 
HOSPC was associated with 1.05% lower hospital costs among decedents, while one additional 
year of HOSPC was associated with 0.33% lower hospital costs for survivors. In addition, one 
additional year of IPAL was associated with 0.22% higher hospital costs among patients who 
were discharged alive, but was not associated with hospital costs among decedents.  
 Length of stay. 
Results of main analysis.  
 Table 19 reports the results generated from the three-level hierarchical models with LOS 
as a dependent variable for patients discharged alive and patients who died during 
hospitalization, respectively. The effects of the model parameters on length of stay are reported 
in incidence rate ratios (IRR). Note that the ICC provided evidence that 99.72% of the variance 
in length of stay was at the patient level, whereas less than half of a percent was at the hospital 
(0.22%) and county level (0.06%). 
Table 19 
19Results of 3-Level Model for Length of Stay, 2007-2011 
Table 19 (continued)   
Variable 
Survivors Decedents 
IRR SE IRR SE 
Research Questions Two and Three         
PAL 1.0078*** 0.0015 1.0164*** 0.0058 
IPAL 0.9875*** 0.0014 0.9769*** 0.0056 
HOSPC 1.0036** 0.0015 0.9970 0.0060 
Years of PAL experience (since 2006) 0.9926*** 0.0004 0.9934*** 0.0016 
Years of IPAL experience (since 2006) 1.0056*** 0.0004 1.0109*** 0.0018 
Years of HOSPC experience (since 2006) 1.0014*** 0.0004 1.0026* 0.0016 
Patient Control Variables         
Patient Age         
50-64 1.0285*** 0.0008 1.0413*** 0.0041 
65-74 1.0545*** 0.0010 1.0327*** 0.0046 
75-84 1.1272*** 0.0011 1.0614*** 0.0047 
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Table 19 (continued)   
Variable 
Survivors Decedents 
IRR SE IRR SE 
85+ 1.1918*** 0.0013 1.0522*** 0.0050 
Patient Gender         
Female 1.0226*** 0.0005 0.9998 0.0019 
Patient Ethnicity/Race         
Black 1.0338*** 0.0008 1.0360*** 0.0034 
Hispanic 1.0021*** 0.0008 1.0002 0.0034 
Other 1.0014 0.0010 0.9883*** 0.0036 
Median HH Income (level: ZIP)         
2nd lowest quartile 0.9880*** 0.0007 1.0012 0.0029 
2nd highest quartile 0.9791*** 0.0007 0.9876*** 0.0030 
Highest quartile  0.9615*** 0.0008 0.9887*** 0.0033 
Patient Location         
Metro 1.0016 0.0012 1.0003 0.0051 
Micro/Rural 0.9699*** 0.0016 0.9701*** 0.0066 
Health Insurance         
Medicaid 1.0573*** 0.0010 1.0733*** 0.0042 
Private 0.8923*** 0.0007 0.9931** 0.0030 
Self-pay 0.9397*** 0.0013 0.9282*** 0.0057 
Other  0.9554*** 0.0014 0.9276*** 0.0060 
Admission Source         
Another hospital 1.0772*** 0.0013 1.0364*** 0.0041 
Another HCF 1.0393*** 0.0015 0.9190*** 0.0028 
Court/Law enforcement 1.1628*** 0.0100 0.8334*** 0.0051 
Routine 0.8568*** 0.0005 0.8249*** 0.0053 
Primary Diagnosis         
HIV 1.2425*** 0.0024 1.0666*** 0.0073 
AMI 0.6002*** 0.0006 0.4957*** 0.0019 
ACD 1.2154*** 0.0011 0.7210*** 0.0025 
CHF 1.0526*** 0.0008 0.9737*** 0.0033 
COPD 1.0776*** 0.0010 1.1753*** 0.0056 
Pneumonia 1.2368*** 0.0010 1.0664*** 0.0035 
Dementia 1.4466*** 0.0025 1.2182*** 0.0155 
Charlson-Comorbidity Index 1.0504*** 0.0001 1.0298*** 0.0005 
Number of surgical procedures 1.1311*** 0.0001 1.1032*** 0.0002 
Palliative care encounter 1.2256*** 0.0020 1.0636 0.0027 
Hospital Control Variables         
Number of set-up and staffed beds (in 10s) 1.0011*** 0.0001 1.0007*** 0.0002 
Operating margin (lagged) 1.0440*** 0.0049 1.1268** 0.0203 
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Table 19 (continued)   
Variable 
Survivors Decedents 
IRR SE IRR SE 
Presence of PC services in health   
system/network/JV 
1.0001 0.0011 0.9913 0.0044 
Share of Medicare patients (%) 1.0009 0.0001 0.9997*** 0.0003 
Teaching hospital 1.0557*** 0.0029 1.0350*** 0.0111 
Public  0.9995*** 0.0042 0.9374 0.0123 
For-profit 1.0169*** 0.0042 0.9940*** 0.0129 
Magnet Hospital 1.0017*** 0.0012 0.9578* 0.0048 
Ratio RN to total nurses 0.9692*** 0.0037 1.0287*** 0.0157 
Hospital all-patient DRG case-mix 0.9824*** 0.0045 0.9472* 0.0153 
Patients with 1 of 8 primary DX (%) 0.9958 0.0004 0.9975*** 0.0015 
Hospital patients Hispanic (%) 0.9997*** 0.0001 0.9990 0.0002 
Hospital patients Black (%) 0.9992*** 0.0002 0.9997** 0.0005 
Hospital patients aged ≥ 65 (%) 1.0016 0.0002 0.9988 0.0006 
County Control Characteristics         
1 - Herfindahl-Hirschman Index  0.9840*** 0.0043 1.0207*** 0.0181 
Area Wage Index  0.8050*** 0.0089 1.1863*** 0.0431 
PPO penetration rate (%) 1.0002** 0.0001 0.9977 0.0003 
HMO penetration rate (%) 1.0004* 0.0002 0.9998** 0.0007 
Per Capita Income (in 1,000 US$)  1.0002 0.0002 0.9989** 0.0004 
Population size (in 10,000 residents) (log) 1.0335*** 0.0062 1.0229*** 0.0097 
Unemployment rate (log) 1.0422*** 0.0043 0.9204*** 0.0142 
Rate of uninsured aged 18 through 64 (%) 0.9984*** 0.0002 1.0021 0.0007 
Year         
2008 0.9629*** 0.0015 0.9907 0.0059 
2009 0.8498*** 0.0029 1.0013 0.0126 
2010 0.8279*** 0.0031 0.9841*** 0.0136 
2011 0.8260*** 0.0030 0.9645 0.0132 
State          
Arizona 0.9901 0.0283 0.8915 0.0370 
Florida 1.0840*** 0.0209 1.0240** 0.0310 
Maryland 1.0273 0.0263 0.9158*** 0.0338 
New Jersey 1.1755*** 0.0258 1.1084*** 0.0338 
New York 1.0751*** 0.0223 1.1666*** 0.0354 
Intercept 3.4726*** 0.1285 4.6567*** 0.3530 
 
Note. ACD=Acute cerebrovascular disease. AMI=Acute myocardial infarction. CHF=Congestive heart failure. 
COPD=Chronic obstructive pulmonary disease. DRG=Diagnosis-related group. DX=Diagnosis. HCF=Healthcare 
facility. HH=Household. HIV=Human immunodeficiency virus. HMO=Health maintenance organization. 
HOSPC=Hospice program. IPAL=Inpatient palliative care unit. IRR=Incidence rate ratio. PAL=Inpatient palliative 
care consultation service. PC=Palliative care. PPO=Preferred provider organization. RN=Registered nurse. 
SE=Standard error. ZIP=Zone improvement plan.  
* p < .1 ** p < .05 *** p < .01. 
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 The following results are interpreted controlling for other variables in the model. The 
empirical results were mixed concerning research questions two and three. The point estimate of 
a 1-year effect of HOSPC was associated with 0.5% (i.e., 𝑒0.0036+0.0014 − 1 = 0.005, p < .01) 
longer lengths of stay for survivors. Each additional year of HOSPC experience was also 
associated with 0.14% longer lengths of stay (p < .01), leading HOSPC of all durations to be 
positively associated with length of stay among survivors. Furthermore, the point estimate of a 1-
year effect of IPAL was associated with 0.7% (i.e., 𝑒−0.0126+0.0056 − 1 = −0.007, p < .01) 
shorter lengths of stay for survivors, whereas each additional year of IPAL experience was 
associated with 0.56% longer lengths of stay (p < .01). That is, while the point estimate of a 2-
year effect was still associated with shorter lengths of stay without being statistically significant, 
the point estimates of the following years were significantly associated between 0.41% and 
1.54% longer lengths of stay. Moreover, the point estimate of a 1-year effect of PAL was not 
statistically significant among survivors. However, each additional year of PAL experience was 
associated with 0.74% shorter lengths of stay (p < .01). Specifically, the point estimates of a 
second through fifth year were consistently associated between 0.7% and 2.88% shorter lengths 
of stay.  
 Among decedents, the point estimate of a 1-year effect of PAL was associated with 
0.97% (i.e., 𝑒0.0163−0.0066 − 1 = 0.0097, p < .1) longer lengths of stay, whereas each additional 
year of PAL experience yielded 0.66% shorter lengths of stay (p < .01). Specifically, the point 
estimates of a fifth year yielded 1.66% shorter lengths of stay (p < .05). The point estimates of a 
second through fourth year were not statistically significant. Furthermore, the point estimate of a 
1-year effect of IPAL was associated with a 1.25% (i.e., 𝑒−0.0234+0.0108 − 1 = −0.0125, p < 
.05) decrease in length of stay for decedents. However, each additional year of IPAL experience 
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was associated with 1.09% longer lengths of stay (p < .01). In particular, the point estimates of a 
third through fifth year were associated with 0.92%, 2.01%, and 3.12% longer lengths of stay, 
respectively. The point estimate of a second year was not significantly associated with length of 
stay among decedents. Although the point estimate of a 1-year-effect of HOSPC was not 
statistically significant (i.e., 𝑒−0.003+0.0026 − 1 = −.0004, p = .95), each additional year of 
HOSPC experience yielded 0.26% longer lengths of stay among decedents. However, the point 
estimates of a second through fifth year were not significantly associated with length of stay.  
 Several patient control variables were associated with length of stay, ceteris paribus. 
Specifically, patient age is a significant risk factor of length of stay among both survivors and 
decedents. Compared with survivors aged 18-49, lengths of stay of survivors in age groups 50-
64, 65-74, 75-85, and 85+ were on average 2.85%, 5.45%, 12.72%, and 19.18% longer, 
respectively. Similar age effects were detected among decedents such that the effects were 
generally larger for older patients. Female survivors had 2.26% longer length of stay compared 
with male survivors. Among decedents, patient gender was not significantly associated with 
length of stay. Black and Hispanic survivors had 3.38% and 0.21% longer length of stay 
compared with white survivors. Decedents of other ethnicities had shorter lengths of stay 
compared with white decedents, whereas Black decedents had 3.6% longer lengths of stay. 
Compared with patients in the lowest quartile of income, patients in the higher quartiles of 
income had between 1.2% and 3.85% shorter lengths of stay. Similar income effects were 
observed among decedents. Moreover, among survivors and decedents, patients residing in micro 
or rural areas had 3% shorter lengths of stay compared with patients residing in urban areas.  
 Survivors covered by Medicaid had 5.73% longer lengths of stay compared to Medicare 
patients, while survivors covered by self-pay, private insurance, and other means had between 
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4.46% and 10.7% shorter lengths of stay compared with Medicare patients. Health insurance had 
a similar effect on the study’s decedents’ lengths of stay. Both survivors and decedents with 
routine admissions had 14.32% and 17.51% shorter lengths of stay compared with patients 
admitted through the emergency room, respectively. In addition, patients in both groups 
transferred from another hospital had 3.64% and 7.72% longer lengths of stay compared to 
patients in the reference group, respectively. Survivors transferred from other health care 
facilities and admitted through court/law enforcement had on average 3.93% and 16.28% longer 
lengths of stay respectively compared to survivors admitted through the emergency room, 
whereas decedents had 8.1% and 16.66% shorter lengths of stay, respectively.  
 Compared with cancer survivors, HIV, COPD, pneumonia, and dementia survivors had 
longer lengths of stay. Conversely, survivors with AMI had on average 40% shorter lengths of 
stay than cancer patients. Similar patterns were observed among decedents. Furthermore, 
survivors with ACD and CHF had 21.54% and 5.26% longer lengths of stay respectively, 
whereas decedents with these primary diagnoses had 27.9% and 2.63% shorter lengths of stay 
compared with cancer patients. One additional surgical procedure was associated with 13.11% 
longer length of stay among survivors and 10.32% longer lengths of stay among decedents. A 
one standard deviation (SD=2.22) increase in a patient’s Charlson-Comorbidity Index was 
associated with 11.53% longer lengths of stay among survivors and 6.7% longer lengths of stay 
among decedents. Survivors with a documented palliative care encounter experienced a 22.56% 
longer lengths of stay compared with survivors without a documented palliative care encounter. 
Among decedents, lengths of stay were 6.36% longer when a palliative care encounter was 
documented.  
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 Several hospital control variables were significantly associated with length of stay, 
keeping other variables constant. Note that hospital effects differed between patient groups. 
Specifically, survivors treated in teaching, for-profit, and Magnet hospitals had longer lengths of 
stay, whereas survivors treated in public hospitals had shorter lengths of stay. More hospital beds 
and a higher lagged operating margin were associated with longer lengths of stay. Conversely, a 
higher ratio of registered nurses and total nurses, hospital all-patient DRG case-mix, percentage 
of Hispanic and Black patients were associated with shorter lengths of stay. Among decedents, 
more hospital beds, a higher lagged operating margin, and a higher ratio of registered nurses and 
total nurses were associated with longer lengths of stay. Decedents treated in for-profit and 
Magnet hospitals had significantly shorter lengths of stay. A higher hospital all-patient DRG 
case-mix, a higher percentage of patients with the study’s eight primary diagnoses, and a higher 
percentage of Black patients were associated with shorter lengths of stay among decedents.  
 The majority of market control variables were significantly associated with length of 
stay, ceteris paribus. Among survivors, patients treated in hospitals located in counties with 
higher market competition, area wage index, and rate of uninsured had shorter lengths of stay. In 
addition, survivors treated in hospitals located in counties with higher PPO and HMO penetration 
rates, population sizes, and unemployment rates had longer lengths of stay. Decedents treated in 
hospitals located in counties with higher market competition, area wage index, and population 
sizes had longer lengths of stay, whereas decedents treated in hospitals located in counties with 
higher HMO penetration rates, per capita income, and unemployment rates had shorter lengths of 
stay. 
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Results of sensitivity analysis.  
 Table 20 presents the results of the sensitivity analyses for length of stay for patients who 
were transferred to hospice.  
Table 20 
20Sensitivity Analyses for Length of Stay until Transfer to Hospice 
Variable IRR SE 
Research Questions Two and Three       
PAL 0.9592*** 0.0082 
IPAL 0.9879 0.0073 
HOSPC 1.0333*** 0.0091 
Years of PAL experience (since 2006) 1.0063*** 0.0022 
Years of IPAL experience (since 2006) 1.0108*** 0.0025 
Years of HOSPC experience (since 2006) 0.9879*** 0.0023 
 
Note. HOSPC=Hospice program. IPAL=Inpatient palliative care unit. IRR=Incidence rate ratio. PAL=Inpatient 
palliative care consultation service. SE=Standard error.  
* p < .1 ** p < .05 *** p < .01. 
 
 The 1-year effect of PAL resulted in 3.47% (i.e., 𝑒−0.0416+0.0063 − 1 = −0.0347, p < 
.01) shorter lengths of stay for patients who were transferred to hospice after hospital discharge, 
whereas the 1-year effect of HOSPC was associated with 2.09% (i.e., 𝑒0.0328−0.0122 − 1 =
0.0209, p < .01) longer lengths of stay for patients who were transferred to hospice after hospital 
discharge. The 1-year effect of hospital-based IPAL was not significantly associated with length 
of stay. Furthermore, one additional year of PAL and IPAL was associated with 0.63% and 
1.08% longer lengths of stay, respectively, whereas one additional year of HOSPC resulted in 
1.21% shorter lengths of stay for patients who were transferred to hospice following discharge. 
In-hospital mortality. 
Results of main analysis. 
 Table 21 presents the results generated from the three-level HGLM with in-hospital 
mortality as the dependent variable. According to the ICC, the vast majority of the total variance  
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Table 21 
21Results of 3-Level Model for In-Hospital Mortality, 2007-2011 
Table 21 (continued)   
Variable Odds Ratio SE 
Research Questions Two and Three     
PAL 0.9732** 0.0127 
IPAL 0.9282*** 0.0135 
HOSPC 0.9750* 0.0139 
Years of PAL experience (since 2006) 0.9822*** 0.0040 
Years of IPAL experience (since 2006) 1.0336*** 0.0050 
Years of HOSPC experience (since 2006) 0.9885*** 0.0043 
Patient Control Variables     
Patient Age     
50-64 1.2414*** 0.0143 
65-74 1.8080*** 0.0234 
75-84 2.4890*** 0.0324 
85+ 3.5884*** 0.0486 
Patient Gender     
Female 0.9488*** 0.0052 
Patient Ethnicity/Race     
Black 0.8709*** 0.0085 
Hispanic 0.8708*** 0.0086 
Other 1.0246** 0.0109 
Median HH Income (level: ZIP)     
2nd lowest quartile 0.9944 0.0080 
2nd highest quartile 0.9661*** 0.0082 
Highest quartile  1.0018 0.0093 
Patient Location     
Metro 0.9516*** 0.0113 
Micro/Rural 0.9098*** 0.0169 
Health Insurance     
Medicaid 1.2162*** 0.0145 
Private 1.2103*** 0.0108 
Self-pay 1.5481*** 0.0252 
Other  1.3531*** 0.0228 
Admission Source     
Another hospital 1.2164*** 0.0141 
Another HCF 1.2870*** 0.0187 
Court/Law enforcement 0.8973 0.1081 
Routine 0.6516*** 0.0050 
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Table 21 (continued)   
Variable Odds Ratio SE 
Primary Diagnosis     
HIV 1.7896*** 0.0416 
AMI 1.0525*** 0.0113 
ACD 3.1308*** 0.0306 
CHF 0.9458*** 0.0095 
COPD 0.6625*** 0.0098 
Pneumonia 1.3795*** 0.0141 
Dementia 0.4200*** 0.0144 
Charlson-Comorbidity Index 1.1419*** 0.0016 
Number of surgical procedures 1.1990*** 0.0010 
Palliative care encounter  20.8885*** 0.1705 
Hospital Control Variables     
Number of set-up and staffed beds (in 10s) 1.0002 0.0002 
Operating margin (lagged) 1.0658* 0.0385 
Presence of PC services in health system/network/JV 1.0170** 0.0085 
Share of Medicare patients (%) 0.9953*** 0.0005 
Teaching hospital 0.8953*** 0.0123 
Public  0.9122*** 0.0126 
For-profit 1.0833*** 0.0169 
Magnet Hospital 0.9759* 0.0139 
Ratio RN to total nurses 0.9343* 0.0338 
Hospital all-patient DRG case-mix 0.6508*** 0.0150 
Patients with 1 of 8 primary DX (%) 0.9786*** 0.0019 
Hospital patients Hispanic (%) 1.0034*** 0.0003 
Hospital patients Black (%) 1.0000 0.0004 
Hospital patients aged ≥ 65 (%) 1.0040*** 0.0008 
Average length of stay (log) 1.9967*** 0.0693 
County Control Characteristics     
1 - Herfindahl-Hirschman Index  0.9817 0.0274 
Area Wage Index  0.8762*** 0.0365 
PPO penetration rate (%) 0.9947*** 0.0008 
HMO penetration rate (%) 0.9951*** 0.0008 
Per Capita Income (in 1,000 US$)  1.0010** 0.0004 
Population size (in 10,000 residents) (log) 0.9075*** 0.0078 
Unemployment rate (log) 0.9454** 0.0244 
Rate of uninsured aged 18 through 64 (%) 1.0082*** 0.0014 
Year     
2008 0.8851*** 0.0107 
2009 0.8137*** 0.0181 
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Table 21 (continued)   
Variable Odds Ratio SE 
2010 0.7433*** 0.0181 
2011 0.7532*** 0.0186 
State      
Arizona 0.6731*** 0.0192 
Florida 0.7539*** 0.0194 
Maryland 1.1247*** 0.0367 
New Jersey 0.9725 0.0250 
New York 1.0718** 0.0290 
Intercept 0.0192*** 0.0020 
 
Note. ACD=Acute cerebrovascular disease. AMI=Acute myocardial infarction. CHF=Congestive heart failure. 
COPD=Chronic obstructive pulmonary disease. DRG=Diagnosis-related group. DX=Diagnosis. HCF=Healthcare 
facility. HH=Household. HIV=Human immunodeficiency virus. HMO=Health maintenance organization. 
HOSPC=Hospice program. IPAL=Inpatient palliative care unit. PAL=Inpatient palliative care consultation service. 
PC=Palliative care. PPO=Preferred provider organization. RN=Registered nurse. SE=Standard error. ZIP=Zone 
improvement plan. 
* p < .1 ** p < .05 *** p < .01. 
 
in the probability of in-hospital mortality was at the patient level (99.25%), whereas the 
remaining variance was between at the hospital (0.39%) and county level (0.36%). 
 The point estimates for a 1-year effect of PAL, IPAL, and HOSPC were associated with 
4.4% (i.e., 𝑒−0.02713−0.01793 − 1 = −0.0441, p < .01), 4.06% (i.e., 𝑒−0.07449+0.03307 − 1 =
−0.0406, p < .01), and 3.63% (i.e., 𝑒−0.02534−0.01159 =  −0.0363, p < .01) lower odds of in-
hospital mortality, controlling for other variables in the model. Furthermore, one additional year 
of experience with PAL and HOSPC was associated with 1.78% and 1.15% lower odds of in-
hospital mortality, respectively. However, one additional year of IPAL experience yielded 3.36% 
higher odds of in-hospital mortality. Specifically, the point estimate for a 2-year effect of IPAL 
was not significantly associated with the odds of in-hospital mortality, whereas the effects of the 
following years yielded between 2.5% and 9.51% higher odds of in-hospital mortality (p < .05). 
Thus, PAL and HOSPC were generally associated with lower odds of in-hospital mortality, 
while IPAL was not.  
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 While the results of three of the outcomes were robust to the addition of the palliative 
care encounter control variable, results with respect to in-hospital mortality were fairly sensitive. 
Hence, this paragraph summarizes the empirical results of the model estimating in-hospital 
mortality without the palliative care encounter control variable. Specifically, when estimating the 
model without the palliative care encounter control variable, only the point estimate for a 1-year 
effect of PAL was associated with a 2.6% (i.e., 𝑒−0.03417+0.0077 − 1 = −0.026, p < .05) 
reduction in the odds of in-hospital mortality, ceteris paribus. One additional year of experience 
with PAL and IPAL was associated with 0.77% and 2.4% higher odds of in-hospital mortality, 
respectively.  
 Several patient control variables are significant predictors of in-hospital mortality. 
Specifically, patient age is a significant risk factor of in-hospital mortality. Compared with 
patients aged 18-49, the odds of in-hospital mortality were 24%, 81%, 249%, and 359% higher 
for patients aged 50-64, 65-74, 75-84, and 85 and older, respectively. In addition, the odds of in-
hospital mortality was 5.12% lower for female patients compared with male patients. Compared 
with white patients, the odds of in-hospital mortality were 11.9% lower for black and Hispanic 
patients, respectively. Conversely, the odds of in-hospital mortality was 2.46% higher for 
patients of other ethnicities/races compared with white patients. Compared with patients in the 
lowest income quartile, the odds of in-hospital mortality was 3.39% lower for patients in the 
second highest quartile. The odds of in-hospital mortality for patients who lived in metro and 
micro/rural areas were 4.84% and 9.02% lower, respectively, compared with patients who 
resided in central/fringe areas. Compared with Medicare patients, patients with other types of 
health insurance had higher odds of in-hospital mortality, with odds ratios ranging between 1.21 
for patients covered by private insurance and 1.55 for patients covered by self-pay. In addition, 
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the odds of in-hospital mortality were 21.64% and 28.7% higher for patients transferred from 
another hospital and health care facility, respectively, compared with patients who were admitted 
through the emergency room. On the contrary, the odds of in-hospital mortality was 34.84% 
lower for patients who were admitted routinely compared with patients in the reference group. 
The odds of in-hospital mortality were 5.42%, 33.75%, and 58% lower for patients with CHF, 
COPD, and dementia, respectively, compared with cancer patients. Conversely, the odds of in-
hospital mortality were 78.96%, 313.08%, and 37.95% higher for patients with HIV, ACD, and 
pneumonia, respectively, compared with cancer patients. Patient severity measures were also 
associated with higher odds of in-hospital mortality. Specifically, one additional surgical 
procedure was associated with 19.9% higher odds of in-hospital mortality. Similarly, an increase 
in Charlson-Comorbidity Index by one standard deviation (SD = 2.22) resulted in 34.25% higher 
odds of in-hospital mortality. Finally, patients with a documented palliative care encounter had a 
2089% higher odds of in-hospital mortality compared with patients who did not have a palliative 
care encounter recorded in their medical records.  
 Several hospital control variables exhibited statistical significance in predicting in-
hospital mortality, ceteris paribus. Specifically, patients treated in teaching, public, and Magnet 
hospitals had lower odds of in-hospital mortality. In addition, a higher share of Medicare 
patients, ratio of registered nurses to total nurses, number of patients with one of the study’s 
eight primary diagnoses, and hospital all-patient DRG case-mix were associated with lower odds 
of in-hospital mortality. Conversely, higher lagged operating margin, percentages of Hispanic 
patients, patients aged 65 and older, and average length of stay were associated with a higher 
odds of in-hospital mortality. Finally, patients treated in hospitals with access to palliative care 
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services through a health system, network, or joint venture had higher odds of in-hospital 
mortality. 
 Some market control variables were significantly associated with the odds of in-hospital 
mortality, keeping other variables constant. Higher area wage index, PPO and HMO penetration 
rates, population size, and unemployment rate were associated with lower odds of in-hospital 
mortality. Higher rates of uninsured and per capita income were associated with somewhat 
higher odds of in-hospital mortality.   
Results of sensitivity analysis. 
 Table 22 presents the results of the sensitivity analyses for in-hospital mortality. Separate 
analyses for patients with each of the study’s primary diagnoses were estimated.  
 In regard to research question two, the 1-year effects of PAL had a consistently negative 
association with the odds of in-hospital mortality for patients with cancer, CHF, COPD, 
dementia, and pneumonia, with odds ratios ranging between 5.64% for cancer patients and 
48.28% for dementia patients. In addition, the 1-year effects of IPAL were associated with 
4.38%, 4.87%, and 9.71% lower odds of in-hospital mortality for patients with ACD, cancer, and 
COPD, respectively. The 1-year effects of HOSPC was associated with 6.46% and 6.11% lower 
odds of in-hospital mortality for patients with ACD and AMI, respectively. But the 1-year effect 
of HOSPC was associated with 11.07% higher odds of in-hospital mortality for COPD patients. 
 In regard to research question three, one additional year of PAL experience resulted in 
lower in-hospital mortality for patients with AMI, cancer, and HIV, whereas one additional year 
of PAL experience resulted in somewhat higher odds of in-hospital mortality for patients with 
dementia and pneumonia. One additional year of IPAL experience was consistently associated 
with higher in-hospital mortality for ACD, AMI, cancer, and dementia patients. Finally, one 
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Table 22 
22Sensitivity Analyses for In-hospital Mortality by Primary Diagnosis, 2007-2011 
Variable 
ACD AMI Cancer  CHF 
Odds 
Ratio 
SE Odds Ratio SE Odds Ratio SE Odds Ratio SE 
Research Questions Two and Three               
PAL 1.0394 0.0313 1.0127 0.0323 0.9739 0.0232 0.9322** 0.0313 
IPAL 0.9319** 0.0303 0.9436 0.0341 0.9082*** 0.0230 0.9521 0.0367 
HOSPC 0.9394* 0.0309 0.9538 0.0331 0.9889 0.0242 1.0304 0.0382 
Years of PAL experience (since 2006) 0.9900 0.0090 0.9726*** 0.0098 0.9688*** 0.0073 1.0053 0.0108 
Years of IPAL experience (since 2006) 1.0261** 0.0109 1.0300** 0.0126 1.0475*** 0.0088 1.0186 0.0134 
Years of HOSPC experience (since 2006) 0.9958 0.0097 0.9844 0.0109 0.9979 0.0076 0.9853 0.0117 
 
Variable 
COPD Dementia HIV Pneumonia 
Odds 
Ratio 
SE Odds Ratio SE 
Odds 
Ratio 
SE Odds Ratio SE 
 Research Questions Two and Three        
        PAL 0.8390*** 0.0510 0.4678*** 0.0811 1.0254 0.1046 0.8254*** 0.0288 
        IPAL 0.8952 0.0665 0.7581 0.1505 0.8460 0.0976 0.9565 0.0396 
        HOSPC 1.1096 0.0769 0.9568 0.1889 0.9981 0.1097 1.0385 0.0407 
Years of PAL experience (since 2006) 1.0068 0.0195 1.1055* 0.0618 0.9440* 0.0331 1.0306*** 0.0114 
Years of IPAL experience (since 2006) 1.0086 0.0258 1.2188*** 0.0728 1.0416 0.0459 0.9983 0.0141 
Years of HOSPC experience (since 2006) 1.0010 0.0222 0.9847 0.0574 1.0058 0.0402 0.9825 0.0123 
 
Note. ACD=Acute cerebrovascular disease. AMI=Acute myocardial infarction. CHF=Congestive heart failure. COPD=Chronic obstructive pulmonary disease. 
HIV=Human immunodeficiency virus. HOSPC=Hospice program. IPAL=Inpatient palliative care unit. PAL=Inpatient palliative care consultation service. 
SE=Standard error. 
* p < .1 ** p < .05 *** p < .01.
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additional year of HOSPC was not associated with the odds of in-hospital mortality for any of 
the eight patient groups. 
Transfer to hospice. 
Results of main analysis. 
Table 23 presents the results generated from the three-level HGLM with transfer to 
hospice as the dependent variable. Note that the ICC suggested that statistically significant 
proportions of the variation in the probability of transfer to hospice were at the patient (70.96%), 
hospital (16.48%), and county level (12.55%). 
Table 23 
23Results of 3-Level Model for Transfer to Hospice, 2007-2011 
Table 23 (continued)   
Variable Odds Ratio SE 
Research Questions Two and Three      
PAL 1.1500*** 0.6130 
IPAL 0.9586*** 0.0249 
HOSPC 0.8843* 0.0198 
Years PAL in place (since 2006) 0.9081*** 0.0058 
Years IPAL in place (since 2006) 0.9965 0.0077 
Years HOSPC in place (since 2006) 1.0401*** 0.0074 
Patient Control Variables     
Patient Age     
50-64 1.5264*** 0.0281 
65-74 2.0263*** 0.0416 
75-84 3.2082*** 0.0655 
85+ 5.8944 0.1232 
Patient Gender     
Female 1.1366*** 0.0086 
Patient Ethnicity/Race     
Black 0.7555*** 0.0105 
Hispanic 0.8807*** 0.0133 
Other 0.8510*** 0.0178 
Median HH Income (level: ZIP)     
2nd lowest quartile 1.0221* 0.0119 
2nd highest quartile 1.0177 0.0121 
 147 
 
Table 23 (continued)   
Variable Odds Ratio SE 
Highest quartile  1.0383*** 0.0135 
Patient Location     
Metro 0.9126*** 0.0189 
Micro/Rural 0.8291*** 0.0216 
Health Insurance     
Medicaid 1.3115*** 0.0240 
Private 0.8708*** 0.0120 
Self-pay 0.9683 0.0270 
Other  1.3956*** 0.0296 
Admission Source     
Another hospital 0.6286*** 0.0139 
Another HCF 0.8791*** 0.0191 
Court/Law enforcement 0.0901*** 0.0347 
Routine 0.4194*** 0.0044 
Primary Diagnosis     
HIV 0.4475*** 0.0151 
AMI 0.4129*** 0.0071 
ACD 0.7821*** 0.0109 
CHF 0.3681*** 0.0047 
COPD 0.2679*** 0.0047 
Pneumonia 0.3759*** 0.0054 
Dementia 0.4940*** 0.0137 
Charlson-Comorbidity Index 1.2815*** 0.0023 
Number of surgical procedures 0.9281*** 0.0017 
Palliative care encounter 15.1091*** 0.1809 
Hospital Control Variables     
Number of set-up and staffed beds (in 10s) 1.0005 0.0010 
Operating margin (lagged) 0.9652 0.0801 
Presence of PC services in health system/network/JV 1.0272 0.0198 
Share of Medicare patients (%) 1.0059*** 0.0010 
Teaching hospital 1.0949** 0.0448 
Public  0.8317*** 0.0528 
For-profit 0.8386* 0.0767 
Magnet Hospital 1.0139 0.0199 
Ratio RN to total nurses 1.1587** 0.0693 
Hospital all-patient DRG case-mix 1.0469 0.0804 
Patients with 1 of 8 primary DX (%)  0.9691*** 0.0066 
Hospital patients Hispanic (%) 1.0014* 0.0007 
Hospital patients Black (%) 1.0117*** 0.0037 
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Table 23 (continued)   
Variable Odds Ratio SE 
Hospital patients aged ≥ 65 (%) 0.9959 0.0034 
Average length of stay (log) 0.6028*** 0.0755 
County Control Characteristics     
1 - Herfindahl-Hirschman Index  0.8256*** 0.0498 
Area Wage Index  0.4958*** 0.0930 
PPO penetration rate (%) 1.0003 0.0015 
HMO penetration rate (%) 0.9899** 0.0040 
Per Capita Income (in 1,000 US$)  0.9960* 0.0024 
Population size (in 10,000 residents) (log) 0.8867 0.0869 
Unemployment rate (log) 1.2984*** 0.0942 
Rate of uninsured aged 18 through 64 (%) 1.0018 0.0032 
Year     
2008 0.9492* 0.0295 
2009 0.8090*** 0.0520 
2010 1.0061 0.0695 
2011 1.5086*** 0.1000 
State      
Arizona 3.3555*** 1.2244 
Florida 2.5531*** 0.6084 
New Jersey 1.5675* 0.3911 
Intercept 0.0384*** 0.0205 
 
ACD=Acute cerebrovascular disease. AMI=Acute myocardial infarction. CHF=Congestive heart failure. 
COPD=Chronic obstructive pulmonary disease. DRG=Diagnosis-related group. DX=Diagnosis. HCF=Healthcare 
facility. HH=Household. HIV=Human immunodeficiency virus. HMO=Health maintenance organization. 
HOSPC=Hospice program. IPAL=Inpatient palliative care unit. PAL=Inpatient palliative care consultation service. 
PC=Palliative care. PPO=Preferred provider organization. RN=Registered nurse. SE=Standard error. ZIP=Zone 
improvement plan. 
* p < .1 ** p < .05 *** p < .01. 
 
 The following results are interpreted controlling for other variables in the model. The 
point estimate of a 1-year effect of IPAL resulted in 4.47% (i.e., 𝑒−0.0422−0.0035 − 1 = −0.0447, 
p < .05) lower odds of hospice transfer. Although one additional year of IPAL experience was 
not significantly associated with the odds of hospice transfer, all year effects of IPAL were 
associated with lower odds of hospice transfer, averaging around 5% lower odds of hospice 
transfer (p < .1). Moreover, the point estimate of a 1-year effect of HOSPC was associated with 
8.02% (i.e., 𝑒−0.123+0.0394 − 1 = −0.0802, p < .01) lower odds of hospice transfer, while one 
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additional year of HOSPC experience was associated with 4.01% higher odds of hospice 
transfer. Specifically, the point estimate of a 2-year effect of HOSPC resulted in 4.3% lower 
odds of hospice transfer (p < .05), whereas the point estimate of a 5-year effect of HOSPC was 
associated with 7.67% higher odds of hospice transfer (p < .05). In addition, the point estimate of 
a 1-year effect of PAL was associated with 4.43% (i.e., 𝑒0.1398−0.0964 − 1 = 0.0443, p < .1) 
higher odds of hospice transfer. However, one additional year of having a PAL in place was 
associated with a 9.19% lower odds of transfer to hospice. In summary, IPAL were generally 
associated with lower odds of hospice transfer, but PAL and HOSPC did not yield consistent 
effects on hospice transfer. Specifically, while the 1-year effect of PAL was associated with 
higher odds of transfer to hospice, the remaining year effects yielded lower odds of transfer to 
hospice. Finally, although the first two year effects of HOSPC were negatively associated with 
hospice transfer, the fifth year effect was associated with higher odds of transfer to hospice. 
 Several patient characteristics were significantly associated with the odds of transfer to 
hospice. Specifically, the odds of transfer to hospice was increasingly higher for patients in 
higher age groups. Compared with patients aged between 18 and 49, the odds of transfer to 
hospice were 53%, 203%, 321%, and 589% higher for patients in age groups 50-64, 65-74, 75-
84, and 85 and older, respectively. In addition, the odds of transfer to hospice was 13.66% higher 
for female patients compared with male patients. Compared with white patients, black, Hispanic, 
and patients of other races/ethnicities had 24.45%, 11.93%, and 14.9% lower odds of transfer to 
hospice. Patients in higher income quartiles had higher odds of transfer to hospice compared 
with patients in the lowest income quartile. Patients in metro and micro/rural areas had 8.74% 
and 17.09% lower odds of transfer to hospice compared with patients in central/fringe areas. 
Compared with Medicare patients, patients covered by Medicaid and other types of insurance 
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had 31.15% and 39.56% higher odds of transfer to hospice, whereas patients covered by private 
insurance had 12.92% lower odds of transfer to hospice.  
 Moreover, patients admitted to the hospitals through the emergency room had a higher 
odds of transfer to hospice compared to patients not admitted through the emergency room. For 
example, patients who were admitted routinely had a 58.06% lower odds of transfer to hospice 
compared with patients admitted through the emergency room. Non-cancer patients had a lower 
odds of transfer to hospice compared with cancer patients, with odds ratios ranging between 
0.7821 for patients with ACD and 0.2679 for COPD patients. Furthermore, an increase in 
Charlson-Comorbidity Index by one standard deviation (SD=2.22) resulted in 73.42% higher 
odds of transfer to hospice. Conversely, one additional surgical procedure yielded a 10.21% 
lower odds of transfer to hospice. Patients with a documented palliative care encounter had a 
1511% higher odds of transfer to hospice compared with patients without a documented 
palliative care encounter.  
 Several hospital characteristics were associated with transfer to hospice, ceteris paribus. 
A higher share of Medicare patients, Black, and Hispanic patients, and ratio of registered nurses 
to total nurses were associated with higher odds of transfer to hospice. Patients treated in public 
and for-profit had lower odds of transfer to hospice, whereas patients treated in teaching 
hospitals were more likely to be transferred to hospice. In addition, a higher average length of 
stay and percentage of patients with the study’s primary diagnoses were associated with a lower 
odds of transfer to hospice.  
 Some market control variables were significantly associated with transfer to hospice, 
keeping other variables constant in the model. Specifically, patients treated in hospitals located 
in counties with a higher market competition, area wage index, HMO penetration rates, and per 
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capita income had lower odds of transfer to hospice. On the other hand, patients treated in 
hospitals in counties with higher unemployment rates had higher odds of transfer to hospice.  
Results of sensitivity analysis. 
 Table 24 presents the results of the sensitivity analyses for transfer to hospice. Separate 
analyses for patients transferred to hospice compared to patients transferred to skilled nursing 
facilities (SNF) or home-health care (HHC).  
Table 24 
24Sensitivity Analyses for Transfer to Hospice vs. Skilled Nursing Facilities/Home-Health Care 
Variable 
Transfer to Hospice  
vs. SNF/HHC 
Odds Ratio SE 
Research Questions Two and Three      
PAL 1.1412*** 0.0323 
IPAL 0.9792 0.0242 
HOSPC 0.8525*** 0.0252 
Years of PAL experience (since 2006) 0.9069*** 0.0064 
Years of IPAL experience (since 2006) 0.9940 0.0085 
Years of HOSPC in place (since 2006) 1.0406*** 0.0081 
 
Note. HHC=Home-health care. HOSPC=Hospice program. IPAL=Inpatient palliative care unit. PAL=Inpatient 
palliative care consultation service. SE=Standard error. SNF=Skilled nursing facility.  
* p < .1 ** p < .05 *** p < .01. 
 
 Among patients discharged to skilled nursing facilities or home/self-care, the 1-year 
effect of HOSPC was associated with 11.29% (i.e., 𝑒−0.1596+0.0398 − 1 = −0.1129, p < .01) 
lower odds of hospice transfer. One additional year of PAL in place was associated with 9.31% 
lower odds of transfer to hospice, whereas one additional year of HOSPC was associated with 
4.06% higher odds of transfer to hospice.  
 Note that the results from a supplemental analytical model for transfer to hospice, which 
excluded decedents from the study sample to allow for a comparison of patients who were 
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transferred to hospice and patients who were discharged alive and transferred to other settings, 
were similar to the results from the main analysis. 
Summary 
 This chapter summarized the results of descriptive, main, and sensitivity analyses to 
address the study’s three research questions. Regarding research question one, the study findings 
indicated that hospital size was significantly associated with a higher probability of hospital-
based palliative care provision (Hypothesis 1). In addition, the presence of palliative care 
services through a hospital’s health system, network, or joint venture was associated with a lower 
probability of hospital-based palliative care provision (Hypothesis 3). Hospital market 
competition (Hypothesis 2), a hospital’s share of Medicare patients (Hypothesis 4) and teaching 
status (Hypothesis 5) were not significantly associated with the probability of hospital-based 
palliative care provision.  
 The study findings also suggested that the 1-year effects of IPAL and HOSPC were 
associated with lower hospital costs; the 1-year effect of PAL was not significantly associated 
with hospital costs (Hypothesis 6a). One additional year of experience in providing IPAL or PAL 
was associated with higher hospital costs, while one additional year of experience in providing 
HOSPC was associated with lower hospital costs (Hypothesis 7a).  
 Among survivors and decedents, the 1-year effect of IPAL was associated with shorter 
lengths of stay. Among decedents, the 1-year effect of PAL was associated with longer lengths 
of stay. In addition, the 1-year effect of HOSPC was associated with longer lengths of stay 
among survivors. Among decedents, the 1-year effect of HOSPC was not significantly associated 
with length of stay (Hypothesis 6b). One additional year of PAL was associated with shorter 
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lengths of stay, while one additional year of IPAL or HOSPC was associated with longer lengths 
of stay for decedents and survivors (Hypothesis 7b).  
 The 1-year effects of PAL, IPAL, and HOSPC were associated with reduced odds of in-
hospital mortality (Hypothesis 6c). The alternative model specification without the patient 
control variable palliative care encounter yielded significantly lower odds of in-hospital 
mortality for a 1-year effect of PAL only. One additional year of providing PAL or HOSPC was 
associated with lower odds of in-hospital mortality but one additional year of IPAL resulted in 
higher odds of in-hospital mortality (Hypothesis 7c). The alternative model specification 
produced higher odds of in-hospital mortality for one additional year of PAL and IPAL. 
 The 1-year effect of PAL was associated with higher odds of hospice transfer, whereas 
the 1-year effects of IPAL and HOSPC were associated with lower odds of hospice transfer 
(Hypothesis 6d). One additional year of providing PAL resulted in a lower probability of being 
transferred to hospice; one additional year of HOSPC resulted in a higher probability of transfer 
to hospice (Hypothesis 7d).  
 The next chapter summarizes and interprets the research findings and closes with a 
review of the study’s limitations, a discussion of the theoretical, practical, and policy 
implications of the empirical results, and suggestions for future research. 
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 Palliative care promises to improve organizational and patient outcomes in the hospital 
setting. Specifically, a hospital’s decision to integrate palliative care models into its service mix 
may influence both hospital performance and quality of patient care, as captured in such 
important metrics as hospital length of stay, hospital costs, in-hospital mortality, and patient 
disposition (e.g., transfer to hospice). Chapter 2 provided a comprehensive overview and 
examination of prior research supporting this notion.  
 The study’s three research questions were stated in the first chapter: 1) Which 
organizational and environmental forces are associated with the provision of hospital-based 
palliative care services? 2) Do hospitals that provide palliative care services have improved 
organizational and patient outcomes compared to those not providing such services? and 3) Is a 
hospital’s experience in providing palliative care services associated with improved 
organizational and patient outcomes? Chapter 3 continued with a presentation and discussion of 
the study’s theoretical framework used to develop propositions and hypotheses to answer the 
study’s research questions. To explore the association between key independent variables and 
palliative care provision and hospital performance measures, analytical models were employed 
controlling for additional patient, hospital, and market characteristics.  
 The study’s methodology, including research design, data sources, study sample, variable 
measurement, and analytical strategy, was developed in Chapter 4. Detailed results from these 
models were presented in Chapter 5. Chapter 6 starts with a summary and interpretation of the 
Chapter 6: Discussion 
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research findings, followed by a review of the study’s limitations and a discussion of the 
theoretical, practical, and policy implications of the empirical results. The chapter closes with 
suggestions for future research.  
Summary of Study Findings 
Hospital adoption of palliative care. 
 This study used Institutional Theory and Resource Dependence Theory to examine the 
association between hospital and market characteristics and the provision of palliative care 
services. The study tested five hypotheses for research question one using a two-level 
hierarchical generalized linear model with a binomial sampling model and a logit link function to 
describe under which circumstances hospitals tend to provide palliative care services. Table 25 
summarizes the five hypotheses and specifies whether they were supported based on the results 
of the main analytical models, as reported in Chapter 5.  
 Regarding Hypothesis 1, the findings suggested that hospital size is positively associated 
with the odds of providing one or more of the three palliative care services under study (i.e., 
PAL, IPAL, and/or HOSPC). This notion was further supported when exploring the relationship 
between hospital size and each of the three palliative care services individually. As hospital size 
increases, a hospital may decide that providing services in-house is necessary to meet the needs 
of its patient population in an efficient and timely manner. 
 The findings did not support the proposition that hospitals located in more competitive 
hospital markets were more likely to provide palliative care services in order to secure revenue 
flow and patient referrals, as proposed in Hypothesis 2. The study’s sensitivity analyses also 
failed to produce significant results regarding this hypothesis. It is possible that hospitals are 
unable to react to higher levels of market competition due to workforce shortages. Since the  
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Table 25 
25Summary of Study Findings, Research Question One 
Hypothesis  Supported 
Research Question One: Which organizational and environmental forces are associated with 
the provision of hospital-based palliative care services? 
 
Hypothesis 1:  
Hospitals with more staffed and set-up beds are more likely to provide palliative 
care services compared to hospitals with fewer staffed and set-up beds.  
 
Yes 
Hypothesis 2:  
Hospitals in more competitive markets are more likely to provide palliative care 
services compared to hospitals in less competitive markets. 
 
No 
Hypothesis 3:  
Hospitals that have access to palliative care services through a health system, 
network, and/or joint venture in their local community are less likely to provide 
palliative care services in-house.  
 
Yes 
Hypothesis 4:  
Hospitals with a greater Medicare share of inpatient days are more likely to 
provide palliative care services compared to hospitals with a smaller Medicare 
share of inpatient days. 
 
No 
Hypothesis 5:  
Hospitals that are members of the COTH are more likely to provide palliative 
care services compared to hospitals that are non-COTH members.  
No 
 
Note. COTH=Council of Teaching Hospitals. 
           
  
American Board of Medical Specialties (ABMS) and the American Osteopathic Association 
(AOA) recognized Hospice and Palliative Medicine (HPM) as a subspecialty in 2008, 7,351 
physicians achieved subspecialty certification in HPM as of 2015 (American Academy of 
Hospice and Palliative Medicine, n.d.). Lupu and the American Academy of Hospice and 
Palliative Medicine Workforce Task Force (2010) estimated that between 6,000 and 18,000 
additional hospice and palliative care physicians were needed to close the gap between the 
physician supply and national demand for hospice and palliative care. However, the current 
board certification process does not facilitate the increase in hospice palliative care physicians to 
meet the supply shortage. Specifically, while physicians with clinical experience and competence 
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in hospice and palliative care were eligible to take the certification exam without completing a 
12-month, accredited HPM fellowship until 2013, subsequent physicians are required to 
complete an HPM fellowship (American Academy of Hospice and Palliative Medicine, n.d.). 
Hospitals that are interested in providing specialty palliative care may be unable to create such 
services because of a lack of HPM-certified physicians. Instead, hospitals in counties with a 
higher level of market competition may resort to focusing on educating clinicians to provide 
primary palliative care to their patients. As this study focused on specialty palliative care 
provision, this relationship may need to be explored in future research studies. 
 The results supported the proposition presented in Hypothesis 3 that the presence of 
palliative care services through a hospital’s health system, network, or joint venture was 
negatively associated with the provision of hospital-based palliative care services. Sensitivity 
analyses further indicated hospitals with access to palliative care services outside the hospital 
were less likely to offer hospital-based IPAL and HOSPC. Although hospitals in highly 
interconnected environments may be more likely to abide by the environmental pressures to 
integrate medical services linked to high-quality care (Zinn et al., 2010), the study findings 
suggested that the availability of such services through other means regulated the need to comply 
with such pressures. Future research may consider including interaction terms of hospital-based 
palliative care services and their not-hospital-based counterparts.  
 The results related to Hypothesis 4 provided no evidence that hospitals with a higher 
percentage of Medicare patients were more likely to provide palliative care services. A possible 
explanation for this finding may be that hospitals with higher percentages of Medicare patients 
incorporate primary palliative care into existing clinical procedures without establishing 
specialty palliative care delivery models. Further research is required to investigate whether 
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having a high percentage of Medicare patients affected the prevalence of primary palliative care. 
It is also probable that CMS’s commitment to high-quality, patient-centered care for seriously ill 
and medically complex patients, including allowing separate billing for advance care planning 
effective in early 2016, did not provide adequate motivation for a hospital to provide palliative 
care services during the study period. Additional research is needed to examine the relationship 
between a hospital’s patient population covered by Medicare and the provision of hospital-based 
palliative care services in the years following the study period. Sensitivity analyses produced 
mixed findings in regard to Hypothesis 4. Supporting the hypothesis’ notion, a hospital’s share of 
Medicare patients was positively associated with the probability of providing IPAL. Conversely, 
hospitals with higher shares of Medicare patients were less likely to offer hospital-based 
HOSPC. One explanation for this negative relationship may be the emergence of hospital 
partnerships with local hospices to provide hospice care to hospital patients with end-of-life care 
needs. In addition, hospital-based hospice programs are expensive and hospitals amy struggle to 
cover the costs associated with caring for hospice patients who are covered by the Medicare 
Hospice Benefit.  
 Regarding Hypothesis 5, the study found that teaching hospitals were not significantly 
more likely to provide palliative care services compared to non-teaching hospitals. The 
sensitivity analyses, however, demonstrated that teaching hospitals were more likely to provide 
inpatient palliative care consultation services (PAL) compared to non-teaching hospitals, which 
is consistent with the proposition presented in Hypothesis 5. This finding is similar to those from 
prior research examining hospital adoption of PAL (Stover, 2005). Conversely, teaching 
hospitals were less likely to provide inpatient palliative care units (IPAL) compared to non-
teaching hospitals. It is possible that teaching hospitals prefer inpatient palliative care 
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consultation services, as these services have a more flexible and versatile scope of application 
within the hospital and may therefore be viewed as more useful in a teaching environment than 
IPAL or HOSPC. Specifically, teaching hospitals are likely to focus on maintaining continuity of 
care to optimize learning, which is easier to accomplish with inpatient palliative care 
consultation services compared to inpatient palliative care units or hospice programs as patients’ 
palliative care needs can be addressed without transferring them to a different unit.  
 Several hospital and market control variables used in the analytical model to address 
research question one were significantly associated with the provision of palliative care services, 
including hospital ownership, the ratio of registered nurses to total nurses, hospital all-patient 
DRG case-mix index, and percentage of Hispanic patients. Note that a hospital’s lagged 
operating margin, although not statistically significant, may be influenced by prior palliative care 
provision such that palliative care might result in lower hospital costs. Finally, the rate of 
uninsured in a county was the only market control variable that reached statistical significance.  
 Not-for-profit hospitals were more likely to provide palliative care services than for-
profit and public hospitals. This finding is consistent with prior research (Dumanovsky et al., 
2015; Morrison et al. 2011; Morrison et al., 2005; Stover, 2005, White et al., 2002). The mission 
of not-for-profit hospitals tends to focus on serving the greater good and prioritizing community 
health needs as required to be granted tax exempt status (Proenca et al., 2000). Among not-for-
profit hospitals, providing access to a variety of palliative care services may be viewed as an 
essential component of high-quality care for patients with serious and terminal illnesses, even if 
these services are potentially not economically viable. Catholic hospitals, in particular, are 
considered early adopters of palliative care, as it aligns with Catholic theology, philosophy and 
mission of care (White, Cochran, & Patel, 2002).  
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 In addition, hospitals with a higher proportion of registered nurses to total nurses were 
more likely to provide palliative care services. Nursing capacity defined by a higher proportion 
of highly skilled nurses, such as registered nurses, may influence a hospital’s decision to provide 
palliative care services. As the nursing profession traditionally focuses on caregiving instead of 
curing, including the care of seriously ill and terminal patients, hospitals that employ more 
registered nurses may also be more likely to integrate services into the service mix that are not 
aimed to cure diseases. Conversely, it is also possible that hospitals with palliative care services 
have a higher demand for higher skill mix of nurses and are therefore more likely to hire highly 
skilled nurses. Furthermore, hospitals with a higher hospital all-patient DRG case-mix were more 
likely to provide palliative care services. These findings are consistent with the proposition that 
hospitals with a sicker patient population are more likely to see the need to provide services 
aimed to manage complex patient needs. Conversely, hospitals with higher percentages of 
Hispanic patients were less likely to provide palliative care services. This finding is in 
accordance with prior research suggesting that barriers to palliative care exist among ethnic 
minorities due to cultural differences in attitudes toward and perceptions of terminal illnesses 
(Johnson, 2013; Johnstone & Kanitsaki, 2009; Kwak & Haley, 2005).  
 Finally, hospitals located in counties with higher rates of uninsured aged 18-64 were 
more likely to provide palliative care services. Kazley and Ozcan (2007) suggested that hospitals 
in wealthier counties, a proxy for resource availability in the environment (i.e., munificence), 
may be more inclined to attract patients who can afford to pay for high-quality services. 
Specifically, a low rate of uninsured in a market may be viewed as a measure of munificence. 
But this study found that hospitals located in markets with a higher rate of uninsured were more 
likely to provide palliative care services. It could be speculated that the predominant focus on 
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curative treatment within the U.S. healthcare system encouraging the provision of (typically 
expensive) life-prolonging treatment implicitly incentivizes hospitals to transition patients to 
palliative care, especially hospice care, when patients are not insured or underinsured. Additional 
research is needed to investigate this relationship. 
Performance effects of palliative care. 
 This study applied Donabedian’s (1980) Structure-Process-Outcome model to examine 
the relation between hospital-based palliative care services and hospital costs, in-hospital 
mortality, transfer to hospice, and length of stay. The study tested eight hypotheses to address 
research questions two and three. The following three-level hierarchical models were employed: 
a Bernoulli sampling model and a logit link function to examine in-hospital mortality and 
transfer to hospice, a normal sampling model and an identity link function to evaluate hospital 
costs, and a Poisson sampling model and log link function to assess hospital length of stay.  
 Tables 26 and 27 present the hypotheses related to research questions two and three, 
respectively, and indicate whether they were supported based on the findings of the main 
analytical models, as reported in the previous chapter. Note that it is difficult to distinguish 
between research questions two and three due to the nature of the palliative care experience 
variables, as discussed in Chapter 4. Consequently, to address research question two, the point 
estimates of a 1-year effect of the three palliative care services were used to approximate the 
effects of such services on the study outcomes. The coefficients of the three palliative care 
experience variables were examined to address research question three.  
  
1
6
2
 
Table 26 
26Summary of Study Findings, Research Question Two 
Hypothesis 
Hypothesis Supported  
(by Patient Disposition) 
Survivors Decedents Total 
Research Question Two: Do hospitals that provide palliative care services have improved organizational and patient outcomes 
compared to those not providing such services?  
Hypothesis 6a: Patients treated in hospitals that provide palliative care services have lower 
hospital costs than patients treated in hospitals that do not provide such services.  
  
  
PAL - - No 
IPAL - - Yes 
HOSPC - - No 
Hypothesis 6b: Patients treated in hospitals that provide palliative care services have shorter 
hospital LOS than patients treated in hospitals that do not provide such services. 
 
  
PAL No No - 
IPAL Yes Yes - 
HOSPC No No - 
Hypothesis 6c: Patients treated in hospitals that provide palliative care services are less 
likely to die during hospitalization than patients treated in hospitals that do not provide such 
services. 
 
  
PAL - - Yes 
IPAL - - Yes 
HOSPC - - Yes 
Hypothesis 6d: Patients treated in hospitals that provide palliative care services are more 
likely to be transferred to hospice than patients treated in hospitals that do not provide such 
services.  
 
  
PAL - - Yes 
IPAL - - No 
HOSPC - - No 
 
Note. HOSPC=Hospice program. IPAL=Inpatient palliative care unit. LOS=Length of stay. PAL=Inpatient palliative care consultation service. 
  
1
6
3
 
Table 27 
27Summary of Study Findings, Research Question Three 
Hypothesis 
Hypothesis Supported 
(by Patient Disposition) 
Survivors Decedents Total 
Research Question Three: Is a hospital’s experience in providing palliative care services associated with improved organizational 
and patient outcomes?  
Hypothesis 7a: Patients treated in hospitals that are more experienced in providing 
palliative care services have lower hospital costs than patients treated in hospitals that are 
less experienced.  
  
  
Years of PAL experience (since 2006) - - No 
Years of IPAL experience (since 2006) - - No 
Years of HOSPC experience (since 2006) - - Yes 
Hypothesis 7b: Patients treated in hospitals that are more experienced in providing 
palliative care services have shorter hospital LOS than patients treated in hospitals that are 
less experienced. 
 
  
Years of PAL experience (since 2006) Yes Yes - 
Years of IPAL experience (since 2006) No No - 
Years of HOSPC experience (since 2006) No No - 
Hypothesis 7c: Patients treated in hospitals that are more experienced in providing 
palliative care services are less likely to die during hospitalization than patients treated in 
hospitals that are less experienced. 
 
  
Years of PAL experience (since 2006) - - Yes 
Years of IPAL experience (since 2006) - - No 
Years of HOSPC experience (since 2006) - - Yes 
Hypothesis 7d: Patients treated in hospitals that are more experienced in providing 
palliative care services are more likely to be transferred to hospice than patients treated in 
hospitals that are less experienced. 
 
  
Years of PAL experience (since 2006) - - No 
Years of IPAL experience (since 2006) - - No 
Years of HOSPC experience (since 2006) - - Yes 
 
Note. HOSPC=Hospice program. IPAL=Inpatient palliative care unit. LOS=Length of stay. PAL=Inpatient palliative care consultation service. 
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Hospital costs. 
 The results suggested that the relationship between palliative care services and lower 
hospital costs was partially supported. The 1-year-effect of an inpatient palliative care unit 
(IPAL) was associated with lower hospital costs (Hypothesis 6a). The point estimates for year 
effects after the first year were also consistently associated with lower hospital costs, although 
the financial benefits of having an IPAL diminished over time (Hypothesis 7a). Conversely, the 
1-year effect of HOSPC was not significantly associated with hospital costs (Hypothesis 6a), but 
one additional year of experience in providing HOSPC was significantly associated with lower 
hospital costs (Hypothesis 7a). The year effects of HOSPC ranged between 0.65% for the second 
year and 1.67% for the fifth year. Finally, the 1-year effect of an inpatient palliative care 
consultation service (PAL) was not significantly associated with hospital costs (Hypothesis 6a), 
and one additional year of experience in providing PAL was significantly associated with 
incrementally higher hospital costs (Hypothesis 7a). That is, the year effects of PAL ranged 
between 1.45% for the second year and 5.02% for the fifth year. In sum, IPAL and HOSPC were 
associated with lower hospital costs, whereas PAL was associated with higher hospital costs.  
 A possible explanation for these mixed findings is that PAL, IPAL, and HOSPC 
potentially have different effects on hospital costs, unlike what has been proposed in this study. 
In future analyses, one may need to address how each of the study’s three types of palliative care 
services individually affect hospital costs. Further research is needed to explain above-mentioned 
differences in effects on hospital costs. It is possible that PAL are focused on providing palliative 
care services to patients in conjunction with curative treatments and thus potentially increase 
hospital costs. On the other hand, HOSPC and IPAL may aim toward transitioning patients from 
curative treatment plans to comfort care only, which potentially reduces hospital costs. 
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Moreover, analyzing the effects of PAL, IPAL, and HOSPC on different subsets of hospital 
costs, such as pharmacy, laboratory, ICU, cardiology, emergency room, or physical therapy costs 
may also provide additional information on the financial impact of palliative care services.  
 The study found several significant associations between patient control variables and 
hospital costs. Compared to patients aged 18-49, patients in the older age groups incurred 
significantly lower hospital costs. While this finding contradicts national findings concerning 
hospital costs for all hospital patients, it is possible that younger age groups incur higher hospital 
costs if they have one of the study’s eight primary diagnoses. It is possible that younger patients 
with these primary diagnoses are more likely to receive curative than palliative treatment. 
Female patients incurred lower hospital costs than male patients. Furthermore, white patients 
incurred higher costs than patients of other ethnicities. Medicare patients incurred higher hospital 
costs than patients covered by Medicaid, private insurance, self-pay, and other means. The study 
findings on patient gender and primary payer are largely consistent with national findings 
concerning hospital costs for all hospital patients (Weiss & Elixhauser, 2014). In addition, 
patients admitted through the emergency room incurred higher hospital costs than patients 
transferred from another hospital, admitted by court or law enforcement or admitted routinely. 
Patients with HIV, ACD, CHF, and pneumonia were among the most expensive patients. 
Furthermore, the number of surgical procedures was associated with higher hospital costs, which 
is consistent with findings from a prior study (Stover, 2005). Furthermore, a higher Charlson-
Comorbidity Index, as a proxy for patient severity, was associated with higher hospital costs, 
consistent with findings from prior studies (e.g., Charlson et al., 2008). Finally, patients with a 
documented palliative care encounter incurred lower hospital costs than patients without a 
documented palliative care encounter.  
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 All hospital control variables were significantly associated with hospital costs. On 
average, higher lagged operating margin, number of beds, and average length of stay were 
associated with higher hospital costs. The findings for hospital costs and number of hospital beds 
are similar to those reported by Jiang et al. (2013). Regarding lagged operating margin, reverse 
causality may exist, because reduced hospital costs influence a hospital’s operating margin. 
Conversely, the presence of palliative care services through a hospital’s health system, network, 
or joint venture, higher share of Medicare patients, higher ratio of registered nurses to total 
nurses, higher hospital all-patient DRG case-mix, higher percentage of Hispanic patients, Black 
patients, and patients aged 65 and older were, on average, associated with lower hospital costs. 
Nurse staffing measures have been found to reduce hospital costs (e.g., Weiss, Yakusheva, & 
Bobay, 2011). White et al. (2005) found a positive association of hospital all-patient DRG case-
mix with hospital costs, although it did not reach statistical significance. In addition, public and 
for-profit hospitals incurred higher hospital costs than not-for-profit hospitals. Teaching hospitals 
incurred higher hospital costs than non-teaching hospitals, which is consistent with prior studies 
(e.g., Jiang et al., 2013; Stover, 2005). Magnet hospitals incurred lower hospital costs than non-
Magnet hospitals. A study published in 2014 found a positive relationship between Magnet status 
and hospital costs (Jayawardhana, Welton, & Lindrooth, 2014).  
 All market control variables were significantly associated with hospital costs. On 
average, higher area wage index, PPO penetration rate, log-transformed population size, and log-
transformed unemployment rate were associated with higher hospital costs. On the contrary, 
higher market competition, HMO penetration rate, per capita income, and rate of uninsured were 
associated with lower hospital costs. The findings for the relationship between HMO penetration, 
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per capita income, and area wage index were similar to those reported by Jiang et al. (2013) and 
Stover (2005).  
Length of stay. 
 The 1-year effect of IPAL was associated with shorter lengths of stay for survivors and 
decedents, supporting Hypothesis 6b. However, one additional year of IPAL experience resulted 
in longer lengths of stay for both patient groups (Hypothesis 7b). Specifically, among decedents, 
the year effects of the third through fifth year ranged between 0.91% longer lengths of stay for 
the third year and 3.12% longer lengths of stay for the fifth year. Among survivors, the year 
effects were between 0.41% longer lengths of stay for the third year and 1.54% longer lengths of 
stay for the fifth year.  
 The 1-year effect of HOSPC was significantly associated with longer lengths of stay 
among survivors, whereas the 1-year effect of HOSPC was not significantly associated with 
length of stay among decedents (Hypothesis 6b). The results of Hypothesis 7b suggested that one 
additional year of HOSPC was associated with longer lengths of stay for both patient groups. 
However, among decedents, the individual year effects were not significantly associated with 
length of stay. Among survivors, all year effects were positively associated with length of stay, 
but with relatively small magnitudes.  
 The 1-year effect of PAL was positively associated with length of stay among decedents, 
but not significantly associated with length of stay among survivors (Hypothesis 6b). One 
additional year of PAL experience was associated with shorter lengths of stay for both patient 
groups (Hypothesis 7b). Among decedents, the fifth year was associated with a 1.66% shorter 
length of stay. Among survivors, all year effects after the first year were statistically significant 
and ranged between 0.7% shorter lengths of stay for the second year and 2.88% shorter lengths 
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of stay for the fifth year. Findings from prior research were also mixed (Cassel et al., 2010b). A 
potential explanation for these inconsistent findings may be that palliative care services have 
different effects at different stages during a patient’s hospitalization. For example, palliative care 
services may reduce LOS in the ICU by earlier transfers to other hospital wards, but may not 
necessarily reduce a patient’s hospital LOS. In addition, patients with a documented palliative 
care encounter stayed significantly longer in the hospital than patients without such an encounter. 
While this finding may suggest that palliative care is associated with longer hospital LOS, it may 
also indicate that palliative care encounters, identified by the billable ICD-9-CM code V66.7, 
were merely assigned to patients with a high likelihood of mortality and patients with prolonged 
LOS. Specifically, endogeneity in terms of reverse causality may be a threat to causal inference 
when examining the effects of palliative care services on hospital LOS, because clinical 
guidelines used regularly include extended hospital LOS as a trigger to initiate palliative care 
consultations (Norton et al., 2007). Moreover, the three-level hierarchical model used to examine 
hospital LOS produced very small hospital-level and market-level ICC (< 1%), which indicates 
that the majority of variation in hospital LOS lies between patients. Hierarchical models with 
very small ICC at the higher levels may increase the potential of Type I errors (Barcikowski, 
1981). Small ICCs also indicate that the assumption of independence may hold, which means 
that traditional statistical approaches potentially suffice to examine hospital LOS. The sensitivity 
analysis demonstrated that, among patients who were transferred to hospice, patients treated in 
hospitals with PAL had shorter in-hospital stays than patients treated in hospitals without PAL. 
This findings suggests that PAL may facilitate hospice transfers for patients at the end of life, 
and is consistent with palliative care teams actively trying to transfer patients out of the hospital 
to their homes or community hospices.   
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 Several patient control variables were significantly associated with length of stay. For 
both survivors and decedents, patient age was positively associated with length of stay. Prior 
studies found similar results for the relationship between length of stay and patient age (e.g., Shi, 
1996; van de Vijsel, Heijink, & Schipper, 2015). On average, female survivors stayed in the 
hospital longer than male survivors. Among decedents, patient gender was not significantly 
associated with length of stay. Compared with white patients, black patients stayed in the 
hospital longer, regardless of patient disposition. Among survivors, Hispanic patients had longer 
lengths of stay than white patients. Conversely, expired patients of other ethnicities had shorter 
lengths of stay.  
 Patient health insurance had similar effects across patient disposition. Compared to 
Medicare patients, patients covered by Medicaid had longer lengths of stay. Patients covered by 
private insurance, self-pay, or other types had shorter lengths of stay than Medicare patients. 
Among survivors, patients with HIV, ACD, CHF, COPD, pneumonia, and dementia had longer 
lengths of stay than cancer patients, whereas AMI patients had significantly shorter lengths of 
stay. The results regarding primary diagnosis were similar for decedents. Among decedents, 
patients with ACD and CHF as a primary diagnoses had a shorter lengths of stay than cancer 
patients. More surgical procedures and a higher Charlson-Comorbidity Index were associated 
with longer hospital stays for both patient groups, which is consistent with prior studies (e.g., van 
de Vijsel et al., 2015). Finally, patients with a documented palliative care encounter had, on 
average, longer hospital stays than patients without such a documented encounter, regardless of 
patient disposition. Again, it is possible that this variable is endogenous, as patients with longer 
lengths of stay are more likely to have a palliative care encounter compared to patients with 
shorter lengths of stay.  
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 Several hospital control variables were significantly associated with length of stay. The 
relationships were similar for survivors and decedents. Specifically, a higher number of hospital 
beds and lagged operating margin were associated with longer lengths of stay. The findings for 
length of stay and number of hospital beds contradicted those reached by White and et al. (2005).  
Conversely, having a higher hospital all-patient DRG case-mix, higher percentage of Hispanic 
and black patients were associated with shorter lengths of stay. A higher ratio of registered 
nurses to total nurses was associated with shorter lengths of stay among survivors, but associated 
with longer lengths of stay among decedents. The findings for length of stay and hospital all-
patient DRG case-mix contradict those reached by White and et al. (2005). Nursing capacity 
measures have been associated with shorter length of stay in prior studies (e.g., Voepel-Lewis, 
Pechlavanidis, Burke, & Talsma, 2013). Compared with non-teaching hospitals, teaching 
hospitals had on average longer lengths of stay. This may indicate that teaching hospitals spend 
more time treating patients than non-teaching hospitals. The findings for length of stay and 
teaching status are similar to those reached by White et al. (2005) and Lin et al. (2006). 
Furthermore, for-profit hospitals had longer lengths of stay than not-for-profit hospitals, whereas 
public hospitals had shorter hospital stays than not-for-profit hospitals among survivors.   
 Seven market control variables were found to be significantly associated with length of 
stay. Higher PPO penetration rate, log-transformed population size, and log-transformed 
unemployment rate were associated with longer lengths of stay. A higher HMO penetration rate 
was associated with longer lengths of stay among survivors, whereas a higher HMO penetration 
rate was associated with shorter lengths of stay. Higher market competition, area wage index, 
and rate of uninsured were associated with shorter lengths of stay. The findings for length of stay 
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and population size and area wage index were consistent with findings reached by White et al. 
(2005).   
In-hospital mortality. 
 Regarding Hypotheses 6c and 7c, the results consistently supported the hypothesis that 
palliative care services reduce the odds of in-hospital mortality. The 1-year effects of PAL, 
IPAL, and HOSPC were associated with reduced odds of in-hospital mortality (Hypothesis 6c). 
One additional year of PAL experience resulted in reduced odds of in-hospital mortality, ranging 
between 4.41% lower odds of in-hospital mortality in the first year and 11% lower odds of in-
hospital mortality in the fifth year. Similarly, one additional year of HOSPC experience was 
associated with lower odds of in-hospital mortality, ranging between 3.63% and 7.99% lower 
odds of in-hospital mortality for the effect of a given year. However, one additional year of IPAL 
resulted in higher odds of in-hospital mortality. That is, the year effects of the third through fifth 
year were associated with incrementally higher odds of in-hospital mortality, ranging between 
2.5% higher odds of in-hospital mortality for the third year and 9.51% higher odds of in-hospital 
mortality for the fifth year. The point estimate of the 2-year effect was negative but statistically 
not significant. It is possible that hospitals with more experience in providing IPAL are more 
likely to provide palliative care to terminally-ill patients rather than transferring them to hospice 
or other health care settings. Transfers out of the hospital are often too time-intensive and painful 
for terminally-ill patients who are imminently dying, so that remaining in the IPAL is often 
preferred over a transfer to hospice. Furthermore, IPAL patients and their families often decide 
against transfers out of the unit because of the bonds made between them and the IPAL staff 
(K.R. White, personal communication, July 5, 2016). 
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 When estimating the model without the palliative care encounter control variable, only 
the 1-year effect of PAL resulted in reduced in-hospital mortality. Similarly, the effects of one 
additional year of providing PAL or IPAL was associated with a higher risk of dying during 
hospitalization.  
 The sensitivity analyses conducted regarding in-hospital mortality were largely consistent 
with the findings of the main analyses. Specifically, separate analyses were estimated for patients 
with the study’s eight primary diagnoses, and the majority of analyses revealed either 
significantly lower in-hospital mortality or no effect on in-hospital mortality for patients treated 
in hospitals with PAL, IPAL, or HOSPC. Similar to the analytical model for length of stay, the 
three-level hierarchical model used to examine in-hospital mortality produced very small 
hospital-level and market-level ICC (< 1%), which indicates that the majority of variation in in-
hospital mortality lies between patients. Hierarchical models with very small ICC at the higher 
levels may increase the potential of Type I errors (Barcikowski, 1981). Small ICCs provide 
evidence that the assumption of independence of hospitals may hold. Therefore, conventional 
single-level approaches may be adequate to evaluate in-hospital mortality. 
 The majority of patient control variables were significant predictors of in-hospital 
mortality. Higher patient age was associated with higher odds for in-hospital mortality. Female 
patients were less likely to die during hospitalization than male patients. Black and Hispanic 
patients had lower odds of in-hospital mortality than white patients. Patients of other ethnicities 
were more likely to die during hospitalization than white patients. These findings are consistent 
with those reported by Stover (2005) and Lackan et al. (2009). Research has shown that 
minorities may have limited resources and access to end-of-life services in their communities, 
such as home hospice services or nursing homes (Kirby & Kaneda, 2005). In addition, Johnson 
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(2013) discussed the factors contributing to racial and ethnic disparities in palliative care, 
including knowledge gaps about palliative care, religious beliefs not in line with palliative care 
delivery models, general distrust in the medical system, and greater preference for curative 
treatment among minority patients. These patients may therefore be more likely to die in the 
hospital than opting for alternative sites of death outside of the hospital. Compared with 
Medicare patients, patients covered by Medicaid, private health insurance, self-pay, and other 
payer types had, on average, higher odds of in-hospital mortality. Patients transferred from other 
hospitals or healthcare facilities had on average higher odds of in-hospital mortality compared 
with patients admitted through the emergency room. Patients admitted routinely were on average 
less likely to die during hospitalization than patients in the reference group. Compared with 
cancer patients, patients with HIV, AMI, ACD, and pneumonia had higher odds of in-hospital 
mortality, whereas patients with CHF, COPD, and dementia had lower odds of in-hospital 
mortality. In addition, a higher Charlson-Comorbidity Index and more surgical procedures were 
associated with higher odds of in-hospital mortality. The findings for in-hospital mortality and 
surgical procedures are similar to those attained by Stover (2005) and for in-hospital mortality 
and the Charlson-Comorbidity Index similar to those reported by Ladha et al. (2015). Finally, 
patients who had a documented palliative care encounter had a higher odds of in-hospital 
mortality than patients without such a documented encounter. 
 Among hospital control variables, lagged operating margin, log-transformed average 
length of stay, percentage of Hispanic patients and patients aged 65 and older were associated 
with higher odds of in-hospital mortality. Conversely, a higher share of Medicare patients, ratio 
of registered nurses to total nurses, hospital all-patient DRG case-mix, and percentage of patients 
with the study’s primary diagnoses were associated with lower odds of in-hospital mortality. 
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Teaching hospitals had lower odds of in-hospital mortality than non-teaching hospitals. The 
findings for teaching status and in-hospital mortality are similar to those reported by Allison et 
al. (2000), who examined the association between teaching status and hospital mortality between 
thirty days and two years after hospital admission for patients with AMI. Shahian et al. (2014) 
also found significantly lower 30-day risk-standardized mortality rates for patients with AMI, 
heart failure, and pneumonia treated in teaching hospitals. Magnet hospitals had lower odds of 
in-hospital mortality than non-Magnet hospitals, which is consistent with prior studies (McHugh 
et al., 2013). While public hospitals had lower odds of in-hospital mortality than not-for-profit 
hospitals, for-profit hospitals had higher odds of in-hospital mortality.  
 Among market control variables, higher area wage index, PPO and HMO penetration 
rates, log-transformed population size, and log-transformed unemployment rate were associated 
with lower odds of in-hospital mortality. The findings for in-hospital mortality, PPO and HMO 
penetration, and area wage index are consistent with those reported in prior studies (e.g., Stover, 
2005). Per capita income and rate of uninsured were associated with higher odds of in-hospital 
mortality.  
Transfer to hospice. 
 The study results generally contradicted the effects of palliative care services on hospice 
transfers depicted in Hypotheses 6d and 7d. The 1-year effect of PAL was associated with higher 
odds of hospice transfer (Hypothesis 6d), whereas one additional year of PAL experience was 
negatively associated with odds of hospice transfer (Hypothesis 7d). Specifically, the year effects 
of PAL after the first year were significantly associated with incrementally lower odds of hospice 
transfer, ranging between 5.17% lower odds of hospice transfer for the second year and 28.99% 
lower odds of hospice transfer for the fifth year. Furthermore, the year effects of IPAL were 
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consistently associated with lower odds of hospice transfer, although one additional year of IPAL 
was not significantly associated with odds of hospice transfer (Hypothesis 7d). In other words, 
the year effects of IPAL remained relatively constant with 4.47% lower odds of hospice transfer 
in the first year and 5.8% lower odds of hospice transfer in the fifth year. The year effects of the 
first two years of HOSPC were associated with 8% and 4.33% lower odds of hospice transfer 
respectively (Hypothesis 6d), whereas the fifth year was associated with 7.67% higher odds of 
hospice transfer. The year effects of the third and fourth year of HOSPC were not statistically 
significant. The findings largely contradicted Hypotheses 6d and 7d and further research is 
needed to understand this relationship. It is possible that hospitals with IPAL and PAL are more 
likely to treat patients at the end of life and therefore view these services as a suitable alternative 
to transferring patients to hospice. A lack of community-based alternatives, such as home 
hospice services, home health services, or nursing homes, may also contribute to fewer hospice 
transfers. Future research studies may need to account for market characteristics that capture the 
availability of alternative resources outside of the hospital setting.  
 All patient control variables significantly predicted the odds of transfer to hospice. On 
average, older patient age were associated with higher odds of transfer to hospice. In addition, 
female patients had a higher odds of transfer to hospice than male patients. Compared to white 
patients, black, Hispanic, and patients of other ethnicities had lower odds of transfer to hospice. 
Compared with any other primary diagnosis, cancer patients had a higher odds of transfer to 
hospice. The findings for hospice transfer, patient age, ethnicity/race, gender, and primary 
diagnosis are consistent with reports on characteristics of the U.S. hospice patient population 
(National Hospice and Palliative Care Organization, 2014). Compared to Medicare patients, 
Medicaid patients and patients covered by other payer types had higher odds of transfer to 
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hospice. Conversely, patients covered by private insurance were less likely to be transferred to 
hospice. Furthermore, patients admitted through the emergency room had higher odds of transfer 
to hospice than patients transferred from another hospital or healthcare facility, admitted by court 
or law enforcement, and admitted routinely. A higher Charlson-Comorbidity Index was 
associated with higher odds of transfer to hospice, whereas a higher number of surgical 
procedures was associated with lower odds of transfer to hospice. Patients with a documented 
palliative care encounter had a higher odds of transfer to hospice than patients who did not have 
such an encounter.  
 Several hospital control variables significantly predicted the odds of transfer to hospice. 
Teaching hospitals had higher odds of transfer to hospice than non-teaching hospitals. Public and 
for-profit hospitals had lower odds of transfer to hospice than not-for-profit hospitals. A higher 
ratio of registered nurses to total nurses, percentage of Hispanic and Black patients, and share of 
Medicare patients were associated with higher odds of transfer to hospice. Conversely, a higher 
percentage of patients with one of eight primary diagnoses and log-transformed average length 
of stay were associated with lower odds of transfer to hospice.  
 Among market control variables, higher market competition, area wage index, HMO 
penetration rate, and per capita income were associated with lower odds of transfer to hospice, 
whereas a higher log-transformed unemployment rate was associated with higher odds of transfer 
to hospice. This study is among the first to examine the relationship between hospice transfers 
and hospital and market characteristics, which limits the ability to compare the study findings 
with those attained by prior studies.  
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Study Limitations 
This study has six noteworthy limitations. These limitations relate to the use of 
administrative data, the construction and representativeness of key variables, the type of analysis, 
the generalizability of the study findings, and the scope of outcome measures.  
First, this study relied on administrative data, primarily information from the AHA 
Annual Survey of Hospitals for the key variables related to palliative care provision and from the 
HCUP SID for the study’s dependent variables to examine research questions two and three. The 
use of these administrative databases has several caveats. First, HCUP SID data are based on 
patient discharge files. This study relies on the fact that patient information is recorded in a 
correct and complete manner. Specifically, discharge coding for patients transferred to hospice 
may be prone to coding errors. Although hospitals should code a patient as discharged to hospice 
regardless of whether that patient is transferred to a hospital-based or on outside hospice facility, 
it is possible that in some instances patients transferred to a hospital-based facility are not coded 
in this manner, which may affect the measurement of hospice transfers and lengths of stay for 
these patients. Second, the AHA Survey of Hospitals was used to determine whether hospitals 
had PAL, IPAL, and/or HOSPC in place in a given year. Approximately 23% of urban, non-
federal, acute care hospitals across the study states had missing information for PAL, IPAL, 
and/or HOSPC in one or more study years and about 30% of hospitals with non-missing 
information showed inconsistent palliative care implementation patterns prior to and during the 
study period, which may be an indication of inaccurate coding. The AHA Survey of Hospitals is 
completed on a voluntary basis by hospital administrative staff. The information provided in the 
survey is not externally checked for accuracy. Third, a definitional issue may arise when 
identifying the source of palliative care services. That is, the AHA Survey of Hospitals 
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distinguishes between palliative care services provided by the health system, network, and joint 
venture. It is unclear whether this distinction is understood and interpreted uniformly across 
participating hospitals. It is also possible that the distinction between hospital-based and not-
hospital-based palliative care services is not fully understood by those completing the survey. 
Thus, these data points may be prone to misinterpretation, which may lead to data inaccuracy.  
Second, the key independent variable to examine research question three is limited in its 
capability to represent the overall construct of a hospital’s experience providing palliative care 
services. First, due to data inconsistencies, information on the presence of palliative care services 
prior to the study period could not be taken into account to determine each service’s 
implementation year. In other words, hospitals with a service in place in 2007 were assigned a 
“1” in that year; that is, these hospitals were considered to have one year of experience in 
providing a palliative care service in 2007. However, these hospitals may have had these services 
in place longer than one year. The palliative care experience variable also assumes that time has 
a linear effect. Given the possibility that the palliative care programs have been in existence for 
several years prior to 2007, this specification may be an imprecise presentation of the underlying 
construct of palliative care experience. It is also possible that there is a selection effect such that 
hospitals that adopted palliative care services early are inherently different from hospitals that 
adopted such services later. Therefore, estimating whether or not a hospital had a palliative care 
service may not be sufficient to explain the true nature of hospital adoption of palliative care 
services. In addition, due to a high rate of inconsistent implementation patterns within the study 
period (~30%), it is also possible that the measurement of palliative care experience for all 
hospital cases suffers from inaccuracy. In addition, this study did not take non-linear effects of 
palliative care services on patient and organizational outcomes into account. For example, it is 
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possible that hospital costs and length of stay increase during the first year of implementation of 
a palliative care service and decrease in the years after due to learning effects. Such non-linear 
effects need to be considered carefully in future study development, data collection, and analysis. 
Similarly, the measurement of market competition corresponding to Hypothesis 5 may not be 
able to accurately define the notion that hospitals are more likely to provide hospital-based 
palliative care services if they are located in a highly competitive market. This study used the 
Herfindahl-Hirschman Index to represent market competition, which was calculated using 
information on total hospital admissions in the county. However, it may be more appropriate to 
focus on hospital admissions of patients with primary diagnoses most likely to benefit and utilize 
palliative care services instead, as hospitals are likely to assess this patient population as a 
potential source of revenue when deciding for or against providing hospital-based palliative care 
services.  
Third, it is likely that not only the presence of palliative care services, but also other 
structural characteristics, such as utilization, organization, or staffing, influence the effectiveness 
of palliative care provision. Integrating procedural attributes (e.g., work processes, care 
protocols) may also help to identify how hospitals deliver palliative care services, which can in 
turn influence hospital costs, length of stay, in-hospital mortality, and transfer to hospice. This 
also raises the question of how experience in providing a palliative care service can influence the 
study’s empirical results, as hospitals potentially need time to identify procedures that are most 
effective in addressing specific patients’ palliative care needs. Similarly, due to limited data 
availability, this study was unable to control for all relevant factors influencing hospital adoption 
of palliative care services and patient outcome measures. Specifically, the prevalence of hospices 
and home health services in the county, as a measure of market supply of palliative care services, 
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may influence a hospital’s decision to provide hospital-based palliative care services. Similarly, a 
large number of hospices and home health services may also affect a hospital’s discharge pattern 
and, in turn, affect the odds of hospice transfers, in-hospital mortality, and length of stay.  
Fourth, the effect of palliative care services on patient and organizational outcomes 
would ideally be evaluated by focusing on patients who actually utilized palliative care services 
(and to what extent). Although the distinction between patients with and without primary 
diagnoses most likely to benefit from and use palliative care services attempts to resolve this 
issue, it is merely an approximation of actual palliative care utilization. For example, it might be 
possible that patients categorized as most likely to benefit from and utilize palliative care 
services in this study did not receive any palliative care. Even in hospitals with established 
specialty palliative care, many patients with palliative care needs do not have access to such care. 
While, on average, 3.4% of hospital admissions receive palliative care, more than twice as many 
hospital patients are estimated to have palliative care needs (Morrison & Meier, 2015). Non-
referrals or late referrals are attributable to uncertainty about disease progression; misconception 
and lack of knowledge about palliative care among medical professionals, families, and patients; 
poor communication skills; and inadequate capacity of specialty palliative care programs to serve 
all hospital patients with palliative care needs (Melvin & Oldham, 2009). Conversely, patients 
who were not categorized as most likely to benefit from and utilize palliative care services may 
have received palliative care services during their hospital stays. A fundamental problem with 
this type of analysis would be related to the identification of a control group; that is, patients who 
did not receive palliative care services. A suitable control group may include hospital patients 
who qualify for palliative care but do not receive such care. Palliative care assessment criteria 
have been introduced to screen patients and assure that unmet palliative care needs are identified 
 181 
 
and met efficiently, such as repeated hospital admissions, comprehensive care needs, advanced 
and incurable cancer, or inadequate social support (Weissman & Meier, 2011). Given such 
information is available for all patients admitted to a hospital, a control group could be 
constructed from patients who meet these and other criteria. However, due to limited patient 
information available through the HCUP SID, this type of study cannot be conducted on a large 
scale and may need to be limited to patients admitted to one or a few hospitals for which 
additional relevant patient data can be obtained.  
Fifth, the generalizability of this study may be limited. Specifically, although this study 
aims for geographic diversity in terms of state selection by choosing states from three of the four 
U.S. census regions, the results may not be reproducible in other states.  
Finally, this study evaluated a limited set of outcome measures due to restricted data 
availability and thus other important quality indicators of palliative care could not be examined. 
Comprehensive assessments of patient-centered health care services, such as palliative care, 
should include a broader set of outcome measures, including patient and family satisfaction, 
symptom and pain management, and alignment of goals of care with patient preferences. 
Implications of the Findings 
Theoretical implications. 
 Regarding research question one, this study used two widely-used organizational 
theories, namely Institutional Theory (IT) and Resource Dependence Theory (RDT), to study 
hospital adoption of palliative care services and derive five propositions and hypotheses. While 
two hypotheses were supported, the remaining three were not. In future analysis, it may therefore 
be necessary to identify additional theories to reconsider the study’s conceptual framework in an 
attempt to assess the hypotheses that were not supported in this study or to establish new 
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hypotheses to provide a more complete perspective on a hospital’s adoption behavior. The 
application of institutional economics, such as transaction cost economics (TCE), may shed 
further light on a hospital’s decision to provide palliative care services. This theory provides a 
rational perspective on organizational decision-making, whereas IT and RDT tend to emphasize 
the role of external constituents to explain organizational behavior (Shortell, 1997). Specifically, 
TCE may be used to explain why hospitals decide to invest in hospital-based palliative care 
services rather than to rely on palliative care services available through the health system, 
network, or joint venture. This theory is often used in the context of make-or-buy decisions, and 
its basic premise is that it is more efficient to produce transactions (or services) in-house if they 
are frequently occurring, uncertain, and asset-specific (Williamson, 1975). Finally, it may also be 
useful to utilize qualitative research methods to gain a more comprehensive understanding about 
the drivers of hospital-based palliative care adoption. It is essential to note that palliative care 
adoption is likely driven by a variety of factors and may be more fully understood when 
additional or alternative theoretical perspectives are utilized. 
 The study also drew from Donabedian’s Structure-Process-Outcome (SPO) model to 
address research questions two and three. However, the SPO model largely failed to explain how 
palliative care services are associated with hospital performance measures and explain 
associations clearly, which may be due to the limited depth of the model. While a framework 
based on structures, processes, and outcomes may be useful to describe and quantify the main 
dimensions of health care quality, it may not be able to sufficiently explain how organizational 
structures, such as the presence of PAL, IPAL, and HOSPC, influence hospital performance 
measures.  
 183 
 
 In addition, this study does not take procedural dimensions regarding the provision of 
palliative care into account due to data limitations, but instead focuses on the presence of 
hospital-based palliative care services and their impact on hospital performance. In the context of 
palliative care, however, it may be more appropriate to quantify a hospital’s processes of how, 
when, and where palliative care services are delivered. While the presence of palliative care 
services is an essential structural component, the procedural characteristics of care delivery and 
management promise more predictive power in terms of hospital performance. Additional data 
and research are required to establish causal relationships between palliative care services and 
hospital performance by focusing on processes related to care delivery and other structural 
components of such services that go beyond the provision of access to palliative care in the 
hospital setting. In order to test these relationships empirically, primary data collection may need 
to be conducted because administrative data on procedural characteristics of health care service 
delivery are currently not collected on a large scale.  
Health care policy implications.  
 Since the publication of the SUPPORT study in 1995, policy makers and leaders in the 
healthcare industry have focused on improving care for patients with serious, complex, life-
limiting and potentially life-threatening illnesses (Cassel, 2014). Given the rising demand for 
palliative care due to an aging population with chronic life-limiting diseases, the results of this 
study provide valuable insight for policy makers in regard to potential barriers or drivers of 
palliative care provision.  
 Increased presence of PAL in the hospital setting has been viewed as a trend toward 
improvement of care for this patient population (Dumanovsky et al., 2015; Morrison et al., 
2005). From a policy perspective, a better understanding of the drivers behind hospital adoption 
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of palliative care may help to accomplish two goals: (1) to ensure full access to palliative care to 
patients with palliative care needs, and (2) to create incentives that motivate hospitals to integrate 
these services in a way that improves both hospital performance and care provision for patients 
with palliative care needs. These goals may be accomplished by overcoming persistent barriers 
to palliative care provision, including payment models (Cassel, 2014; Center to Advance 
Palliative Care, 2016). For example, linking hospital performance with financial incentive 
programs, such as value-based purchasing, is an important step toward rewarding quality rather 
than quantity of care. It is questionable, however, whether the presence of such services is 
synonymous with adequate delivery. Merely encouraging hospitals to provide palliative care may 
not suffice to ensure that patients with palliative care needs are effectively identified and 
managed. In other words, providing palliative care does not necessarily equate with quality of 
palliative care. Consequently, policy makers could structure incentive programs based on 
outcome-related quality measures that can be addressed effectively by palliative care, such as the 
alignment of goals of care with patient preferences, provider-patient and provider-family 
communication and interaction, bereavement support, and symptom management. In addition to 
outcome-related quality measures, incentives should also reward the structural and procedural 
components of palliative care services, such as those promoted in NCP’s clinical practice 
guidelines for quality palliative care (National Consensus Project for Quality Palliative Care, 
2013). For example, the NCP encourages “a comprehensive and timely interdisciplinary 
assessment of patient and family” (p. 14) to identify patient and family needs early in the disease 
trajectory, typically within 24-72 hours of hospital admission. Processes and structures that 
ensure early identification of patients with palliative care needs may be a better indication of 
quality palliative care than the mere presence of palliative care services.  
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Practice implications. 
 Healthcare administrators, in cooperation with clinical staff, need to decide whether and 
how palliative care services fit into their service mix. A variety of factors drive the decision-
making process, including available resources and demand. Although clinical guidelines 
proposed by the National Quality Forum and NCP provide general guidance on how optimal 
palliative care should be structured and delivered, clearer direction is needed for hospitals to 
decide which type of palliative care service is most appropriate to meet the palliative care needs 
of their patient population.  
 This study has shed some light on the association of three types of hospital-based 
specialty palliative care services with hospital costs, in-hospital mortality, length of stay, and 
transfer to hospice. However, the study findings are in part inconclusive and may not provide 
clear guidance in regard to the benefits of specialty palliative care in the hospital setting. 
Therefore, healthcare administrators may also investigate the use of primary palliative care, 
although not examined in this study, as a means to improve care for patients with serious and 
potentially life-limiting illnesses. Relying on palliative care competencies of clinical staff to 
provide basic palliative care to patients on a day-to-day basis may provide hospitals with an 
opportunity to reserve palliative care specialists for managing the most complex patients 
(Weissman & Meier, 2011). While prior research has shown that primary palliative care services, 
such as integrative care models, are associated with hospital performance, further research is 
needed to determine to what extent both primary and specialty palliative care fit into a hospital’s 
service mix. In this context, it is also important to assess how hospitals educate clinical staff to 
provide primary palliative care. Primary palliative care education often lacks an interdisciplinary 
team approach, where clinical staff are trained within their respective professions (K. White, 
 186 
 
personal communication, July 7, 2016). A hospital may be better equipped to meet patients’ 
basic palliative care needs if its clinical staff trains in a collaborative environment, in which the 
roles of each profession or discipline are taught and applied.  
 In addition, health care administrators may be advised to evaluate a variety of outcome 
measures, not just the outcome measures evaluated in this study. Prior research, as summarized 
in Chapter 2, and this study have provided evidence of palliative care’s benefits with respect to 
cost savings, efficient delivery of patient-centered care and health care utilization, and patient 
discharge patterns. Research findings consistently support the notion that palliative care reduces 
hospital costs, whereas the empirical evidence on how hospital LOS and in-hospital mortality are 
influenced is mixed. Thus, health care administrators may be advised to avoid hospital LOS and 
in-hospital mortality as measures to evaluate quality of care in the context of palliative care and 
instead “focus on other validated and highly valued outcomes that their work produces, such as 
reductions in hospital costs and improved clinical outcomes.” (Cassel et al., 2010b, p. 766) 
Suggestions for Future Research 
 This study provides several suggestions for future research based on the limitations 
identified in the previous section. First, future studies could optimize the measurement accuracy 
of palliative care variables and reduce missing information. The use of additional data sources 
may be able to validate the presence of palliative care services as indicated in the AHA Annual 
Survey of Hospitals. Furthermore, the construction of palliative care experience could be 
optimized by using information from years prior to the study period to determine the year of 
service inception. This study treated hospitals with palliative care services in place at the 
beginning of the study period as hospitals with one year of experience. In particular, information 
from prior years were not used due to missing values and inconsistent implementation patterns. 
 187 
 
Additional data sources to confirm palliative care presence may be used to reach a more accurate 
presentation of palliative care diffusion and experience. Alternatively, future studies may include 
a dummy variable to identify programs that were already in place in 2007 to capture the effect of 
having a program in place for more than five years; that is, the average effect of palliative care 
experience prior to 2006. Ideally, however, future studies focus on tracing the origins of 
palliative care services to measure the exact length of time they have been in effect. Also, as 
hospitals may not adopt palliative care services randomly (i.e., possible selection effects), it may 
be useful to consider modeling the effects of hospital and environmental factors on the timing of 
palliative care service adoption. In addition, future research may consider constructing the 
Herfindahl-Hirschman Index using only information on hospital admissions for patients with 
primary diagnoses most likely to benefit and use palliative care services in a county to measure 
market competition, as a hospital’s decision to provide hospital-based palliative care provision is 
likely influenced by a perceived competitive advantage in securing revenue from a patient 
population that may benefit from palliative care.  
 Second, this study evaluated the impact of palliative care on four outcome measures, 
namely hospital LOS, in-hospital mortality, transfer to hospice, and hospital costs. Future 
research should evaluate the effects of palliative care services on additional outcome measures, 
including pain and symptom management, patient and family satisfaction, ICU LOS, ICU 
mortality, alignment of goals of care with patient preferences, and hospital readmissions. In 
regard to hospital costs, it is also important to examine hospital costs pertaining to specific costs 
centers, such as ICU, emergency room, pharmacy, laboratory, subacute care, or oncology. More 
specific data collection is needed as these measures are all dependent on the availability of well-
defined data. With regard to estimating the effects of palliative care services on length of stay, 
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future research may also consider modeling length of stay as a duration model with competing 
hazards, where death and discharge to other settings are distinct outcomes.  
 Third, this study was limited to evaluating the association of the presence of specialty 
palliative care, namely inpatient palliative care consultation services, hospice programs, and 
inpatient palliative care units on certain dependent variables. The AHA Survey of Hospitals does 
not collect detailed information on structural or procedural attributes of hospital services, such as 
palliative care services. Researchers could therefore gather primary data on processes of care 
(e.g., timing of services, care protocols) and structural components (e.g., staffing, resources) and 
examine their impact on patient and organizational outcomes. Future research could also 
examine the nature and diffusion of primary palliative care in different hospital units, such as 
ICUs or emergency rooms. Primary palliative care is essential in treating patients’ basic 
palliative care needs and can be provided by the attending physician, whereas specialty palliative 
care typically focuses on patients with complex illnesses and symptoms that are difficult to 
manage and require medical attention of palliative care specialists. Studies that focus on the use 
and attributes of primary palliative care may provide valuable insights for health care 
administrators about the relative performance of primary and specialty palliative care.  
 Fourth, this study evaluated how the presence of palliative care services was associated 
with care received by patients most likely to benefit from these services. It was unclear whether 
or to what extend the patients in the sample received palliative care services. Future research 
could focus on comparing differences in outcomes for patients who actually received palliative 
care services and those who did not. However, this patient information is currently not collected 
and available on a larger scale. Alternatively, future research could apply a different method for 
identifying patients who are most likely to use and benefit from palliative care. For example, the 
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diagnosis-related groups (DRG) or all-patient refined DRGs (APR-DRG), developed by 3M 
Health Information Systems, are patient classification approaches with groups of patients who 
are similar in terms of resource usage and clinical attributes. These classification schemes may 
be valuable alternatives to select appropriate patient populations in the context of palliative care. 
Another possibility to approximate actual palliative care utilization without available data on 
which patients received palliative care services during hospitalization is to compare the effects of 
hospital-based palliative care services on outcomes between patients with primary diagnoses 
most likely to benefit from palliative care services (e.g., COPD patients) and patients with 
primary diagnoses not likely to utilize palliative care during hospitalization (e.g., patients 
admitted for normal pregnancies). Considering the former patient group the intervention group 
and the latter the control group, it may be expected that hospital-based palliative care services 
affect the outcomes of the former patient group only. This approach may be used to gauge 
whether the presence of hospital-based palliative care services is synonymous with palliative 
care utilization among patients who are most likely to use and benefit from palliative care 
services. Future research may also evaluate the impact of two advance care planning CPT 
(Current Procedural Terminology) billing codes introduced by CMS in early 2016 (Centers for 
Medicare and Medicaid Services, 2015a). This change in reimbursement may incentivize 
palliative care adoption among hospitals, as palliative care consultations become more profitable. 
At the patient level, designated billing codes to reimburse advance care planning may also 
provide an opportunity to identify patients who received advance care planning and evaluate the 
impact of such services on patient outcomes more accurately using large databases, such as the 
SID files. The systematic documentation of patients who received palliative care services is 
currently not possible, as no billable CPT codes exist. Common, billable ICD-9-CM and ICD-10-
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CM codes used by palliative care physicians are related to the symptoms they treat, such as 
delirium, depression, shortness of breath, weight loss, and pain (EPEC Project, 1999). Although 
these codes are available through the HCUP SID, they are not unique to palliative care services 
and are thus not meaningful in identifying palliative care patients. Note that one ICD-9-CM 
code, V66.7, indicates whether a patient had a palliative care encounter during hospitalization 
and is used as a patient control variable in the analytical models to address research questions 
two and three. It was introduced in 1996 and belongs to a supplementary list of ICD-9-CM 
codes, which may be used to further describe health care services provided to a hospital patient. 
However, research has demonstrated infrequent use of this code among palliative care patients in 
the hospital setting (Kroch, Johnson, Martin, & Duan, 2010). It is also likely that palliative care 
encounters under this code occur when death is imminent. Cassel et al. (2010a) noted that V66.7 
“appears to be geared toward end-of-life care (only) and not concurrent management of pain and 
symptoms.” (p. 921) Some palliative care providers primarily use the V66.7 code to flag patients 
to be excluded from a hospital’s mortality rate calculation (L. Blackhall, personal 
communication, January 6, 2015). Hence, this code was deemed unsuitable for use as a key 
explanatory variable to evaluate the effects of palliative care services on the study’s outcomes as 
proposed under research questions two and three and, instead, was used as a control variable. 
 Finally, this study limited its sample to hospitals located in six states, namely Arizona, 
California, Florida, Maryland, New Jersey, and New York and which were in operation from 
2007 until 2011. Additional future studies could be conducted with hospitals located in different 
states and evaluate different time periods to explore whether the study findings are generalizable 
to other health care markets and time periods. 
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Conclusion 
 This study used organizational theories to explore three research questions. First, research 
question one employed a two-level hierarchical generalized linear model to examine the 
organizational and environmental factors associated with the provision of hospital-based 
palliative care services. This study found that hospital size was significantly associated with a 
higher probability of hospital-based palliative care provision, whereas the presence of palliative 
care services through a hospital’s health system, network, or joint venture was associated with a 
lower probability of hospital-based palliative care provision.  
 Research questions two and three investigated whether hospitals that provide palliative 
care services have improved organizational and patient outcomes compared to those not 
providing such services; and whether a hospital’s experience in providing palliative care services 
is associated with improved organizational and patient outcomes. This study found that hospitals 
with an IPAL or HOSPC incurred lower hospital costs than hospitals that do not provide such 
services; hospitals with PAL incurred higher hospital costs than hospitals without such services.  
 Among survivors and decedents, the 1-year effects of IPAL were associated with shorter 
lengths of stay, whereas the remaining year effects of IPAL were associated with longer lengths 
of stay. Among decedents, while the 1-year effect of PAL was associated with longer lengths of 
stay, the fifth year effect was associated with shorter lengths of stay. In addition, the 1-year 
effect of PAL was not significantly associated with length of stay among survivors but the 
remaining year effects were associated with shorter lengths of stay. Finally, survivors treated in 
hospitals with HOSPC had longer lengths of stay. The presence of HOSPC was not significantly 
associated with length of stay among decedents.  
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 All year effects of PAL and HOSPC were associated with lower odds of in-hospital 
mortality. The 1-year effect of IPAL was associated with lower odds of in-hospital mortality but 
the effects of the third through fifth year indicated higher odds of in-hospital mortality.  
 While the 1-year effect of PAL was associated with higher odds of hospice transfer, the 
annual effects of the second through fifth year indicated incrementally lower odds of transfer to 
hospice. In addition, all year effects of IPAL suggested lower odds of hospice transfer. Finally, 
the first two year effects of HOSPC were associated with lower odds of hospice transfer, whereas 
the fifth year effect of HOSPC was associated with higher odds of hospice transfer.  
 Several sensitivity analyses were conducted to examine the robustness of these 
associations. In general, findings corresponding to research questions two and three were robust 
across model specifications. Further research is necessary to fully understand the association 
between hospital and environmental factors and the presence of individual palliative care 
services. 
 Although this study has several limitations, the study findings are relevant to hospital 
administrators and policy makers. Hospital administrators who plan to provide or expand 
hospital-based palliative care services may use the study findings to assist them in deciding 
which palliative care services are most appropriate for their patient population. Similarly, policy 
makers can use the study findings as a guidance for structuring incentive programs aiming to 
promote outcome-related quality measures that can be addressed effectively by palliative care. 
As the prevalence of hospital-based palliative care has been growing steadily since the beginning 
of the 21st century, an understanding of drivers of hospital provision of palliative care services 
and subsequent care outcomes offers valuable guidance for future efforts to assure access to 
palliative care and high quality of such services for patients with palliative care needs. 
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